Diet and Supplements
3.8K views | +3 today
Diet and Supplements
Dr. Alex Jimenez covers different diet and supplements plans for achieving overall wellness, including weight-loss, conditioning, and strengthening through healthy eating.  Book Appointment Today: https://bit.ly/Book-Online-Appointment
Your new post is loading...
Your new post is loading...
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
February 12, 2018 9:06 PM
Scoop.it!

Organic Diet: 5 Reasons Why

Organic Diet: 5 Reasons Why | Diet and Supplements | Scoop.it

Organic Diet: It seems our moms were right; we are what we eat. Unfortunately in today's marketplace, there are many valid worries about the foods we consume. Antibiotics, pesticides, and foods tainted with dangerous diseases are a top concern for many Americans. In addition, processed and genetically modified foods and artificial ingredients contribute to a number of health issues from obesity to cancer.

 

Our diet is one of the most important facets of maintaining overall good health for the long term. Farmer's markets, small grocery stores, and the movement toward organic labeling shows the trend toward making healthier food choices.

 

If you are thinking about adding a few organic foods to your meal plan, or chucking all processed foods altogether, you are moving toward a healthier, higher performing body with fewer health issues.

Organic Diet: Five Reasons Why

#1: Fewer Chemicals

The practice of using a variety of pesticides in non-organic farming is widespread in the United States. No matter how fastidiously you wash them, foods with these toxins are harmful to your body. A recent article in The Huffington Post stated that toxic pesticides are present in 70% of the food found in grocery stores!

 

Many large, traditional farms aim to produce as much food as possible, as cheaply as they can. They turn to pesticides and herbicides to make the crops grow faster and last longer. It's a sad fact, but the American public ends up paying a price anyway. An organic diet offers a respite from these chemically laden foods.

#2: Tastes Better

You may not even realize the taste you DON'T get when eating processed foods. Toxins that make them grow and keep them fresh deplete the taste dramatically.

 

Growing from properly maintained soil without the presence of pesticides, organic foods deliver a richer, more engaging flavor. Individuals who eat organic often eat less and are better satisfied with their meals because of the increased taste.

#3: More Nutrient Density

According to The Ideal Bite, organic foods contain up to 50% more nutrients than their non-organic counterparts. Depleted soil quality from over farming is a key reason for this situation. This means a person needs to eat less organic food to maintain the necessary dietary vitamins and minerals that ensures good health, offsetting the initial higher cost of choosing organic.

#4: Less Antibiotic Exposure

Large food manufacturing farms often choose to pump their animals full of antibiotics to reduce illness and promote rapid growth. Obviously, these make their way into the end product that we end up eating.

 

Too much exposure to antibiotics causes everything from early puberty in children to antibiotic resistance. If you become ill and require antibiotic medical treatment, long-term consumption of non-organic meat could literally hinder you from responding.

#5: Supports The Local Economy

In addition to building a strong body and mind, choosing organic contributes to the local community by supporting the small farmer. The small farmer is able to adopt to organic standards with less effort, and is more likely to embrace healthy soil practices and other ethical farming traits in the first place. Seek out local establishments for the widest variety of the freshest, locally grown food.

 

There are an assortment of reasons to choose an organic diet. In a nutshell, it is proven to offer great benefits to your long-term overall health. If you can't commit to an entirely organic diet, substitute a few organic choices from your present food selections. Even changing small areas of your diet will provide better taste, greater nutrition, and stronger well-being.

 

Have more questions? We’re here for you! Simply ask our Doctor of Chiropractic during your next visit how eating organic foods can benefit you.

Good Nutrition & Chiropractic Care Contribute To Overall Well-Being

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

El Paso, TX. Organic diet: There are many valid worries about the foods we consume. Antibiotics, pesticides, and foods tainted with dangerous diseases are a top concern for many Americans. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 22, 2017 6:24 PM
Scoop.it!

Physiology of Calcium for Heart Health | El Paso, TX Chiropractor | Call: 915-850-0900

Physiology of Calcium for Heart Health | El Paso, TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

Several research studies indicate that just about 30 percent of the United States population consumes the Recommended Dietary Allowance of calcium, which calls for approximately 1000 to 1200 milligrams on a regular daily basis. Furthermore, humans can absorb only about 30 percent of calcium from foods, based on the particular source. The body will in turn, demineralize its own skeletal system to maintain the proper serum calcium levels in scenarios where dietary calcium is inadequate and/or absorption is decreased, and/or excretion is increased.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Calcium is one of the most omnipresent mineral in the human body. While most is used by the bones, the rest circulates throughout the blood and soft tissues, as it plays fundamental roles in cell conduction, muscle function, hormone regulation and vitamin K-dependent pathways, as well as for proper cardiac and blood vessel function. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 15, 2017 8:14 PM
Scoop.it!

Drinks & Additional Compounds for Heart Health | El Paso TX Chiropractor | Call: 915-850-0900

Drinks & Additional Compounds for Heart Health | El Paso TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

If for no other reason, tea, coffee and cocoa, have been recognized within the medical field because, not only are they consumed worldwide, they are also important dietary sources of polyphenols (flavonols and cathechins). Several in vitro and in vivo studies have tried to elucidate the role of these foods, as well as various other compounds like pomegranate juice, and a large amount of experimental studies clearly indicated a beneficial effect of polyphenols in influencing cardiovascular disease. 

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

A diet rich in fruit, vegetables, complex carbohydrates, monounsaturated fat and fish, saturated fat and simple sugars, can play a fundamental role in protect against cardiovascular disease, or CVD. Cocoa, coffee and tea, unfairly not included in the “traditional healthy food basket”, have received much attention over the past few years for their effect on cardiovascular disease. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 13, 2017 6:23 PM
Scoop.it!

Effects of Lycopene in Cardiovascular Disease | El Paso, TX Chiropractor | Call: 915-850-0900

Effects of Lycopene in Cardiovascular Disease | El Paso, TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

Lycopene is a fat-soluble phytonutrient in the carotenoid family which has received attention because of its potential role in preventing cardiovascular diseases. Although similar in construction to the more studied β-carotene, lycopene doesn’t have provitamin A activity. Carotenoids and their many conjugated double bonds turns them into potentially strong antioxidants, and lycopene is no exception.

 

Sources include tomatoes, guava, pink grapefruit, watermelon, apricots and papaya in high concentrations. Tomato products, including ketchup, tomato juice, and pizza sauce, are the richest sources of lycopene in the United States diet, accounting for 80 percent of the lycopene consumption of Americans. Tomatoes also contain a significant amount of β-carotene. In fact, they are the fourth-leading contributor to provitamin A and vitamin A intake in the American diet. Tomatoes are rich in potassium and folate, and there is nearly 3 times as much vitamin C as lycopene in a tomato. In studies of health benefits of tomatoes, an individual has to consider that they are also rich in nutrients aside from lycopene.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Substantial evidence indicates that lycopene has significant antioxidant potential and may play a role in preventing cardiovascular disease as well as prostrate cancer in individuals. Lycopene is believed to possess a cholesterol synthesis-inhibiting effect and might enhance LDL cholesterol, or “bad cholesterol”, degradation. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 11, 2017 7:00 PM
Scoop.it!

The Role of Fiber in Cardiovascular Disease | El Paso, TX Chiropractor | Call: 915-850-0900

Many different definitions of fiber have been created to-date. In an attempt to create a single definition of fiber that everyone can utilize, the Nutrition and Food Board constructed a panel that came up with the following definitions:

 

Dietary fiber consists of non-digestible carbohydrates and lignin that are intrinsic and intact in plants. This includes plant non-starch polysaccharides (by way of example, cellulose, pectin, gums, hemicellulose, and fibers inside oat and wheat bran), oligosaccharides, lignin, and several forms of resistant starch.


Functional fiber consists of isolated, non-digestible carbohydrates which are beneficial in humans. These include non-digestible plant (for instance, resistant starch, pectin, and gums), chitin, chitosan, or commercially generated (by way of example, resistant starch, polydextrose, inulin, and indigestible dextrins) carbohydrates.


Total fiber is the sum of dietary fiber and functional fiber. It’s not important to differentiate between which types of the fibers you are getting in your daily dietary and nutritional program. Your total fiber intake is what matters.

 

Whichever definition is the most suitable to each individual, remember that fiber is an essential part of everyone’s diet. While fiber does fall under the category of carbohydrates, in comparison, it does not provide the same number of calories, nor is it processed the way that other sources of carbohydrates are. Fiber, however, can be further classified as soluble or insoluble.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Foods high in saturated and trans fats, for example, can lead to high blood pressure and cardiovascular disease. While vitamin and mineral deficiencies as well as the improper intake of other important compounds, like amino acids, have been linked to CVD, several research studies have found that fiber can have a tremendous influence in the risk of cardiovascular disease. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 7, 2017 6:23 PM
Scoop.it!

Omega 3-6-9 Fatty Acids and Cardiovascular Disease | El Paso TX Chiropractor | Call: 915-850-0900

Omega 3-6-9 Fatty Acids and Cardiovascular Disease | El Paso TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

Since the original American Heart Association, or the AHA, Science Advisory was published in 1996, several fundamental new findings have been reported about the benefits of omega fatty acids on cardiovascular disease, CVD, particularly that of omega-3 fatty acids. The evidence supporting the clinical benefits of omega fatty acids and CVD comes from a variety of research studies as well as randomized, controlled trials.

 

How are omega fatty acids beneficial for cardiovascular disease?

Large-scale epidemiologic studies suggest that people at risk for coronary heart disease, or CHD, benefit from consuming omega-3 fatty acids from plants and marine sources. Further research studies suggest that both omega 3 and omega 6 fatty acids are most essential towards improving heart health, although omega-9 fatty acids also provide beneficial properties for individuals with CVD, CHD and hypertension.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Cardiovascular disease is often the result of an improper diet, however, research has demonstrated that a balanced nutrition, rich in omega fatty acids can improve cardiovascular disease. Omega fatty acids can help reduce high blood pressure. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
November 6, 2017 5:35 PM
Scoop.it!

Dietary Strategies: Prevention/Treatment Of Metabolic Syndrome

Dietary Strategies: Prevention/Treatment Of Metabolic Syndrome | Diet and Supplements | Scoop.it

Dietary Strategies:

 

Abstract: Metabolic syndrome (MetS) is established as the combination of central obesity and different metabolic disturbances, such as insulin resistance, hypertension and dyslipidemia. This cluster of factors affects approximately 10%–50% of adults worldwide and the prevalence has been increasing in epidemic proportions over the last years. Thus, dietary strategies to treat this heterogenic disease are under continuous study. In this sense, diets based on negative-energy-balance, the Mediterranean dietary pattern, n-3 fatty acids, total antioxidant capacity and meal frequency have been suggested as effective approaches to treat MetS. Furthermore, the type and percentage of carbohydrates, the glycemic index or glycemic load, and dietary fiber content are some of the most relevant aspects related to insulin resistance and impaired glucose tolerance, which are important co-morbidities of MetS. Finally, new studies focused on the molecular action of specific nutritional bioactive compounds with positive effects on the MetS are currently an objective of scientific research worldwide. The present review summarizes some of the most relevant dietary approaches and bioactive compounds employed in the treatment of the MetS to date.

 

Keywords: metabolic syndrome; dietary strategies; bioactive compounds

1. Metabolic Syndrome

It was during the period between 1910 and 1920 when it was suggested for the first time that a cluster of associated metabolic disturbances tended to coexist together [1]. Since then, different health organisms have suggested diverse definitions for metabolic syndrome (MetS) but there has not yet been a well-established consensus. The most common definitions are summarized in Table 1. What is clear for all of these is that the MetS is a clinical entity of substantial heterogeneity, commonly represented by the combination of obesity (especially abdominal obesity), hyperglycemia, dyslipidemia and/or hypertension [2–6].

 

Obesity consists of an abnormal or excessive fat accumulation, for which the main cause is a chronic imbalance between energy intake and energy expenditure [7,8]. The excess of energy consumed is primarily deposited in the adipose tissue as triglycerides (TG) [9].

 

Dyslipidemia encompasses elevated serum TG levels, increased low density lipoprotein- cholesterol (LDL-c) particles, and reduced levels of high density lipoprotein-cholesterol (HDL-c) [10]. It is associated with hepatic steatosis [11], dysfunction of pancreatic β-cells [12] and elevated risk of atherosclerosis [13], among others.

 

Another main modifiable MetS manifestation is hypertension, which is mainly defined as a resting systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg or drug prescription to lower hypertension [14]. It usually involves narrowed arteries and is identified as a major cardiovascular and renal risk factor, related to heart and vascular disease, stroke and myocardial infarction [13,15–17].

 

Hyperglycemia, related insulin resistance and type 2 diabetes mellitus are characterized by an impaired uptake of glucose by the cells, that lead to elevated plasma glucose levels, glycosuria and ketoacidosis [18]. It is responsible for different tissue damage that shortens the life expectancy of diabetics, involving cardiovascular diseases (CVD), atherosclerosis, hypertension [19], β-cell dysfunction [12], kidney disease [20] or blindness [21]. Currently, diabetes is considered the leading cause of death in developed countries [22].

 

Moreover, oxidative stress and low grade inflammation are two important mechanisms implicated in the etiology, pathogenesis, and development of MetS [23]. Oxidative stress is defined as an imbalance between the pro-oxidants and antioxidants in the body [24]. It plays a key role in the development of atherosclerosis by different mechanisms such as the oxidation of LDL-c particles [25] or impairment of HDL-c functions [26]. Inflammation is an immune system response to injury hypothesized to be a major mechanism in the pathogenesis and progression of obesity related disorders and the link between adiposity, insulin resistance, MetS and CVD [27].

 

Although the prevalence of the MetS varies broadly around the word and depends on the source used for its definition, it is clear that over the last 40–50 years the number of people presenting with this syndrome has risen in epidemic proportions [28]. Moreover, the frequency of this syndrome is increased in developed countries, sedentary people, smokers, low socioeconomic status population, as well as in individuals with unhealthy dietary habits [29,30].

 

For all of this, there is currently a wide concern to find effective strategies to detect, treat and control the comorbidities associated with MetS. This is a complex challenge as MetS is a clinical entity of substantial heterogeneity and therefore, the different cornerstones implicated in its development should be addressed. In this review we compiled and examined different dietary patterns and bioactive compounds that have pointed out to be effective in MetS treatment.

2. Dietary Patterns

Several dietary strategies and their potential positive effects on the prevention and treatment of the different metabolic complications associated to the MetS, are described below and summarized in Table 2.

2.1. Energy-Restricted Diet Strategies

Energy restricted diets are probably the most commonly used and studied dietary strategies for combating excess weight and related comorbidities. They consist in personalized regimes that supply less calories than the total energy expended by a specific individual [31].

 

A hypocaloric diet results in a negative energy balance and subsequently, in body weight reduction [31]. Weight loss is achieved via fat mobilization from different body compartments as a consequence of the lipolysis process necessary to provide energy substrate [32,33]. In people who are overweight or suffering from obesity, as is the case of most people with MetS, weight loss is important as it is associated with improvement of related disorders such as abdominal obesity (visceral adipose tissue), type 2 diabetes, CVD or inflammation [32–36].

 

Moreover, as described above, low grade inflammation is associated with MetS and obesity. Therefore, of particular importance is the fact that in obese individuals following a hypocaloric diet, a depletion of plasma inflammatory markers such as interleukin (IL)-6 has been observed [34]. Thus, caloric restriction in obese people suffering MetS may improve the whole-body pro-inflammatory state.

 

At the same time, body weight reduction is associated with improvements in cellular insulin signal transduction, increments in peripheral insulin sensitivity and higher robustness in insulin secretory responses [32,36]. People with excess body weight who are at risk of developing type 2 diabetes, may benefit from a hypocaloric regime by improving plasma glucose levels and insulin resistance.

 

In addition, different intervention trials have reported a relationship between energy restricted diets and lower risk of developing CVD. In this sense, in studies with obese people following a hypocaloric diet, improvements in lipid profile variables such as reductions of LDL-c and plasma TG levels, as well as improvements in hypertension via depletion of SBP and DBP levels have been observed [35,37].

 

Among the different nutritional intervention trials, a reduction of 500–600 kcal a day of the energy requirements is a well-established hypocaloric dietary strategy, which has demonstrated to be effective in weight reduction [38,39]. However, the challenge lies in maintaining the weight loss over time, as many subjects can follow a prescribed diet for a few months, but most people have difficulty in maintaining the acquired habits over the long term [40,41].

2.2. Diets Rich in Omega-3 Fatty Acids

The very long-chain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential omega-3 polyunsaturated fatty acids (n-3 PUFAs) for human physiology. Their main dietary sources are fish and algal oils and fatty fish, but they can also be synthesized by humans from α-linolenic acid [40].

 

There is a moderate body of evidence suggesting that n-3 PUFAs, mainly EPA and DHA, have a positive role in the prevention and treatment of the pathologies associated to MetS [42].

 

In this context, it has been described that EPA and DHA have the ability to reduce the risk of developing CVD and cardiometabolic abnormalities as well as CVD-related mortality [42]. These beneficial effects are thought to be mainly due to the ability of these essential fatty acids to reduce plasma TG levels [43].

 

Moreover, different studies have shown that people following an increased n-3 PUFA diet have reduced plasma levels of the pro-inflammatory cytokines IL-6 and tumor necrosis factor-alpha (TNFα), as well as plasma C-reactive protein (CRP) [44]. These effects are probably mediated by resolvins, maresins and protectins, which are EPA and DHA metabolic products with anti-inflammatory properties [44].

 

There are some studies that have observed an association between n-3 ingestion and improvements or prevention of type 2 diabetes development. However, other studies found opposite results [44]. Thus, it cannot be made any specific affirmation in this respect.

 

The European Food Safety Authority recommends and intake of 250 mg EPA + DHA a day, in the general healthy population as a primary prevention of CVD [45]. These amounts can be achieved with an ingestion of 1–2 fatty fish meals per week [45].

2.3. Diets Based on Low Glycemic Index/Load

Over the last ten years, the concern about the quality of the carbohydrates (CHO) consumed has risen [46]. In this context, the glycemic index (GI) is used as a CHO quality measure. It consists in a ranking on a scale from 0 to 100 that classifies carbohydrate-containing foods according to the postprandial glucose response [47]. The higher the index, the more promptly the postprandial serum glucose rises and the more rapid the insulin response. A quick insulin response leads to rapid hypoglycemia, which is suggested to be associated with an increment of the feeling of hunger and to a subsequent higher caloric intake [47]. The glycemic load (GL) is equal to the GI multiplied by the number of grams of CHO in a serving [48].

 

There is a theory which states that MetS is a consequence of an elevated intake of high GI foods over time, among others unhealthy dietary habits [49]. In this sense, following a diet rich in high GI CHO has been associated with hyperglycemia, insulin resistance, type 2 diabetes, hypertriglyceridemia, CVD, and obesity [47,50,51], abnormalities directly related to MetS.

 

On the contrary, a low GI diet has been associated with slower absorption of the CHO and subsequently smaller blood glucose fluctuations, which indicate better glycemic control [46]. In patients with type 2 diabetes, diets based on low GI are associated with reductions in glycated hemoglobin (HbA1c) and fructosamine blood levels, two biomarkers used as key monitoring factors in diabetes management [52,53].

 

For all of this, it is common to find the limitation of CHO at high GI among the advice for MetS treatment [28], in particular with respect to “ready-to-eat processed foods” including sweetened beverages, soft drinks, cookies, cakes, candy, juice drinks, and other foods which contain high amounts of added sugars [54].

2.4. Diets with High Total Antioxidant Capacity

Dietary total antioxidant capacity (TAC) is an indicator of diet quality defined as the sum of antioxidant activities of the pool of antioxidants present in a food [55]. These antioxidants have the capacity to act as scavengers of free radicals and other reactive species produced in the organisms [56]. Taking into account that oxidative stress is one of the remarkable unfortunate physiological states of MetS, dietary antioxidants are of main interest in the prevention and treatment of this multifactorial disorder [57]. Accordingly, it is well-accepted that diets with a high content of spices, herbs, fruits, vegetables, nuts and chocolate, are associated with a decreased risk of oxidative stress-related diseases development [58–60]. Moreover, several studies have analyzed the effects of dietary TAC in individuals suffering from MetS or related diseases [61,62]. In the Tehran Lipid and Glucose Study it was demonstrated that a high TAC has beneficial effects on metabolic disorders and especially prevents weight and abdominal fat gain [61]. In the same line, research conducted in our institutions also evidenced that beneficial effects on body weight, oxidative stress biomarkers and other MetS features were positively related with higher TAC consumption in patients suffering from MetS [63–65].

 

In this sense, the World Health Organization (WHO) recommendation for fruit and vegetables consumption (high TAC foods) for the general population is a minimum of 400 g a day [66]. Moreover, cooking with spices is recommended in order to increase the TAC dietary intake and, at the same time, maintain flavor while reducing salt [67].

2.5. Moderate-High Protein Diets

The macronutrient distribution set in a weight loss dietary plan has commonly been 50%–55% total caloric value from CHO, 15% from proteins and 30% from lipids [57,68]. However, as most people have difficulty in maintaining weight loss achievements over time [69,70], research on increment of protein intake (>20%) at the expense of CHO was carried out [71–77].

 

Two mechanisms have been proposed to explain the potential beneficial effects of high-moderate protein diets: the increment of diet-induced thermogenesis [73] and the increase of satiety [78]. The increment of the thermogenesis is explained by the synthesis of peptide bonds, production of urea and gluconeogenesis, which are processes with a higher energy requirement than the metabolism of lipids or CHO [75]. An increment of different appetite-control hormones such as insulin, cholecystokinin or glucagon-like peptide 1, may clarify the satiety effect [79].

 

Other beneficial effects attributed to moderate-high protein diets in the literature are the improvement of glucose homeostasis [80], the possibility of lower blood lipids [81], the reduction of blood pressure [82], the preservation of lean body mass [83] or the lower of cardiometabolic disease risk [84,85]. However, there are other studies that have not found benefits associated to a moderate-high protein diet [76]. This fact may be explained by the different type of proteins and their amino acid composition [80], as well as by the different type of populations included in each study [85]. Therefore, more research in the field is needed in order to make these results consistent.

 

In any case, when a hypocaloric diet is implemented, it is necessary to slightly increase the amount of proteins. Otherwise it would be difficult to reach the protein energy requirements, established as 0.83 g/kg/day for isocaloric diets and which should probably be at least 1 g/kg/day for energy-restricted diets [86].

2.6. High Meal Frequency Pattern

The pattern of increasing meal frequency in weight loss and weight control interventions has currently become popular among professionals [87,88]. The idea is to distribute the total daily energy intake into more frequently and smaller meals. However, there is no strong evidence about the efficacy of this habit yet [89]. While some investigations have found an inverse association between the increment of meals per day and body weight, body mass index (BMI), fat mass percentage or metabolic diseases such as coronary heart disease or type 2 diabetes [71,88,90–92], others have found no association [93–95].

 

Different mechanisms by which high meal frequency can have a positive effect on weight and metabolism management have been proposed. An increment of energy expenditure was hypothesized; however, the studies carried out in this line have concluded that total energy expenditure does not differ among different meal frequencies [96,97]. Another postulated hypothesis is that the greater the number of meals a day, the higher the fat oxidation, but again no consensus has been achieved [89,98]. An additional suggested mechanism is that increasing meal frequency leads to plasma glucose levels with lower oscillations and reduced insulin secretion which is thought to contribute to a better appetite control. However, these associations have been found in population with overweight or high glucose levels but in normal-weight or normoglycaemic individuals the results are still inconsistent [93,99–101].

2.7. The Mediterranean Diet

The concept of the Mediterranean Diet (MedDiet) was for the first time defined by the scientific Ancel Keys who observed that those countries around the Mediterranean Sea, which had a characteristic diet, had less risk of suffering coronary heart diseases [102,103].

 

The traditional MedDiet is characterized by a high intake of extra-virgin olive oil and plant foods (fruits, vegetables, cereals, whole grains, legumes, tree nuts, seeds and olives), low intakes of sweets and red meat and moderate consumption of dairy products, fish and red wine [104].

 

There is a lot of literature supporting the general health benefits of the MedDiet. In this sense, it has been reported that a high adherence to this dietary pattern protects against mortality and morbidity from several causes [105]. Thus, different studies suggested the MedDiet as a successful tool for the prevention and treatment of MetS and related comorbidities [106–108]. Moreover, recent meta-analysis concluded that the MedDiet is associated with less risk of developing type 2 diabetes and with a better glycemic control in people with this metabolic disorder [107,109,110]. Other studies have found a positive correlation between the adherence to a MedDiet pattern and reduced risk of developing CVD [111–114]. In fact, many studies have found a positive association between following a MedDiet and improvements in lipid profile by reduction of total cholesterol, LDL-c and TG, and an increase in HDL-c [111–115]. Finally, different studies also suggest that the MedDiet pattern may be a good strategy for obesity treatment as it has been associated with significant reductions in body weight and waist circumference [108,116,117].

 

The high amount of fiber which, among other beneficial effects, helps to weight control providing satiety; and the high antioxidants and anti-inflammatory nutrients such as n-3 fatty acids, oleic acid or phenolic compounds, are thought to be the main contributors to the positive effects attributed to the MedDiet [118].

 

For all these reasons, efforts to maintain the MedDiet pattern in Mediterranean countries and to implement this dietary habits in westernized countries with unhealthy nutritional patterns should be made.

3. Dietary: Single Nutrients and Bioactive Compounds

New studies focused on the molecular action of nutritional bioactive compounds with positive effects on MetS are currently an objective of scientific research worldwide with the aim of designing more personalized strategies in the framework of molecular nutrition. Among them, flavonoids and antioxidant vitamins are some of the most studied compounds with different potential benefits such as antioxidant, vasodilatory, anti-atherogenic, antithrombotic, and anti-inflammatory effects [119]. Table 3 summarizes different nutritional bioactive compounds with potential positive effects on MetS, including the possible molecular mechanism of action involved.

 

3.1. Ascorbate

Vitamin C, ascorbic acid or ascorbate is an essential nutrient as human beings cannot synthesize it. It is a water-soluble antioxidant mainly found in fruits, especially citrus (lemon, orange), and vegetables (pepper, kale) [120]. Several beneficial effects have been associated to this vitamin such as antioxidant and anti-inflammatory properties and prevention or treatment of CVD and type 2 diabetes [121–123].

 

This dietary component produces its antioxidant effect primarily by quenching damaging free radicals and other reactive oxygen and nitrogen species and therefore preventing molecules such as LDL-c from oxidation [122]. It can also regenerate other oxidized antioxidants like tocopherol [124].

 

Moreover, it has been described that ascorbic acid may reduce inflammation as it is associated with depletion of CRP levels [125]. This is an important outcome to take in consideration in the treatment of MetS sufferers, as they usually present low grade inflammation [27].

 

Supplementation with vitamin C have also been associated with prevention of CVD by improving the endothelial function [126] and probably by lowering blood pressure [121]. These effects are thought to be exerted by the ability of vitamin C to enhance the endothelial nitric oxide synthase enzyme (eNOS) activity and to reduce HDL-c glycation [127].

 

Additionally, several studies have attributed to ascorbate supplementation an antidiabetic effect by improving whole body insulin sensitivity and glucose control in people with type 2 diabetes [123]. These antidiabetic properties are thought to be mediated by optimization of the insulin secretory function of the pancreatic islet cells by increasing muscle sodium-dependent vitamin C transporters (SVCTs) [128].

 

Despite all of this, it should be taken into account that most people reach ascorbic acid requirements (established at 95–110 mg/day in the general population) from diet and do not need supplementation [122,129]. Besides, it should be considered that an excess of vitamin C ingestion leads to the opposite effect and oxidative particles are formed [130,131].

3.2. Hydroxytyrosol

Hydroxytyrosol (3,4-dihydroxyphenylethanol) is a phenolic compound mainly found in olives [132].

 

It is considered the strongest antioxidant of olive oil and one of the main antioxidants in nature [133]. It acts as a powerful scavenger of free radicals, as a radical chain breaker and as metal chelator [134]. It has the ability of inhibiting LDL-c oxidation by macrophages [132]. In this sense, it is the only phenol recognized by the European Food Safety Authority (EFSA) as a protector of blood lipids from oxidative damage [135].

 

Hydroxytyrosol has also been reported to have anti-inflammatory effects, probably by suppressing cyclooxygenase activity and inducing eNOS expression [136]. Thus, enhancement of olives/olive oil intakes or hydroxytyroxol supplementation in people suffering from MetS may be a good strategy in order to improve inflammatory status.

 

Another beneficial effect attributed to this phenolic compound is its cardiovascular protective effect. It presents anti-atherogenic properties by decreasing the expression of vascular cell adhesion protein 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) [132,137], which are probably the result of an inactivation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), activator protein 1 (AP-1), GATA transcription factor and nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase [138,139]. Hydroxytyrosol also provides antidyslipidemic effects by lowering plasma levels of LDL-c, total cholesterol and TG, and by rising HDL-c [138].

 

Despite the beneficial effects attributed to hydfroxytyrosol as an antioxidant, for its antiinflamatory properties and as cardiovascular protector, it should be taken into account that most studies focused on this compound have been performed with mixtures of olive phenols, thus a synergic effect cannot be excluded [140].

3.3. Quercetin

Quercetin is a predominant flavanol naturally present in vegetables, fruits, green tea or red wine. It is commonly found as glycoside forms, where rutin is the most common and important structure found in nature [141].

 

Many beneficial effects that can contribute to MetS improvement have been attributed to quercetin. Among them, its antioxidant capacity should be highlighted, as it has been reported to inhibit lipid peroxidation and increase antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) or glutathione peroxidase (GPX) [142].

 

Moreover, an anti-inflammatory effect mediated via attenuation of tumor necrosis factor α (TNF-α), NFκB and mitogen-activated protein kinases (MAPK), as well as depletion of IL-6, IL-1β, IL-8 or monocyte chemoattractant protein-1 (MCP-1) gene expression has also been attributed to this polyphenol [143].

 

As most people with MetS are overweight or obese, the role of quercetin in body weight reduction and obesity prevention has been of special interest. In this sense, it stands out the capacity of quercetin to inhibit adipogenesis through inducing the activation of AMP-activated protein kinase (AMPK) and decreasing the expression of CCAAT-enhancer-binding protein-α (C/EBPα), peroxisome proliferator-activated receptor gamma (PPARγ), and sterol regulatory element-binding protein 1 (SREBP-1) [141,144].

 

According to the antidiabetic effects, it is proposed that quercetin may act as an agonist of peroxisome proliferator-activated receptor gamma (PPARγ), and thus improve insulin-stimulated glucose uptake in mature adipocytes [145]. Moreover, quercetin may ameliorate hyperglycemia by inhibiting glucose transporter 2 (GLUT2) and insulin dependent phosphatidylinositol-3-kinase (PI3K) and blocking tyrosine kinase (TK) [142].

 

Finally, different studies observed that quercetin has the ability to reduce blood pressure [146–148]. However, the mechanisms of action are not clear, since some authors have suggested that quercetin increases eNOS, contributing to inhibition of platelet aggregation and improvement of the endothelial function [146,147], but there are other studies that have not come across these results [148].

3.4. Resveratrol

Resveratrol (3,5,4′-trihidroxiestilben) is a phenolic compound mainly found in red grapes and derived products (red wine, grape juice) [149]. It has shown antioxidant and anti-inflammatory activities, and cardioprotective, anti-obesity and antidiabetic capacities [150–156].

 

The antioxidant effects of resveratrol have been reported to be carried out by scavenging of hydroxyl, superoxide, and metal-induced radicals as well as by antioxidant effects in cells producing reactive oxygen species (ROS) [150].

 

Moreover, it has been reported that the anti-inflammatory effects of resveratrol are mediated by inhibiting NFκB signaling [151]. Furthermore, this polyphenol reduces the expression of proinflammatory cytokines such as interleukin 6 (IL-6), interleukin 8 (IL-8), TNF-α, monocyte chemoattractant protein-1 (MCP-1) and eNOS [152]. In addition, resveratrol inhibits the cyclooxygenase (COX) expression and activity, a pathway involved in the synthesis of proinflammatory lipid mediators [152].

 

Concerning the effects of resveratrol against development of type 2 diabetes, it has been reported that treatment of diabetes patients with this polyphenol provides significant improvements in the status of multiple clinically relevant biomarkers such as fasting glucose levels, insulin concentrations or glycated hemoglobin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) [153,154].

 

Additionally, cardioprotective effects have been attributed to resveratrol. In this sense, it is suggested that resveratrol improves the endothelial function by producing nitric oxide (NO) through increasing the activity and expression of eNOS. This effect is thought to be conducted through activation of nicotinamide adenine dinucleotide-dependent deacetylase sirtuin-1 (Sirt 1) and 5′ AMP-activated protein kinase (AMPK) [155]. Besides, resveratrol exerts endothelial protection by stimulation of NF-E2-related factor 2 (Nrf2) [156] and decreasing the expression of adhesion proteins such as ICAM-1 and VCAM-1 [152].

 

Finally, it has been described that resveratrol may have a role in preventing obesity as it has been related with energy metabolism improvement, increasing lipolysis and reducing lipogenesis [157]. However, more studies are needed in order to corroborate these findings.

3.5. Tocopherol

Tocopherols, also known as vitamin E, are a family of eight fat-soluble phenolic compounds whose main dietary sources are vegetable oils, nuts and seeds [130,158].

 

For a long time, it has been suggested that vitamin E could prevent different metabolic diseases as a potent antioxidant, acting as scavenger of lipid peroxyl radicals by hydrogen donating [159]. In this sense, it was described that tocopherols inhibit peroxidation of membrane phospholipids and prevent generation of free radicals in cell membranes [160].

 

Moreover, it has been shown that supplementation with α-tocopherol or γ-tocopherol, two of the different isoforms of vitamin E, could have an effect on inflammation status by reducing CRP levels [161]. Additionally, inhibition of COX and protein kinase C (PKC) and reduction of cytokines such as IL-8 or plasminogen activator inhibitor-1 (PAI-1) are other mechanisms that may contribute to these anti-inflammatory effects [162,163].

 

However, the beneficial effects attributed to this vitamin previously have lately became controversial as different clinical trials have not come across such benefits, but ineffective or even harmful effects have been observed [164]. It has been recently suggested that this may be explained by the fact that vitamin E may lose most of the antioxidant capacity when ingested by human beings through different mechanisms [162].

3.6. Anthocyanins

Anthocyanins are water-soluble polyphenolic compounds responsible for the red, blue and purple colors of berries, black currants, black grapes, peaches, cherries, plums, pomegranate, eggplant, black beans, red radishes, red onions, red cabbage, purple corn or purple sweet potatoes [165–167]. Actually, they are the most abundant polyphenols in fruits and vegetables [167]. Moreover, they can also be found in teas, honey, nuts, olive oil, cocoa, and cereals [168].

 

These compounds have high antioxidant capacity inhibiting or decreasing free radicals by donating or transferring electrons from hydrogen atoms [167].

 

Regarding clinical studies, it has been shown that these bioactive compounds may prevent type 2 diabetes development by improving insulin sensitivity [169]. The exact mechanisms by which anthocyanins exert their antidiabetic effect are not yet clear, but an enhancement of the glucose uptake by muscle and adipocyte cells in an insulin-independent manner has been suggested [169].

 

Moreover, it has been shown that anthocyanins may have the capacity to prevent CVD development by improving endothelial function via increasing brachial artery flow-mediated dilation and HDL-c, and decreasing serum VCAM-1 and LDL-c concentrations [170–173].

 

Finally, these polyphenolic compounds may exert anti-inflamatory effects via reducing proinflamatory molecules such as IL-8, IL-1β or CRP [172,174].

 

However, most studies have used anthocyanin-rich extracts instead of purified anthocyanins; thus, a synergic effect with other polyphenols cannot be discarded.

3.7. Catechins

Catechins are polyphenols that can be found in a variety of foods including fruits, vegetables, chocolate, wine, and tea [175]. The epigallocatechin 3-gallate present in tea leaves is the catechin class most studied [176].

 

Anti-obesity effects have been attributed to these polyphenols in different studies [176]. The mechanisms of action suggested to explain these beneficial effects on body weight are: increasing energy expenditure and fat oxidation, and reducing fat absorption [177]. It is thought that energy expenditure is enhanced by catechol-O-methyltransferase and phosphodiesterase inhibition, which stimulates the sympathetic nervous system causing an activation of the brown adipose tissue [178]. Fat oxidation is mediated by upregulation of acyl-CoA dehydrogenase and peroxisomal b-oxidation enzymes [178,179].

 

Moreover, catechin intake has also been associated with lower risk of CVD development by improving lipid biomarkers. Thus, it has been reported that consumption of this kind of polyphenols may increase HDL-c and decrease LDL-c and total cholesterol [180].

 

Finally, and antidiabetic effect has also been related to catechin comsumption, lowering fasting glucose levels [175] and improving insulin sensitivity [178].

4. Conclusions

As the prevalence of MetS reaches epidemic rates, the finding of an effective and easy-to-follow dietary strategy to combat this heterogenic disease is still a pending subject. This work recompiled different dietary nutrients and nutritional patterns with potential benefits in the prevention and treatment of MetS and related comorbidities (Figure 1) with the aim of facilitating future clinical studies in this area. The challenge now is to introduce precision bioactive compounds in personalized nutritional patterns in order to gain the most benefits for prevention and treatment of this disease through nutrition.

 

Conflicts of Interest: The authors declare no conflict of interest.

 

1. Sarafidis, P.A.; Nilsson, P.M. The metabolic syndrome: A glance at its history. J. Hypertens. 2006, 24, 621–626.
[CrossRef] [PubMed]
2. Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications.
Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
Diabet. Med. 1998, 15, 539–553. [CrossRef]
3. Balkau, B.; Charles, M.A. Comment on the provisional report from the WHO consultation. European Group
for the Study of Insulin Resistance (EGIR). Diabet. Med. 1999, 16, 442–423. [PubMed]
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive
Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA
2001, 285, 2486–2497.
5. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.;
Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome:
An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation
2005, 112, 2735–2752. [CrossRef] [PubMed]
6. Alberti, K.G.; Zimmet, P.; Shaw, J. The metabolic syndrome—A new worldwide definition. Lancet 2005, 366,
1059–1062. [CrossRef]
7. Selassie, M.; Sinha, A.C. The epidemiology and aetiology of obesity: A global challenge. Best Pract. Res.
Clin. Anaesthesiol. 2011, 25, 1–9. [CrossRef] [PubMed]
8. WHO, W.H.O. Available online: http://www.who.int/mediacentre/factsheets/fs311/es/ (accessed on
4 June 2016).
9. Shimano, H. Novel qualitative aspects of tissue fatty acids related to metabolic regulation: Lessons from
Elovl6 knockout. Prog. Lipid Res. 2012, 51, 267–271. [CrossRef] [PubMed]
10. Bosomworth, N.J. Approach to identifying and managing atherogenic dyslipidemia: A metabolic
consequence of obesity and diabetes. Can. Fam. Phys. 2013, 59, 1169–1180.
11. Vidal-Puig, A. The Metabolic Syndrome and its Complex Pathophysiology. In A Systems Biology Approach to
Study Metabolic Syndrome; Oresic, M., Ed.; Springer: New York, NY, USA, 2014; pp. 3–16.
12. Poitout, V.; Robertson, R.P. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr. Rev. 2008, 29,
351–366. [CrossRef] [PubMed]
13. Rizza, W.; Veronese, N.; Fontana, L. What are the roles of calorie restriction and diet quality in promoting
healthy longevity? Ageing Res. Rev. 2014, 13, 38–45. [CrossRef] [PubMed]
14. Lloyd-Jones, D.M.; Levy, D. Epidemiology of Hypertension. In Hypertension: A Companion to Braunwald’s
Heart Disease; Black, H.R., Elliott, W.J., Eds.; Elsevier: Philadephia, PA, USA, 2013; pp. 1–11.
15. Zanchetti, A. Challenges in hypertension: Prevalence, definition, mechanisms and management. J. Hypertens.
2014, 32, 451–453. [CrossRef] [PubMed]
16. Thomas, G.; Shishehbor, M.; Brill, D.; Nally, J.V., Jr. New hypertension guidelines: One size fits most?
Clevel. Clin. J. Med. 2014, 81, 178–188. [CrossRef] [PubMed]
17. James, P.A.; Oparil, S.; Carter, B.L.; Cushman, W.C.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, D.T.;
LeFevre, M.L.; MacKenzie, T.D.; Ogedegbe, O.; et al. 2014 evidence-based guideline for the management
of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National
Committee (JNC 8). JAMA 2014, 311, 507–520. [CrossRef] [PubMed]
18. Klandorf, H.; Chirra, A.R.; DeGruccio, A.; Girman, D.J. Dimethyl sulfoxide modulation of diabetes onset in
NOD mice. Diabetes 1989, 38, 194–197. [CrossRef] [PubMed]
19. Ballard, K.D.; Mah, E.; Guo, Y.; Pei, R.; Volek, J.S.; Bruno, R.S. Low-fat milk ingestion prevents postprandial
hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic
syndrome. J. Nutr. 2013, 143, 1602–1610. [CrossRef] [PubMed]
20. Pugliese, G.; Solini, A.; Bonora, E.; Orsi, E.; Zerbini, G.; Fondelli, C.; Gruden, G.; Cavalot, F.; Lamacchia, O.;
Trevisan, R.; et al. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes
according to different classification systems for chronic kidney disease: A cross-sectional analysis of the
renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc. Diabetol. 2014,
13, 59. [PubMed]
21. Asif, M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J. Educ.
Health Promot. 2014, 3, 1. [CrossRef] [PubMed]
22. Russell, W.R.; Baka, A.; Bjorck, I.; Delzenne, N.; Gao, D.; Griffiths, H.R.; Hadjilucas, E.; Juvonen, K.;
Lahtinen, S.; Lansink, M.; et al. Impact of Diet Composition on Blood Glucose Regulation. Crit. Rev. Food
Sci. Nutr. 2016, 56, 541–590. [CrossRef] [PubMed]
23. Soares, R.; Costa, C. Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome; Springer:
Heidelberg, Germany, 2009.
24. Rahal, A.; Kumar, A.; Singh, V.; Yadav, B.; Tiwari, R.; Chakraborty, S.; Dhama, K. Oxidative Stress,
Prooxidants, and Antioxidants: The Interplay. BioMed Res. Int. 2014, 2014, 761264. [CrossRef] [PubMed]
25. Parthasarathy, S.; Litvinov, D.; Selvarajan, K.; Garelnabi, M. Lipid peroxidation and decomposition—Conflicting
roles in plaque vulnerability and stability. Biochim. Biophys. Acta 2008, 1781, 221–231. [CrossRef] [PubMed]
26. McGrowder, D.; Riley, C.; Morrison, E.Y.; Gordon, L. The role of high-density lipoproteins in reducing the
risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011, 2011, 496925. [CrossRef]
[PubMed]
27. Ferri, N.; Ruscica, M. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome:
Insights on insulin resistance, inflammation, and atherogenic dyslipidemia. Endocrine 2016. [CrossRef]
28. Oresic, M.; Vidal-Puig, A. A Systems Biology Approach to Study Metabolic Syndrome; Springer: Heidelberg,
Germany, 2014.
29. Lee, E.G.; Choi, J.H.; Kim, K.E.; Kim, J.H. Effects of a Walking Program on Self-management and Risk Factors
of Metabolic Syndrome in Older Korean Adults. J. Phys. Ther. Sci. 2014, 26, 105–109. [CrossRef] [PubMed]
30. Bernabe, G.J.; Zafrilla, R.P.; Mulero, C.J.; Gomez, J.P.; Leal, H.M.; Abellan, A.J. Biochemical and nutritional
markers and antioxidant activity in metabolic syndrome. Endocrinol. Nutr. 2013, 61, 302–308.
31. Bales, C.W.; Kraus, W.E. Caloric restriction: Implications for human cardiometabolic health. J. Cardiopulm.
Rehabil. Prev. 2013, 33, 201–208. [CrossRef] [PubMed]
32. Grams, J.; Garvey, W.T. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle
Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr. Obes. Rep. 2015, 4, 287–302.
[CrossRef] [PubMed]
33. Lazo, M.; Solga, S.F.; Horska, A.; Bonekamp, S.; Diehl, A.M.; Brancati, F.L.; Wagenknecht, L.E.; Pi-Sunyer, F.X.;
Kahn, S.E.; Clark, J.M. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with
type 2 diabetes. Diabetes Care 2010, 33, 2156–2163. [CrossRef] [PubMed]
34. Rossmeislova, L.; Malisova, L.; Kracmerova, J.; Stich, V. Adaptation of human adipose tissue to hypocaloric
diet. Int. J. Obes. 2013, 37, 640–650. [CrossRef] [PubMed]
35. Wing, R.R.; Lang, W.; Wadden, T.A.; Safford, M.; Knowler, W.C.; Bertoni, A.G.; Hill, J.O.; Brancati, F.L.;
Peters, A.; Wagenknecht, L. Benefits of modest weight loss in improving cardiovascular risk factors in
overweight and obese individuals with type 2 diabetes. Diabetes Care 2011, 34, 1481–1486. [CrossRef]
[PubMed]
36. Golay, A.; Brock, E.; Gabriel, R.; Konrad, T.; Lalic, N.; Laville, M.; Mingrone, G.; Petrie, J.; Phan, T.M.;
Pietilainen, K.H.; et al. Taking small steps towards targets—Perspectives for clinical practice in diabetes,
cardiometabolic disorders and beyond. Int. J. Clin. Pract. 2013, 67, 322–332. [CrossRef] [PubMed]
37. Fock, K.M.; Khoo, J. Diet and exercise in management of obesity and overweight. J. Gastroenterol. Hepatol.
2013, 28, 59–63. [CrossRef] [PubMed]
38. Abete, I.; Parra, D.; Martinez, J.A. Energy-restricted diets based on a distinct food selection affecting the
glycemic index induce different weight loss and oxidative response. Clin. Nutr. 2008, 27, 545–551. [CrossRef]
[PubMed]
39. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.;
Loria, C.M.; Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the
International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung,
and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis
Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [PubMed]
40. Fleming, J.A.; Kris-Etherton, P.M. The evidence for alpha-linolenic acid and cardiovascular disease benefits:
Comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv. Nutr. 2014, 5, 863S–876S. [CrossRef]
[PubMed]
41. Gray, B.; Steyn, F.; Davies, P.S.; Vitetta, L. Omega-3 fatty acids: A review of the effects on adiponectin and
leptin and potential implications for obesity management. Eur. J. Clin. Nutr. 2013, 67, 1234–1242. [CrossRef]
[PubMed]
42. Wen, Y.T.; Dai, J.H.; Gao, Q. Effects of Omega-3 fatty acid on major cardiovascular events and mortality
in patients with coronary heart disease: A meta-analysis of randomized controlled trials. Nutr. Metab.
Cardiovasc. Dis. 2014, 24, 470–475. [CrossRef] [PubMed]
43. Lopez-Huertas, E. The effect of EPA and DHA on metabolic syndrome patients: A systematic review of
randomised controlled trials. Br. J. Nutr. 2012, 107, 185–194. [CrossRef] [PubMed]
44. Maiorino, M.I.; Chiodini, P.; Bellastella, G.; Giugliano, D.; Esposito, K. Sexual dysfunction in women with
cancer: A systematic review with meta-analysis of studies using the Female Sexual Function Index. Endocrine
2016, 54, 329–341. [CrossRef] [PubMed]
45. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on Dietary
Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated
fatty acids, trans fatty acids, and cholesterol1. EFSA J. 2010, 8, 1461–1566.
46. Bellastella, G.; Bizzarro, A.; Aitella, E.; Barrasso, M.; Cozzolino, D.; di Martino, S.; Esposito, K.; de Bellis, A.
Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with
vasopressin cell antibodies: Description of two cases. Eur. J. Endocrinol. 2015, 172, K11–K17. [CrossRef]
[PubMed]
47. Sun, F.H.; Li, C.; Zhang, Y.J.; Wong, S.H.; Wang, L. Effect of Glycemic Index of Breakfast on Energy Intake at
Subsequent Meal among Healthy People: A Meta-Analysis. Nutrients 2016, 8, 37. [CrossRef] [PubMed]
48. Barclay, A.W.; Brand-Miller, J.C.; Wolever, T.M. Glycemic index, glycemic load, and glycemic response are
not the same. Diabetes Care 2005, 28, 1839–1840. [CrossRef] [PubMed]
49. Nakagawa, T.; Hu, H.; Zharikov, S.; Tuttle, K.R.; Short, R.A.; Glushakova, O.; Ouyang, X.; Feig, D.I.;
Block, E.R.; Herrera-Acosta, J.; et al. A causal role for uric acid in fructose-induced metabolic syndrome.
Am. J. Physiol. Ren. Physiol. 2006, 290, F625–F631. [CrossRef] [PubMed]
50. Symons Downs, D.; Hausenblas, H.A. Women’s exercise beliefs and behaviors during their pregnancy and
postpartum. J. Midwifery Women Health 2004, 49, 138–144.
51. Brand-Miller, J.; McMillan-Price, J.; Steinbeck, K.; Caterson, I. Dietary glycemic index: Health implications.
J. Am. Coll. Nutr. 2009, 28, 446S–449S. [CrossRef] [PubMed]
52. Thomas, D.; Elliott, E.J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus.
Cochrane Database Syst. Rev. 2009. [CrossRef]
53. Barrea, L.; Balato, N.; di Somma, C.; Macchia, P.E.; Napolitano, M.; Savanelli, M.C.; Esposito, K.; Colao, A.;
Savastano, S. Nutrition and psoriasis: Is there any association between the severity of the disease and
adherence to the Mediterranean diet? J. Transl. Med. 2015, 13, 18. [CrossRef] [PubMed]
54. Mathias, K.C.; Ng, S.W.; Popkin, B. Monitoring changes in the nutritional content of ready-to-eat grain-based
dessert products manufactured and purchased between 2005 and 2012. J. Acad. Nutr. Diet. 2015, 115, 360–368.
[CrossRef] [PubMed]
55. Serafini, M.; del Rio, D. Understanding the association between dietary antioxidants, redox status and
disease: Is the Total Antioxidant Capacity the right tool? Redox Rep. 2004, 9, 145–152. [CrossRef] [PubMed]
56. Bellastella, G.; Maiorino, M.I.; Olita, L.; della Volpe, E.; Giugliano, D.; Esposito, K. Premature ejaculation is
associated with glycemic control in Type 1 diabetes. J. Sex. Med. 2015, 12, 93–99. [CrossRef] [PubMed]
57. Zulet, M.A.; Moreno-Aliaga, M.J.; Martinez, J.A. Dietary Determinants of Fat Mass and Body Composition.
In Adipose Tissue Biology; Symonds, M.E., Ed.; Springer: New York, NY, USA, 2012; pp. 271–315.
58. Carlsen, M.H.; Halvorsen, B.L.; Holte, K.; Bohn, S.K.; Dragland, S.; Sampson, L.; Willey, C.; Senoo, H.;
Umezono, Y.; Sanada, C.; et al. The total antioxidant content of more than 3100 foods, beverages, spices,
herbs and supplements used worldwide. Nutr. J. 2010, 9, 3. [CrossRef] [PubMed]
59. Harasym, J.; Oledzki, R. Effect of fruit and vegetable antioxidants on total antioxidant capacity of blood
plasma. Nutrition 2014, 30, 511–517. [CrossRef] [PubMed]
60. Maiorino, M.I.; Bellastella, G.; Petrizzo, M.; della Volpe, E.; Orlando, R.; Giugliano, D.; Esposito, K. Circulating
endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction. Endocrine 2015, 49, 415–421.
[CrossRef] [PubMed]
61. Bahadoran, Z.; Golzarand, M.; Mirmiran, P.; Shiva, N.; Azizi, F. Dietary total antioxidant capacity and the
occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and
Glucose Study. Nutr. Metab. 2012, 9, 70. [CrossRef] [PubMed]
62. Chrysohoou, C.; Esposito, K.; Giugliano, D.; Panagiotakos, D.B. Peripheral Arterial Disease and
Cardiovascular Risk: The Role of Mediterranean Diet. Angiology 2015, 66, 708–710. [CrossRef] [PubMed]
63. De la Iglesia, R.; Lopez-Legarrea, P.; Celada, P.; Sanchez-Muniz, F.J.; Martinez, J.A.; Zulet, M.A. Beneficial
effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome
with hyperglycemia are associated to dietary TAC and fruit consumption. Int. J. Mol. Sci. 2013, 14, 6903–6919.
[CrossRef] [PubMed]
64. Lopez-Legarrea, P.; de la Iglesia, R.; Abete, I.; Bondia-Pons, I.; Navas-Carretero, S.; Forga, L.; Martinez, J.A.;
Zulet, M.A. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese
with metabolic syndrome symptoms: The RESMENA randomized controlled trial. Nutr. Metab. 2013, 10, 22.
[CrossRef] [PubMed]
65. Puchau, B.; Zulet, M.A.; de Echavarri, A.G.; Hermsdorff, H.H.; Martinez, J.A. Dietary total antioxidant
capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition
2010, 26, 534–541. [CrossRef] [PubMed]
66. World Health Organization. Obesity: Preventing and Managing the Global Epidemic; Report of a WHO
Consultation; World Health Organization Technical Report Series; WHO: Geneva, Switzerland, 2000.
67. Tapsell, L.C.; Hemphill, I.; Cobiac, L.; Patch, C.S.; Sullivan, D.R.; Fenech, M.; Roodenrys, S.; Keogh, J.B.;
Clifton, P.M.; Williams, P.G.; et al. Health benefits of herbs and spices: The past, the present, the future.
Med. J. Aust. 2006, 185, S4–S24. [PubMed]
68. Abete, I.; Astrup, A.; Martinez, J.A.; Thorsdottir, I.; Zulet, M.A. Obesity and the metabolic syndrome: Role of
different dietary macronutrient distribution patterns and specific nutritional components on weight loss and
maintenance. Nutr. Rev. 2010, 68, 214–231. [CrossRef] [PubMed]
69. Ebbeling, C.B.; Swain, J.F.; Feldman, H.A.; Wong, W.W.; Hachey, D.L.; Garcia-Lago, E.; Ludwig, D.S. Effects
of dietary composition on energy expenditure during weight-loss maintenance. JAMA 2012, 307, 2627–2634.
[CrossRef] [PubMed]
70. Abete, I.; Goyenechea, E.; Zulet, M.A.; Martinez, J.A. Obesity and metabolic syndrome: Potential benefit
from specific nutritional components. Nutr. Metab. Cardiovasc. Dis. 2011, 21, B1–B15. [CrossRef] [PubMed]
71. Arciero, P.J.; Ormsbee, M.J.; Gentile, C.L.; Nindl, B.C.; Brestoff, J.R.; Ruby, M. Increased protein intake and
meal frequency reduces abdominal fat during energy balance and energy deficit. Obesity 2013, 21, 1357–1366.
[CrossRef] [PubMed]
72. Wikarek, T.; Chudek, J.; Owczarek, A.; Olszanecka-Glinianowicz, M. Effect of dietary macronutrients on
postprandial incretin hormone release and satiety in obese and normal-weight women. Br. J. Nutr. 2014, 111,
236–246. [CrossRef] [PubMed]
73. Bray, G.A.; Smith, S.R.; de Jonge, L.; Xie, H.; Rood, J.; Martin, C.K.; Most, M.; Brock, C.; Mancuso, S.;
Redman, L.M. Effect of dietary protein content on weight gain, energy expenditure, and body composition
during overeating: A randomized controlled trial. JAMA 2012, 307, 47–55. [CrossRef] [PubMed]
74. Westerterp-Plantenga, M.S.; Nieuwenhuizen, A.; Tome, D.; Soenen, S.; Westerterp, K.R. Dietary protein,
weight loss, and weight maintenance. Annu. Rev. Nutr. 2009, 29, 21–41. [CrossRef] [PubMed]
75. Koppes, L.L.; Boon, N.; Nooyens, A.C.; van Mechelen, W.; Saris, W.H. Macronutrient distribution over
a period of 23 years in relation to energy intake and body fatness. Br. J. Nutr. 2009, 101, 108–115. [CrossRef]
[PubMed]
76. De Jonge, L.; Bray, G.A.; Smith, S.R.; Ryan, D.H.; de Souza, R.J.; Loria, C.M.; Champagne, C.M.;
Williamson, D.A.; Sacks, F.M. Effect of diet composition and weight loss on resting energy expenditure in
the POUNDS LOST study. Obesity 2012, 20, 2384–2389. [CrossRef] [PubMed]
77. Stocks, T.; Angquist, L.; Hager, J.; Charon, C.; Holst, C.; Martinez, J.A.; Saris, W.H.; Astrup, A.; Sorensen, T.I.;
Larsen, L.H. TFAP2B-dietary protein and glycemic index interactions and weight maintenance after weight
loss in the DiOGenes trial. Hum. Hered. 2013, 75, 213–219. [CrossRef] [PubMed]
78. Giugliano, D.; Maiorino, M.I.; Esposito, K. Linking prediabetes and cancer: A complex issue. Diabetologia
2015, 58, 201–202. [CrossRef] [PubMed]
79. Bendtsen, L.Q.; Lorenzen, J.K.; Bendsen, N.T.; Rasmussen, C.; Astrup, A. Effect of dairy proteins on appetite,
energy expenditure, body weight, and composition: A review of the evidence from controlled clinical trials.
Adv. Nutr. 2013, 4, 418–438. [CrossRef] [PubMed]
80. Heer, M.; Egert, S. Nutrients other than carbohydrates: Their effects on glucose homeostasis in humans.
Diabetes Metab. Res. Rev. 2015, 31, 14–35. [CrossRef] [PubMed]
81. Layman, D.K.; Evans, E.M.; Erickson, D.; Seyler, J.; Weber, J.; Bagshaw, D.; Griel, A.; Psota, T.; Kris-Etherton, P.
A moderate-protein diet produces sustained weight loss and long-term changes in body composition and
blood lipids in obese adults. J. Nutr. 2009, 139, 514–521. [CrossRef] [PubMed]
82. Pedersen, A.N.; Kondrup, J.; Borsheim, E. Health effects of protein intake in healthy adults: A systematic
literature review. Food Nutr. Res. 2013, 57, 21245. [CrossRef] [PubMed]
83. Daly, R.M.; O’Connell, S.L.; Mundell, N.L.; Grimes, C.A.; Dunstan, D.W.; Nowson, C.A. Protein-enriched
diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass
and muscle strength and reduces circulating IL-6 concentrations in elderly women: A cluster randomized
controlled trial. Am. J. Clin. Nutr. 2014, 99, 899–910. [CrossRef] [PubMed]
84. Arciero, P.J.; Gentile, C.L.; Pressman, R.; Everett, M.; Ormsbee, M.J.; Martin, J.; Santamore, J.; Gorman, L.;
Fehling, P.C.; Vukovich, M.D.; et al. Moderate protein intake improves total and regional body composition
and insulin sensitivity in overweight adults. Metab. Clin. Exp. 2008, 57, 757–765. [CrossRef] [PubMed]
85. Gregory, S.M.; Headley, S.A.; Wood, R.J. Effects of dietary macronutrient distribution on vascular integrity in
obesity and metabolic syndrome. Nutr. Rev. 2011, 69, 509–519. [CrossRef] [PubMed]
86. Consenso FESNAD-SEEDO. Recomendaciones nutricionales basadas en la evidencia para la prevención y el
tratamiento del sobrepeso y la obesidad en adultos (Consenso FESNAD-SEEDO). Rev. Esp. Obes. 2011, 10, 36.
87. Jakubowicz, D.; Froy, O.; Wainstein, J.; Boaz, M. Meal timing and composition influence ghrelin levels,
appetite scores and weight loss maintenance in overweight and obese adults. Steroids 2012, 77, 323–331.
[CrossRef] [PubMed]
88. Schwarz, N.A.; Rigby, B.R.; La Bounty, P.; Shelmadine, B.; Bowden, R.G. A review of weight control strategies
and their effects on the regulation of hormonal balance. J. Nutr. Metab. 2011, 2011, 237932. [CrossRef]
[PubMed]
89. Ohkawara, K.; Cornier, M.A.; Kohrt, W.M.; Melanson, E.L. Effects of increased meal frequency on fat
oxidation and perceived hunger. Obesity 2013, 21, 336–343. [CrossRef] [PubMed]
90. Ekmekcioglu, C.; Touitou, Y. Chronobiological aspects of food intake and metabolism and their relevance on
energy balance and weight regulation. Obes. Rev. 2011, 12, 14–25. [CrossRef] [PubMed]
91. Lioret, S.; Touvier, M.; Lafay, L.; Volatier, J.L.; Maire, B. Are eating occasions and their energy content related
to child overweight and socioeconomic status? Obesity 2008, 16, 2518–2523. [CrossRef] [PubMed]
92. Bhutani, S.; Varady, K.A. Nibbling versus feasting: Which meal pattern is better for heart disease prevention?
Nutr. Rev. 2009, 67, 591–598. [CrossRef] [PubMed]
93. Leidy, H.J.; Tang, M.; Armstrong, C.L.; Martin, C.B.; Campbell, W.W. The effects of consuming frequent,
higher protein meals on appetite and satiety during weight loss in overweight/obese men. Obesity 2011, 19,
818–824. [CrossRef] [PubMed]
94. Mills, J.P.; Perry, C.D.; Reicks, M. Eating frequency is associated with energy intake but not obesity in midlife
women. Obesity 2011, 19, 552–559. [CrossRef] [PubMed]
95. Cameron, J.D.; Cyr, M.J.; Doucet, E. Increased meal frequency does not promote greater weight loss in subjects
who were prescribed an 8-week equi-energetic energy-restricted diet. Br. J. Nutr. 2010, 103, 1098–1101.
[CrossRef] [PubMed]
96. Smeets, A.J.; Lejeune, M.P.; Westerterp-Plantenga, M.S. Effects of oral fat perception by modified sham
feeding on energy expenditure, hormones and appetite profile in the postprandial state. Br. J. Nutr. 2009,
101, 1360–1368. [CrossRef] [PubMed]
97. Taylor, M.A.; Garrow, J.S. Compared with nibbling, neither gorging nor a morning fast affect short-term
energy balance in obese patients in a chamber calorimeter. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 519–528.
[CrossRef] [PubMed]
98. Smeets, A.J.; Westerterp-Plantenga, M.S. Acute effects on metabolism and appetite profile of one

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Some of the most dietary-strategies-treatment-metabolic dietary strategies and bioactive compounds employed in the treatment of MetS to date. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
November 2, 2017 7:16 PM
Scoop.it!

Metabolic Syndrome And Chiropractic | Dr. Alex Jimenez D.C.

Metabolic Syndrome And Chiropractic | Dr. Alex Jimenez D.C. | Diet and Supplements | Scoop.it

Metabolic Syndrome:

 

Key indexing terms:

  • Metabolic syndrome X
  • Insulin resistance
  • Hyperglycemia
  • Inflammation
  • Weight loss

 

Abstract
Objective: This article presents an overview of metabolic syndrome (MetS), which is a collection of risk factors that can lead to diabetes, stroke, and heart disease. The purposes of this article are to describe the current literature on the etiology and pathophysiology of insulin resistance as it relates to MetS and to suggest strategies for dietary and supplemental management in chiropractic practice.

 

Methods: The literature was searched in PubMed, Google Scholar, and the Web site of the American Heart Association, from the earliest date possible to May 2014. Review articles were identified that outlined pathophysiology of MetS and type 2 diabetes mellitus (T2DM) and relationships among diet, supplements, and glycemic regulation, MetS, T2DM, and musculoskeletal pain.

 

Results: Metabolic syndrome has been linked to increased risk of developing T2DM and cardiovascular disease and increased risk of stroke and myocardial infarction. Insulin resistance is linked to musculoskeletal complaints both through chronic inflammation and the effects of advanced glycosylation end products. Although diabetes and cardiovascular disease are the most well-known diseases that can result from MetS, an emerging body of evidence demonstrates that common musculoskeletal pain syndromes can be caused by MetS.

 

Conclusions: This article provides an overview of lifestyle management of MetS that can be undertaken by doctors of chiropractic by means of dietary modification and nutritional support to promote blood sugar regulation.

Introduction: Metabolic Syndrome

Metabolic syndrome (MetS) has been described as a cluster of physical examination and laboratory findings that directly increases the risk of degenerative metabolic disease expression. Excess visceral adipose tissue, insulin resistance, dyslipidemia, and hypertension are conditions that significantly contribute to the syndrome. These conditions are united by a pathophysiological basis in low-grade chronic inflammation and increase an individual's risk of cardiovascular disease, type 2 diabetes mellitus (T2DM), and all-cause mortality.1

 

The National Health and Nutrition Examination Survey (NHANES) 2003-2006 estimated that approximately 34% of United States adults aged 20 years and more had MetS.2 The same NHANES data found that 53% had abdominal adiposity, a condition that is closely linked to visceral adipose stores. Excess visceral adiposity generates increased systemic levels of pro-inflammatory mediator molecules. Chronic, low- grade inflammation has been well documented as an associated and potentially inciting factor for the development of insulin resistance and T2DM.1

 

NHANES 2003-2006 data showed that 39% of subjects met criteria for insulin resistance. Insulin resistance is a component of MetS that significantly contributes to the expression of chronic, low-grade inflammation and predicts T2DM expression. T2DM costs the United States in excess of $174 billion in 2007. 3 It is estimated that 1 in 4 adults will have T2DM by the year 2050.3 Currently, more than one third of US adults (34.9%) are obese, 4 and, in 2008, the annual medical cost of obesity was $147 billion.4,5 This clearly represents a health care concern.

 

The pervasiveness of MetS dictates that doctors of chiropractic will see a growing proportion of patients who fit the syndrome criteria.6 Chiropractic is most commonly used for musculoskeletal complaints believed to be mechanical in nature;6 however, an emerging body of evidence identifies MetS as a biochemical promoter of musculoskeletal complaints such as neck pain, shoulder pain, patella tendinopathy, and widespread musculoskeletal pain. 7–13 As an example, the cross-linking of collagen fibers can be caused by increased advanced glycation end-product (AGE) formation as seen in insulin resistance.14 Increased collagen cross-linking is observed in both osteoarthritis and degenerative disc disease, 15 and reduced mobility in elderly patients with T2DM has also been attributed to AGE-induced collagen cross-linking. 16,17

 

A diagnosis of MetS is made from a patient having 3 of the 5 findings presented in Table 1. Fasting hyperglycemia is termed impaired fasting glucose and indicates insulin resistance. 18,19 An elevated hemoglobin A1c (HbA1c) level measures long-term blood glucose regulation and is diagnostic for T2DM when elevated in the presence of impaired fasting glucose. 3,18

 

The emerging evidence demonstrates that we cannot view musculoskeletal pain as only coming from conditions that are purely mechanical in nature. Doctors of chiropractic must demonstrate prowess in identification and management of MetS and an understanding of insulin resistance as its main pathophysiological feature. The purposes of this article are to describe the current literature on the etiology and pathophysiology of insulin resistance as it relates to MetS and to suggest strategies for dietary and supplemental management in chiropractic practice.

Methods

PubMed was searched from the earliest possible date to May 2014 to identify review articles that outlined the pathophysiology of MetS and T2DM. This led to further search refinements to identify inflammatory mechanisms that occur in the pancreas, adipose tissue, skeletal muscle, and hypothalamus. Searches were also refined to identify relationships among diet, supplements, and glycemic regulation. Both animal and human studies were reviewed. The selection of specific supplements was based on those that were most commonly used in the clinical setting, namely, gymnema sylvestre, vanadium, chromium and α-lipoic acid.

Discussion

Insulin Resistance Overview

Under normal conditions, skeletal muscle, hepatic, and adipose tissues require the action of insulin for cellular glucose entry. Insulin resistance represents an inability of insulin to signal glucose passage into insulin-dependent cells. Although a genetic predisposition can exist, the etiology of insulin resistance has been linked to chronic low-grade inflammation.1 Combined with insulin resistance-induced hyperglycemia, chronic low-grade inflammation also sustains MetS pathophysiology.1

 

Two thirds of postprandial blood glucose metabolism occurs within skeletal muscle via an insulin-dependent mechanism.18,19 Insulin binding to its receptor triggers glucose entry and subsequently inhibits lipolysis within the target tissue.21,22 Glucose enters skeletal muscles cells by way of a glucose transporter designated Glut4. 18 Owing to genetic variability, insulin-mediated glucose uptake can vary more than 6-fold among non-diabetic individuals. 23

 

Prolonged insulin resistance leads to structural changes within skeletal muscle such as decreased Glut4 transporter number, intramyocellular fat accu- mulation, and a reduction in mitochondrial con- tent.19,24 These events are thought to impact energy generation and functioning of affected skeletal mus- cle.24 Insulin-resistant skeletal muscle is less able to suppress lipolysis in response to insulin binding.25 Subsequently, saturated free fatty acids accumulate and generate oxidative stress. 22 The same phenomenon within adipose tissue generates a rapid adipose cell expansion and tissue hypoxia.26 Both these processes increase inflammatory pathway activation and the generation of proinflammatory cytokines (PICs).27

 

Multiple inflammatory mediators are associated with the promotion of skeletal muscle insulin resistance. The PICs tumor necrosis factor α (TNF-α), interleukin 1 (IL- 1), and IL-6 have received much attention because of their direct inhibition of insulin signaling.28–30 Since cytokine testing is not performed clinically, elevated levels of high- sensitivity C-reactive protein (hsCRP) best represent the low-grade systemic inflammation that characterizes insulin resistance.31,32

 

Insulin resistance–induced hyperglycemia can lead to irreversible changes in protein structure, termed glycation, and the formation of AGEs. Cells such as those of the vascular endothelium are most vulnerable to hyperglycemia due to utilization of an insulin-independent Glut1 transporter. 33 This makes AGE generation responsible for most diabetic complications, 15,33,34 including collagen cross-linking.15

 

If unchanged, prolonged insulin resistance can lead to T2DM expression. The relationship between chronic low-grade inflammation and T2DM has been well characterized. 35 Research has demonstrated that patients with T2DM also have chronic inflammation within the pancreas, termed insulitis, and it worsens hyperglycemia due to the progressive loss of insulin- producing β cells.36–39

Visceral Adiposity And Insulin Resistance

Caloric excess and a sedentary lifestyle contribute to the accumulation of subcutaneous and visceral adipose tissue. Adipose tissue was once thought of as a metabolically inert passive energy depot. A large body of evidence now demonstrates that excess visceral adipose tissue acts as a driver of chronic low-grade inflammation and insulin resistance.27,34

 

It has been documented that immune cells infiltrate rapidly expanding visceral adipose tissue. 26,40 Infil- trated macrophages become activated and release PICs that ultimately cause a phenotypic shift in resident macrophage phenotype to a classic inflammatory M1 profile.27 This vicious cycle creates a chronic inflam- matory response within adipose tissue and decreases the production of adipose-derived anti-inflammatory cytokines.43 As an example, adiponectin is an adipose- derived anti-inflammatory cytokine. Macrophage- invaded adipose tissue produces less adiponectin, and this has been correlated with increasing insulin resistance. 26

Hypothalamic Inflammation And Insulin Resistance

Eating behavior in the obese and overweight has been popularly attributed to a lack of will power or genetics. However, recent research has demonstrated a link between hypothalamic inflammation and increased body weight.41,41

 

Centers that govern energy balance and glucose homeostasis are located within the hypothalamus. Recent studies demonstrate that inflammation in the hypothalamus coincides with metabolic inflammation and an increase in appetite.43 These hypothalamic centers simultaneously become resistant to anorexigenic stimuli, leading to altered energy intake. It has been suggested that this provides a neuropathological basis for MetS and drives a progressive increase in body weight. 41

 

Central metabolic inflammation pathologically activates hypothalamic immune cells and disrupts central insulin and leptin signaling.41 Peripherally, this has been associated with dysregulated glucose homeostasis that also impairs pancreatic β cell functioning.41,44 Hypothalamic inflammation contributes to hypertension through similar mechanisms, and it is thought that central inflammation parallels chronic low-grade systemic inflammation and insulin resistance.41–44

Clinical Correlates Diet-Induced Inflammation & Insulin Resistance

Feeding generally leads to a short-term increase in both oxidative stress and inflammation. 41 Total calories consumed, glycemic index, and fatty acid profile of a meal all influence the degree of postprandial inflammation. It is estimated that the average American consumes approximately 20% of calories from refined sugar, 20% from refined grains and flour, 15% to 20% from excessively fatty meat products, and 20% from refined seed/legume oils.45 This pattern of eating contains a macronutrient composition and glycemic index that promote hyperglycemia, hyperlipemia, and an acute postprandial inflammatory response. 46 Collectively referred to as postprandial dysmetabolism, this pro-inflammatory response can sustain levels of chronic low-grade inflammation that leads to excess body fat, coronary heart disease (CHD), insulin resistance, and T2DM.28,29,47

 

Recent evidence suggests that several MetS criteria may not sufficiently identify all individuals with postprandial dysmetabolism. 48,49 A 2-hour oral glucose tolerance test (2-h OGTT) result greater than 200 mg/dL can be used clinically to diagnose T2DM. Although MetS includes a fasting blood glucose level less than 100 mg/dL, population studies have shown that a fasting glucose as low as 90 mg/dL can be associated with an 2-h OGTT level greater than 200 mg/dL.49 Further, a recent large cohort study indicated that an increased 2-h OGTT was independently predictive of cardiovascular and all-cause mortality in a nondiabetic population. 48 Mounting evidence indicates that post- prandial glucose levels are better correlated with MetS and predicting future cardiovascular events than fasting blood glucose alone.41,48

 

Fasting triglyceride levels generally correlate with postprandial levels, and a fasting triglyceride level greater than 150 mg/dL reflects MetS and insulin resistance. Contrastingly, epidemiologic data indicate that a fasting triglyceride level greater than 100 mg/dL influences CHD risk via postprandial dysmetabolism. 48 The acute postprandial inflammatory response that contributes to CHD risk includes an increase in PICs, free radicals, and hsCRP.48,49 These levels are not measured clinically but, monitoring fasting glucose, 2-hour postprandial glucose and fasting triglycerides can be used as correlates of postprandial dysmetabolic and low-grade systemic inflammation.

MetS And Disease Expression

Diagnosis of MetS has been linked to an increased risk of developing T2DM and cardiovascular disease over the following 5 to 10 years. 1 It further increases a patient's risk of stroke, myocardial infarction, and death from any of the aforementioned conditions.1

 

Facchini et al47 followed 208 apparently healthy, non-obese subjects for 4 to 11 years while monitoring the incidence of clinical events such as hypertension, stroke, CHD, cancer, and T2DM. Approximately one fifth of participants experienced clinical events, and all of these subjects were either classified as intermediately or severely insulin resistant. It is important to note that all of these clinical events have a pathological basis in chronic low-grade inflammation,50 and no events were experienced in the insulin-sensitive groupings. 47

 

Insulin resistance is linked to musculoskeletal com- plaints both through chronic inflammation and the effects of AGEs. Advanced glycation end-products have been shown to extensively accumulate in osteoarthritic cartilage and treatment of human chondrocytes with AGEs increased their catabolic activity. 51 Advanced glycation end-products increase collagen stiffness via cross-linking and likely contribute to reduced joint mobility seen in elderly patients with T2DM.52 Com- pared to non-diabetics, type II diabetic patients are known to have altered proteoglycan metabolism in their intervertebral discs. This altered metabolism may pro- mote weakening of the annular fibers and subsequently, disc herniation.53 The presence of T2DM increases a person's risk of expressing disc herniation in both the cervical and lumbar spines.17,54 Patients with T2DM are also more likely to develop lumbar stenosis compared with non-diabetics, and this has been documented as a plausible relationship between MetS risk factors and physician-diagnosed lumbar disc herniation. 55–57

 

There are no specific symptoms that denote early skeletal muscle structural changes. Fatty infiltration and decreased muscle mitochondria content are observed within age-related sarcopenia 58 ; however, it is still being argued whether fatty infiltration is a risk factor for low back pain. 59,60

 

Clinical management of MetS should be geared toward improving insulin sensitivity and reducing chronic low-grade inflammation. 1 Regular exercise without weight loss is associated with reduced insulin resistance, and at least 30 minutes of aerobic activity and resistance training is recommended daily. 61,62 Although frequently considered preventative, exercise, dietary, and weight loss interventions should be considered alongside pharmacological management in those with MetS. 1

 

Data regarding the exact amount of weight loss needed to improve chronic inflammation are inconclusive. In overweight individuals without diagnosed MetS, a very-low-carbohydrate diet (b 10% calories from carbohydrate) has significantly reduced plasma inflammatory markers (TNF-α, hsCRP, and IL-6) with as little as 6% reduction in body weight.63,64 Individuals who meet MetS criteria may require 10% to 20% body weight loss to reduce inflammatory markers. 65 Interestingly, the Mediterranean Diet has been shown to reduce markers of systemic inflammation independent of weight loss65 and was recommended in the American College of Cardiology and American Heart Association Adult Treatment Panel 4 guidelines.66

 

A growing body of research has examined the effects of the Spanish ketogenic Mediterranean diet, including olive oil, green vegetables and salads, fish as the primary protein, and moderate red wine consumption. In a sample of 22 patients, adoption of the Spanish ketogenic Mediterranean diet with 9 g of supplemental salmon oil on days when fish was not consumed has led to complete resolution of MetS.67 Significant reductions in markers of chronic systemic inflammation were seen in 31 patients following this diet for 12 weeks.68

 

A Paleolithic diet based on lean meat, fish, fruits, vegetables, root vegetables, eggs, and nuts has been described as more satiating per calorie than a diabetes diet in patients with T2DM.69 In a randomized crossover study, a Paleolithic diet resulted in lower mean HbA1c values, triglycerides, diastolic blood pressure, waist circumference, improved glucose tolerance, and higher high-density lipoprotein (HDL) values compared to a diabetes diet.70 Within the context of these changes, a referral for medication management may be advisable.

 

Irrespective of name, a low-glycemic diet that focuses on vegetables, fruits, lean meats, omega-3 fish, nuts, and tubers can be considered anti-inflammatory and has been shown to ameliorate insulin resistance. 49,71–73 Inflammatory markers and insulin resistance further improve when weight loss coincides with adherence to an anti-inflammatory diet.70 A growing body of evidence suggests that specific supplemental nutrients also reduce insulin resistance and improve chronic low-grade inflammation.

Key Nutrients That Promote Insulin Sensitivity

Research has identified nutrients that play key roles in promoting proper insulin sensitivity, including vitamin D, magnesium, omega-3 (n-3) fatty acids, curcumin, gymnema, vanadium, chromium, and α-lipoic acid. It is possible to get adequate vitamin D from sun exposure and adequate amounts of magnesium and omega-3 fatty acids from food. Contrastingly, the therapeutic levels of chromium and α-lipoic acid that affect insulin sensitivity and reduce insulin resistance cannot be obtained in food and must be supplemented.

Vitamin D, Magnesium, Omega-3 Fatty Acids, & Curcumin

Vitamin D, magnesium, and n-3 fatty acids have multiple functions, and generalized inflammation reduction is a common mechanism of action.74–80 Their supplemental use should be considered in the context of low-grade inflammation reduction and health promotion, rather than as a specific treatment for MetS or T2DM.

 

Evidence pertaining to the precise role of vitamin D in MetS and insulin resistance is inconclusive. Increas- ing dietary and supplemental vitamin D intake in young men and women may lower the risk of MetS and T2DM development,81 and a low serum vitamin D level has been associated with insulin resistance and T2DM expression. 82 Supplementation to improve low serum vitamin D (reference range, 32-100 ng/mL) is effective, but its impact on improving central glycemia and insulin sensitivity is conflicting. 83 Treating insulin resistance and MetS with vitamin D as a monotherapy appears to be unsuccessful. 82,83 Achieving normal vitamin D blood levels through adequate sun exposure and/or supplementation is advised for general health. 84–86

 

The average American diet commonly contains a low magnesium intake.80 Recent studies suggest that supple- mental magnesium can improve insulin sensitivity. 81,82 Taking 365 mg/d may be effective in reducing fasting glucose and raising HDL cholesterol in T2DM,83 as well as normomagnesemic, overweight, nondiabetics. 84

 

Diets high in the omega-6 fat linoleic acid have been associated with insulin resistance85 and higher levels of serum pro-inflammatory mediator markers including IL-6, IL-1β, TNF-α, and hsCRP.87 Supplementation to increase dietary omega-3 fatty acids at the expense of omega-6 fatty acids has been shown to improve insulin sensitivity. 88–90 Six months of omega-3 supplementation at 3 g/d with meals has been shown to reduce MetS markers including fasting triglycerides, HDL cholesterol, and an increase in anti-inflammatory adiponectin. 91

 

Curcumin is responsible for the yellow pigmentation of the spice turmeric. Its biological effects can be characterized as antidiabetic and antiobesity via down- regulating TNF-α, suppressing nuclear factor κB activation, adipocytokine expression, and leptin level modulation,. 92–95 Curcumin has been reported to activate peroxisome proliferator-activated receptor-γ, the nuclear target of the thiazolidinedione class of antidiabetic drugs,93 and it also protects hepatic and pancreatic cells. 92,93 Numerous studies have reported weight loss, hsCRP reduction, and improved insulin sensitivity after curcumin supplementation.92–95

 

There is no established upper limit for curcumin, and doses of up to 12 g/d are safe and tolerable in humans. 96 A randomized, double-blinded, placebo- controlled trial (N = 240) showed a reduced progression of prediabetes to T2DM after 9 months of 1500 mg/d curcumin supplementation.97

 

Curcumin, 98 vitamin D, 84 magnesium, 91 and omega-3 fatty acids80 are advocated as daily supplements to promote general health. A growing body of evidence supports the views of Gymnema sylvestre, vanadium, chromium, and α-lipoic acid should as therapeutic supplements to assist in glucose homeostasis.

G Sylvestre

Gymnemic acids are the active component of the G sylvestre plant leaves. Gymnemic acids are the active component of the G sylvestre plant leaves. Studies evaluating G sylvestre's effects on diabetes in humans have generally been of poor methodological quality. Experimental animal studies have found that gymnemic acids may decrease glucose uptake in the small intestine, inhibit gluconeogenesis, and reduce hepatic and skeletal muscle insulin resistance.99 Other animal studies suggest that gymnemic acids may have comparable efficacy in reducing blood sugar levels to the first-generation sulfonylurea, tolbutamide.100

 

Evidence from open-label trials suggests its use as a supplement to oral antidiabetic hypoglycemic agents. 96 One quarter of patients were able to discontinue their drug and maintain normal glucose levels on an ethanolic gymnema extract alone. Although the evidence to date suggests its use in humans and animals is safe and well tolerated, higher quality human studies are warranted.

Vanadyl Sulfate

Vanadyl sulfate has been reported to prolong the events of insulin signaling and may actually improve insulin sensitivity.101 Limited data suggest that it inhibits gluconeogenesis, possibly ameliorating hepatic insulin resistance. 100,101 Uncontrolled clinical trials have reported improvements in insulin sensitivity using 50 to 300 mg daily for periods ranging from 3 to 6 weeks. 101–103 Contrastingly, a recent randomized, double-blind, placebo-controlled trial found that 50 mg of vanadyl sulfate twice daily for 4 weeks had no effect in individuals with impaired glucose tolerance. 104 Limited clinical and experimental data exist supporting the use of vanadyl sulfate to improve insulin resistance, and further research is warranted regarding its safety and efficacy.

Chromium

Diets high in refined sugar and flour are deficient in chromium (Cr) and lead to an increased urinary excretion of chromium. 105,106 The progression of MetS is not likely caused by a chromium deficiency, 107 and dosages that benefit glycemic regulation are not achievable through food. 106,108,109

 

A recent randomize, double-blind trial demonstrated that 1000 μg Cr per day for 8 months improved insulin sensitivity by 10% in subjects with T2DM.110 Cefalu et al110 further suggested that these improvements might be more applicable to patients with a greater degree of insulin resistance, impaired fasting plasma glucose, and higher HbA1c values. Chromium's mechanism of action for improving insulin sensitivity is through increased Glut4 translocation via prolonging insulin receptor signaling.109 Chromium has been well tolerated at 1000 μg/d,105 and animal models using significantly more than 1000 μ Cr per day were not associated with toxicological consequences.109

α-Lipoic Acid

Humans derive α-lipoic acid through dietary means and from endogenous synthesis. 111 The foods richest in α-lipoic acid are animal tissues with extensive metabolic activity such as animal heart, liver, and kidney, which are not consumed in large amounts in the typical American diet. 111 Supplemental amounts of α-lipoic acid used in the treatment of T2DM (300-600 mg) are likely to be as much as 1000 times greater than the amounts that could be obtained from the diet.112

 

Lipoic acid synthase (LASY) appears to be the key enzyme involved in the generation of endogenous lipoic acid, and obese mice with diabetes have reduced LASY expression when compared with age-and sex- matched controls.111 In vitro studies to identify potential inhibitors of lipoic acid synthesis suggest a role for diet-induced hyperglycemia and the PIC TNF- α in the down-regulation of LASY.113 The inflammatory basis of insulin resistance may therefore drive lowered levels of endogenous lipoic acid via reducing the activity of LASY.

 

α-Lipoic acid has been found to act as insulin mimetic via stimulating Glut4-mediated glucose trans- port in muscle cells. 110,114α-Lipoic acid is a lipophilic free radical scavenger and may affect glucose homeostasis through protecting the insulin receptor from damage114 and indirectly via decreasing nuclear factor κB–mediated TNF-α and IL-1 production. 110 In postmenopausal women with MetS (presence of at least 3 ATPIII clinical criteria) 4 g/d of a combined inositol and α-lipoic acid supplement for 6 months significantly improved OGTT scores by 20% in two thirds of the subjects. 114 A recent randomized double-blinded placebo-controlled study showed that 300 mg/d α- lipoic acid for 90 days significantly decreased HbA1c values in subjects with T2DM.115

 

Side effects to α-lipoic acid supplementation as high as 1800 mg/d have largely been limited to nausea. 116 It may be best to take supplemental α-lipoic acid on an empty stomach (1 hour before or 2 hours after eating) because food intake reportedly reduces its bioavailability.117 Clinicians should be aware that α-lipoic acid supplementation might increase the risk of hypoglycemia in diabetic patients using insulin or oral antidiabetic agents.117

Limitations

This is a narrative overview of the topic of MetS. A systematic review was not performed; therefore, there may be relevant information missing from this review. The contents of this overview focuses on the opinions of the authors, and therefore, others may disagree with our opinions or approaches to management. This overview is limited by the studies that have been published. To date, no studies have been published that identify the effectiveness of a combination of a dietary intervention, such as the Spanish ketogenic diet, and nutritional supplementation on the expression of the MetS. Similarly, this approach has not been studied in patients with musculoskeletal pain who also have the MetS. Consequently, the information presented in this article is speculative. Longitudinal studies are needed before any specific recommendations can be made for patients with musculoskeletal that may be influenced by the MetS.

Conclusion: Metabolic Syndrome

This overview suggests that MetS and type 2 diabetes are complex conditions, and their prevalence is expected to increase substantially in the coming years. Thus, it is important to identify if the MetS may be present in patients who are nonresponsive to manual care and to help predict who may not respond adequately.

 

We suggest that diet and exercise are essential to managing these conditions, which can be supported with key nutrients, such as vitamin D, magnesium, and omega-3 fatty acids. We also suggest that curcumin, G sylvestre, vanadyl sulfate chromium, and α-lipoic acid could be viewed as specific nutrients that may be taken during the process of restoring appropriate insulin sensitivity and signaling.

Chiropractic Care

David R. Seaman DC, MS,⁎, Adam D. Palombo DC

 

Professor, Department of Clinical Sciences, National University of Health Sciences, Pinellas Park, FL Private Chiropractic Practice, Newburyport, MA

Funding Sources and Conflicts of Interest

No funding sources were reported for this study. David Seaman is a paid consultant for Anabolic Laboratories, a manufacturer of nutritional products for health care professionals. Adam Palombo was sponsored and remunerated by Anabolic laboratories to speak at chiropractic conventions/meetings.

 

References:

1. Kaur J. A comprehensive review on metabolic syndrome.<br />
Cardiol Res Pract 2014:943162, http://dx.doi.org/10.1155/<br />
2014/943162.<br />
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic<br />
syndrome among US adults. Findings from the Third National<br />
Health and Nutrition Examination Survey. J Am Med Assoc<br />
2006;287:356–9.<br />
3. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson<br />
DF. Projection of the year 2050 burden of diabetes in the US<br />
adult population: dynamic modeling of incidence, mortality,<br />
and prediabetes prevalence. Popul Health Metr 2010;8:29,<br />
http://dx.doi.org/10.1186/1478-7954-8-29.<br />
4. [Internet]Centers for Disease Control and Prevention.<br />
Adult Obesity Facts. Atlanta: CDC; 2014. [Available from<br />http://www.cdc.gov/obesity/data/adult.html].<br />
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of<br />
childhood and adult obesity in the United States, 2011–2012.<br />
JAMA 2014;311(8):806–14.<br />
6. Riksman JS, Williamson OD, Walker BF. Delineating<br />
inflammatory and mechanical sub-types of low back pain: a<br />
pilot survey of fifty low back pain patients in a chiropractic<br />
setting. Chiropr Man Therap 2011;19(1):5, http://dx.doi.org/<br />
10.1186/2045-709X-19-5.<br />
7. Dobretsov M, Ghaleb AH, Romanovsky D, Pablo CS, Stimers<br />
JR. Impaired insulin signaling as a potential trigger of<br />
pain in diabetes and prediabetes. Int Anesthesiol Clin<br />
2007;45(2):95–105.<br />
8. Mantyselka P, Miettola J, Niskanen L, Kumpusalo E. Glucose<br />
regulation and chronic pain at multiple sites. Rheumatology<br />
2008;47(8):1235–8.<br />
9. Mäntyselkä P, Miettola J, Niskanen L, Kumpusalo E.<br />
Persistent pain at multiple sites—connection to glucose<br />
derangement. Diabetes Res Clin Pract 2009;84(2):e30–2.<br />
10. Mantyselka P, Kautianen H, Vanhala M. Prevalence of neck<br />
pain in subjects with metabolic syndrome—a cross-sectional<br />
population-based study. BMC Musculoskelet Disord 2010;11:<br />
171, http://dx.doi.org/10.1186/1471-2474-11-171.<br />
11. Rechardt M, Shiri R, Karppinen J, Jula A, Heliövaara M,<br />
Viikari-Juntura E. Lifestyle and metabolic factors in relation<br />
to shoulder pain and rotator cuff tendinitis: a population-based<br />
study. BMC Musculoskelet Disord 2010;11:165.<br />
12. Gaida JE, Alfredson L, Kiss ZS, Wilson AM, Alfredson H,<br />
Cook JL. Dyslipidemia in Achilles tendinopathy is<br />
characteristic of insulin resistance. Med Sci Sports Exerc<br />
2009;41:1194–7.<br />
13. Malliaras P, Cook JL, Kent PM. Anthropometric risk factors<br />
for patellar tendon injury among volleyball players. Br J<br />
Sports Med 2007;41:259–63.<br />
14. Skrzynski S. DSC study of collagen in disc disease. J Biophys<br />
2009;2009:819635, http://dx.doi.org/10.1155/2009/819635.<br />
15. Luevano-Contreras C, Chapman-Novakofski K. Dietary<br />
advanced glycation end products and aging. Nutrients<br />
2010;2(12):1247–65 [2009;2009:819635].<br />
16. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint<br />
mobility (LJM) in elderly subjects with type II diabetes<br />
mellitus. Arch Gerontol Geriatrics 2011;53:135–40.<br />
17. Sakellaridis N. The influence of diabetes mellitus on lumbar<br />
intervertebral disk herniation. Surg Neurol 2006;66:152–4.<br />
18. Shepherd PR, Kahn BB. Glucose transporters and insulin<br />
action: implications for insulin resistance and diabetes<br />
mellitus. New Eng J Med 1999;341(4):248–57.<br />
19. Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin<br />
resistance in skeletal muscle. J Biomed Biotechnol 2010:19,<br />
http://dx.doi.org/10.1155/2010/476279 [Article ID 476279].<br />
20. [Internet]American Heart Association. About metabolic<br />
syndrome. Dallas: The Association; 2014. [Available from<br />http://www.heart.org/HEARTORG/Conditions/More/<br />MetabolicSyndrome/About-Metabolic-Syndrome_UCM_<br />301920_Article.jsp].<br />
21. Hotamisligil GS. Inflammation and metabolic disorders.<br />
Nature 2006;444:860–7.<br />
22. Glass CK, Olefsky JM. Inflammation and lipid signaling in the<br />
etiology of insulin resistance. Cell Metab 2012;15(5):635–45.<br />
23. Reaven GM. All obese individuals are not created equal:<br />
insulin resistance is the major determinant of cardiovascular<br />
disease in overweight/obese individuals. Diabetes Vasc Dis<br />
Res 2005;2:105–12.<br />
24. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster<br />
BH, Kelley DE. Deficiency of subsarcolemmal mitochondria<br />
in obesity and type 2 diabetes. Diabetes 2005;54:8–14.<br />
25. Corcoran MP, Lamon-Fava S, Fielding RA. Trans fats and<br />
insulin resistance: skeletal muscle lipid deposition and insulin<br />
resistance: effect of dietary fatty acids and exercise. Am J Clin<br />
Nutr 2007;85:662–77.<br />
26. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose<br />
tissue-resident immune cells: key players in immunometabolism.<br />
Trends Endocrinol Metab 2012;23:407–15.<br />
27. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines:<br />
the missing link between insulin resistance and obesity.<br />
Diabetes Metab 2008;34:2–11.<br />
28. Grimble RF. Inflammatory status and insulin resistance. Curr<br />
Opin Clin Nutr Metab Care 2003;5:551–9.<br />
29. Tilg H, Moschen AR. Inflammatory mechanisms in<br />
the regulation of insulin resistance. Mol Med 2008;3–4:222–31.<br />
30. Johnson DR, O'Conner JC, Satpathy A, Freund GG.<br />
Cytokines in type 2 diabetes. Vitam Horm 2006;74:405–41.<br />
31. Ridker PM, Wilson PW, Grundy SM. Should C-reactive<br />
protein be added to the metabolic syndrome and to<br />
assessment of global cardiovascular risk? Circulation 2004;<br />
109:2818–25.<br />
32. Gelaye B, Revilla L, Lopez T, et al. Association between<br />
insulin resistance and c-reactive protein among Peruvian<br />
adults. Diabetol Metab Syn 2010;2:30.<br />
33. Singh VP, Bali A, Singh N, et al. Advanced glycation end<br />
products and diabetic complications. Korean J Physiol<br />
Pharmacol 2014;18(1):1–14.<br />
34. Baker RG, Hayden MS. NF-kB, inflammation and metabolic<br />
disease. Cell Metab 2011;13(1):11–22.<br />
35. Purkayastha S, Cair D. Neuroinflammatory basis of metabolic<br />
syndrome. Mol Metab Nov 2013;2(4):356–63.<br />
36. Ehse JA, Boni-Schnetzler M, Faulenbach M, Donath MY.<br />
Macrophages, cytokines and beta-cell death in type 2 diabetes.<br />
Biochem Soc Trans 2008;36(3):340–2.<br />
37. Boni-Schnetzler M, Ehses JA, Faulenbach M, Donath MY.<br />
Insulitis in type 2 diabetes. Diabetes Obes Metab 2008;10<br />
(Suppl 4):201–4.<br />
38. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H,<br />
Perren A, Ehses JA. Islet inflammation in type 2<br />
diabetes: from metabolic stress to therapy. Diabetes Care<br />
2008;31(Suppl 2):S161–4.<br />
39. Donath MY, Boni-Schnetzler M, Ellingsgaard H, Ehses JA.<br />
Islet inflammation impairs the pancreatic beta-cell in type 2<br />
diabetes. Physiology 2009;24:325–31.<br />
40. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM.<br />
Fats, inflammation and insulin resistance: insights to the role<br />
of macrophage and T-cell accumulation in adipose tissue.<br />
Proc Nutr Soc 2011;70:408–17.<br />
41. Munoz A, Costa M. Nutritionally mediated oxidative stress and<br />
inflammation. Oxid Med Cell Longev 2013;2013:610950, http://<br />
dx.doi.org/10.1155/2013/610950.<br />
42. Wisse BE, Schwartz MW. Does hypothalamic inflammation<br />
cause obesity? Cell Metab 2009;10(4):241–2.<br />
43. Purkayastha S, Cair D. Neuroinflammatory basis of metabolic<br />
syndrome. Mol Metab Nov 2013;2(4):356–63.<br />
44. Calegari VC, Torsoni AS, Vanzela EC, Araújo EP, Morari<br />
J, Zoppi CC, et al. Inflammation of the hypothalamus leads<br />
to defective pancreatic islet function. J Biol Chem 2011;<br />
286(15):12870–80.<br />
45. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution<br />
of the Western diet: health implications for the 21st century.<br />
Am J Clin Nutr 2005;81:341–54.<br />
46. Barclay AW, Petocz P, McMillan-Price J, et al. Glycemic<br />
index, glycemic load, and chronic disease risk—a metaanalysis<br />
of observational studies. Am J Clin Nutr<br />
2008;87:627–37.<br />
47. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance<br />
as a predictor of age-related disease. J Clin Endocrinol Metab<br />
2001;86:3574–8.<br />
48. Lin H, Lee B, Ho Y, et al. Postprandial glucose improves the<br />
risk prediction of cardiovascular death beyond the metabolic<br />
syndrome in the nondiabetic population. Diabetes Care Sep<br />
2009;32(9):1721–6.<br />
49. O'Keefe JH, Bell DS. Postprandial hyperglycemia/<br />
hyperlipidemia (postprandial dysmetabolism) is a cardiovascular<br />
risk factor. Am J Cardiol 2007;100:899–904.<br />
50. Cao H. Adipocytokines in obesity and metabolic disease.<br />
J Endocrinol 2014;220(2):T47–59.<br />
51. Nah SS, Choi IY, Lee CK, et al. Effects of advanced glycation<br />
end products on the expression of COX2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford)<br />
2008;47(4):425–31.<br />
52. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint<br />
mobility (LJM) in elderly subjects with type II diabetes<br />
mellitus. Arch Gerontol Geriatr 2011;53:135–40.<br />
53. Robinson D, Mirovsky Y, Halperin N, Evron Z, Nevo Z.<br />
Changes in proteoglycans of intervertebral disc in diabetic<br />
patients: a possible cause of increased back pain. Spine<br />
1998;23:849–56.<br />
54. Sakellaridis N, Androulis A. Influence of diabetes mellitus on<br />
cervical intervertebral disc herniation. Clin Neurol Neurosurg<br />
2008;110:810–2.<br />
55. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Cardiovascular<br />
risk factors for physician-diagnosed lumbar disc<br />
herniation. Spine J 2006;6:684–91.<br />
56. Lotan R, Oron A, Anekstein Y, Shalmon E, Mirovsky Y.<br />
Lumbar stenosis and systemic diseases: is there any relevance.<br />
J Spinal Disord Tech 2008;21:247–51.<br />
57. Anekstein Y, Smorgick Y, Lotan R, et al. Diabetes mellitus as<br />
a risk factor for the development of lumbar spinal stenosis. Isr<br />
Med Assoc J 2010;12:16–20.<br />
58. Choi KM. Sarcopenia and sarcopenic obesity. Endocrinol<br />
Metab (Seoul) 2013;28(2):86–9.<br />
59. D'hooge R, Cagnie B, Crombez G, et al. Increased<br />
intramuscular fatty infiltration without differences in lumbar<br />
muscle cross-sectional area during remission of unilateral<br />
recurrent low back pain. Man Ther 2012 Dec;17(6):5584–8.<br />
60. Chen YY, Pao JL, Liaw CK, et al. Image changes of paraspinal<br />
muscles and clinical correlations in patients with unilateral<br />
lumbar spinal stenosis. Eur Spine J 2014;23(5):999–1006.<br />
61. Kim Y, Park H. Does regular exercise without weight loss<br />
reduce insulin resistance in children and adolescents? In J<br />
Endocrinol 2013:402592, http://dx.doi.org/10.1155/2013/<br />
402592 [Epub 2013 Dec 12].<br />
62. Strasser B, Siebert U, Schobersberger W. Resistance training<br />
in the treatment of the metabolic syndrome: a systematic<br />
review and meta-analysis of the effect of resistance training on<br />
metabolic clustering in patients with abnormal glucose<br />
metabolism. Sports Med 2010;40:397–415.<br />
63. Sharman MJ, Volek JS. Weight loss leads to reductions in<br />
inflammatory biomarkers after a very-low-carbohydrate diet<br />
and a low-fat diet in overweight men. Clin Sci (Lond)<br />
2004;13:365–9.<br />
64. Teng KT, Chang CY, Chang LF, et al. Modulation of obesityinduced<br />
inflammation by dietary fats: mechanisms and<br />
clinical evidence. Nutr J 2014;13:12, http://dx.doi.org/<br />
10.1186/1475-2891-13-12.<br />
65. Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss<br />
and conditional cardiovascular risk factors. Obes Rev 2011;12<br />
(5):e282–9.<br />
66. Stone N, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA<br />
Guideline on the Treatment of Blood Cholesterol to Reduce<br />
Atherosclerotic Cardiovascular Risk in Adults: A report of<br />
the American College of Cardiology/American Heart<br />
Association Task Force on practice guidelines. Circulation<br />
2014;129(25 Suppl 2):S1–S45.<br />
67. Pérez-Guisado J, Muñoz-Serrano A. A pilot study of the<br />
Spanish ketogenic Mediterranean diet: an effective therapy for<br />
the metabolic syndrome. J Med Food 2011;14(7–8):681–7.<br />
68. Pérez-Guisado J, Muñoz-Serrano A, Alonso-Moraga A.<br />
Spanish ketogenic Mediterranean diet: a healthy cardiovascular<br />
diet for weight loss. Nutr J 2008;7:30, http://dx.doi.org/<br />
10.1186/1475-2891-7-30.<br />
69. Jonsson T, Granfeldt Y, Lindeberg S, et al. Subjective satiety<br />
and other experiences of a Paleolithic diet compared to a<br />
diabetes diet in patients with T2DM. Nutr J 2013;12:105,<br />
http://dx.doi.org/10.1186/1475-2891-12-105.<br />
70. Jonsson T, Granfeldt Y, Ahren B, et al. Beneficial effects of a<br />
Paleolithic diet on cardiovascular risk factors in T2DM: a<br />
randomized cross-over pilot study. Cardiovasc Diabetol<br />
2009;8:35, http://dx.doi.org/10.1186/1475-2840-8-35.<br />
71. Nicklas BJ, You T, Pahor M. Behavioural treatments<br />
for chronic system inflammation: effects of dietary<br />
weight loss and exercise training. Can Med Assoc J<br />
2005;172(9):1199–209.<br />
72. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary<br />
strategies for improving post-prandial glucose, lipids, inflammation,<br />
and cardiovascular health. J Am Coll Cardiol<br />
2008;51:249–55.<br />
73. O'Keefe Jr JH, Cordain L. Cardiovascular disease resulting<br />
from a diet and lifestyle at odds with our Paleolithic genome:<br />
how to become a 21st-century hunter–gatherer. Mayo Clin<br />
Proc 2004;79(1):101–8.<br />
74. Ames BN. Low micronutrient intake may accelerate the<br />
degenerative diseases of aging through allocation of scarce<br />
micronutrients by triage. Proc Natl Acad Sci U S A 2006;103<br />
(47):17589–94.<br />
75. Holick MF, Chen TC. Vitamin D deficiency: a worldwide<br />
problem with health consequences. Am J Clin Nutr<br />
2008;87:1080S–6S [Suppl.].<br />
76. Toubi E, Shoenfeld Y. The role of vitamin D in regulating<br />
immune responses. Isr Med Assoc J 2010;12(3):174–5.<br />
77. King DE, Mainous AG, Geesey ME, Egan BM, Rehman S.<br />
Magnesium supplement intake and C-reactive protein levels<br />
in adults. Nutr Res 2006;26:193–6.<br />
78. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium<br />
status in the United States: are the health consequences<br />
underestimated? Nutr Rev 2012;70(3):153–64.<br />
79. Simopoulos AP. Omega-3 fatty acids in inflammation and<br />
autoimmune diseases. J Am Coll Nutr 2002;21(6):495–505.<br />
80. Simopoulos AP. The importance of the omega-6/omega-3<br />
fatty acid ratio in cardiovascular disease and other chronic<br />
diseases. Exp Biol Med 2008;233:674–88.<br />
81. Fung GJ, Steffen LM, Zhou X, et al. Vitamin D intake is<br />
inversely related to risk of developing metabolic syndrome<br />
in African American and white men and women over 20 y:<br />
the Coronary Artery Risk Development in Young Adults<br />
study. Am J Clin Nutr 2012;96(1):24–9 [Published online<br />2012 May 30].<br />
82. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio<br />
D. Role of vitamin D in the pathogenesis of type 2 diabetes<br />
mellitus. Diabetes Obes Metab 2008;10:185–97.<br />
83. Guadarrama-Lopez AL, Valdes-Ramos R, Martinex-Carrillo<br />
BE. T2DM, PUFAs, and vitamin D: their relation to<br />
inflammation. J Immunol Res 2014;2014:860703, http://dx.<br />
doi.org/10.1155/2014/860703.<br />
84. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice.<br />
Altern Med Rev 2008;13(1):6–20.<br />
85. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose<br />
vitamin D supplementation in people with prediabetes and<br />
hypovitaminosis D. Diabetes Care 2013;36(2):260–6, http://<br />
dx.doi.org/10.2337/dc12-1204.<br />
86. Schwalfenberg G. Vitamin D, and diabetes: improvement of<br />
glycemic control with vitamin D3 repletion. Can Fam<br />
Physician 2008;54:864–6.<br />
87. Kim DJ, Xun P, Liu K, et al. Magnesium intake in relation to<br />
systemic inflammation, insulin resistance, and the incidence<br />
of diabetes. Diabetes Care 2010;33(12):2604–10, http://dx.<br />
doi.org/10.2337/dc10-0994.<br />
88. Guerrero-Romero F, Tamez-Perez HE, González-González G,<br />
et al. Oral magnesium supplementation improves insulin<br />
sensitivity in non-diabetic subjects with insulin resistance. A<br />
double-blind placebo-controlled randomized trial. Diabetes<br />
Metab 2004;30(3):253–8.<br />
89. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium<br />
supplementation improves insulin sensitivity and metabolic<br />
control in type 2 diabetic subjects: a randomized double-blind<br />
controlled trial. Diabetes Care 2003;26(4):1147–52.<br />
90. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral<br />
magnesium supplementation on glycaemic control in type 2<br />
diabetes: a meta-analysis of randomized double-blind controlled<br />
trials. Diabet Med 2006;23(10):1050–6.<br />
91. Mooren FC, Krüger K, Völker K, Golf SW,Wadepuhl M, Kraus<br />
A. Oral magnesium supplementation reduces insulin resistance<br />
in non-diabetic subjects—a double-blind, placebo-controlled,<br />
randomized trial. Diabetes Obes Metab 2011;13(3):281–4.<br />
92. Aggarwal BB. Targeting inflammation induced obesity and<br />
metabolic diseases by curcumin and other nutraceuticals.<br />
Annu Rev Nutr 2010;30:173–9.<br />
93. Alappat L, Awad AB. Curcumin and obesity: evidence and<br />
mechanisms. Nutr Rev 2010;68(12):729–38.<br />
94. Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit<br />
nuclear factor-kappaB-mediated cytokine expression in adipocytes.<br />
Nutr Metab 2008;5:17, http://dx.doi.org/10.1186/<br />
1743-7075-5-17.<br />
95. Sahebkar A. Why it is necessary to translate curcumin into<br />
clinical practice for the prevention and treatment of metabolic<br />
syndrome? Biofactors 2012, http://dx.doi.org/10.1002/<br />
biof.1062 [Epub ahead of print].<br />
96. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp<br />
Med Biol 2007;595:471–80.<br />
97. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R,<br />
Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention<br />
of type 2 diabetes. Diabetes Care 2012;35(11):2121–7.<br />
98. Jurenka JS. Anti-inflammatory properties of curcumin, a<br />
major constituent of curcuma longa: a review of preclinical<br />
and clinical research. Altern Med Rev 2009;14(2):141–53.<br />
99. Leach M. Gymnema sylvestre for diabetes mellitus: a systematic<br />
review. J Altern Complement Med 2007;13(9):977–83.<br />
100. Chattopadhyay R. A comparative evaluation of some blood<br />
sugar lowering agents of plant origin. J Ethnopharmacol<br />
1999;67:367–72.<br />
101. Nahas R, Moher M. Complementary and alternative medicine<br />
for the treatment of type 2 diabetes. Can Fam Physician<br />
2009;55:591–6.<br />
102. Vanadium/Vanadyl sulfate: monograph. Altern Med Rev<br />
2009;14:17–80.<br />
103. Boden G, Chen X, Ruiz J, et al. Effects of vanadyl sulfate<br />
on carbohydrate and lipid metabolism in patients with noninsulin-dependent<br />
diabetes mellitus. Metabolism 1996;45:<br />
1130–5.<br />
104. Jacques-Camarena O, González-Ortiz M, Martínez-Abundis E,<br />
et al. Effect of vanadium on insulin sensitivity in patients with<br />
impaired glucose tolerance. Ann Nutr Metab 2008;53:195–8.<br />
105. Vincent JB. The biochemisty of chromium. J Nutr<br />
2000;130:715–8.<br />
106. Anderson RA. Chromium and insulin resistance. Nutr Res<br />
Rev 2003;16:267–75.<br />
107. Vincent JB. Chromium: celebrating 50 years as an essential<br />
element? Dalton Trans 2010;39:3787–94.<br />
108. Office of Dietary Supplements. [Internet]. Dietary supplement<br />
fact sheet: Chromium. Washington, DC: United States<br />
Department of Health and Human Services. http://ods.od.nih.<br />
gov/factsheets/chromium/. Reviewed November 4, 2013.<br />
109. Anderson RA. Chromium, glucose intolerance and diabetes.<br />
J Am Coll Nutr 1998;17(6):548–55.<br />
110. Cefalu WT, Rood J, Patricia Pinsonat P, et al. Characterization<br />
of the metabolic and physiologic response to chromium<br />
supplementation in subjects with type 2 diabetes mellitus.<br />
Metab Clin Exp 2010;59:755–62.<br />
111. Heimbach JT, Anderson RA. Chromium: recent studies regarding<br />
nutritional roles and safety. Nutr Today 2005;40(4):180–95.<br />
112. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM.<br />
Alpha-lipoic acid as a dietary supplement: molecular<br />
mechanisms and therapeutic potential. Biochim Biophys<br />
Acta 2009;1790:1149–60.<br />
113. Morikawa T, Yasuno R, Wada H. Do mammalian cells<br />
synthesize lipoic acid? Identification of a mouse cDNA<br />
encoding a lipoic acid synthase located in mitochondria.<br />
FEBS Lett 2001;498:16–21.<br />
114. Singh U, Jialal I. Alpha-lipoic acid supplementation and<br />
diabetes. Nutr Rev 2008;66(11):646–57.<br />
115. Padmalayam I, Hasham S, Saxena U, Pillarisetti S. Lipoic acid<br />
synthase (LASY): a novel role in inflammation, mitochondrial<br />
function, and insulin resistance. Diabetes 2009;58:600–8.<br />
116. Capasso I, Esposito E, Maurea N, et al. Combination of<br />
inositol and alpha lipoic acid in metabolic syndrome-affected<br />
women: a randomized placebo-controlled trial. Trial<br />
2013;14:273, http://dx.doi.org/10.1186/1745-6215-14-273.<br />
117. Udupa A, Nahar P, Shah S, et al. A comparative study of<br />
effects of omega-3 fatty acids, alpha lipoic acid and vitamin E<br />
in T2DM. Ann Med Health Sci Res 2013;3(3):442–6.

 

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Metabolic syndrome or MetS can be managed by chiropractic by dietary modification and nutrition to promote blood sugar regulation. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

good health's curator insight, January 15, 2024 12:01 PM

Acquista Online La Prescrizione Di Perdita Di Peso
Crediamo che i farmaci a volte possano essere molto urgenti da assumere. Se hai urgente bisogno di farmaci, possiamo anche fornirti una consegna espressa,


https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/

https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://globalefarmacia.com/Prodotto/acquista-metadone/
https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/


<a href="https://globalefarmacia.com/Prodotto/acquista-ozempic-online/">acquista-ozempic-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-victoza-online/">acquista-victoza-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/">acquista-mounjaro-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-mysimba-online/">acquista-mysimba-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-wegovy-online/">acquista-wegovy-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/">acquistare-saxenda-6mg-ml-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-phentermine-online/">acquista-phentermine-online</a>;
<a href="https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/">ephedrine-hcl-30mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/">acquista-ossicodone-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/">acquista-oxycontin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-percocet-online/">acquista-percocet-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-stilnox-online/">acquista-stilnox-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/">acquista-suboxone-8mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-subutex-online/">acquista-subutex-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-metadone/">acquista-metadone</a>;
<a href="https://globalefarmacia.com/Prodotto/buy-vyvanse-online/">buy-vyvanse-online</a>;
<a href="https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/">a-215-ossicodone-actavis</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/">acquista-adderall-30mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adipex-online/">acquista-adipex-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adma-online/">acquista-adma-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-ativan-online/">acquista-ativan-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-botox-online/">acquista-botox-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/">acquista-cerotti-al-fentanil</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/">acquista-codeina-linctus-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-codeina-online/">ta-codeina-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-demerol-online/">acquista-demerol-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-depalgo-online/">acquista-depalgo-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-diazepam-online/">acquista-diazepam-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/">acquista-dilaudid-8mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-endocet-online/">acquista-endocet-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/">acquista-eroina-bianca</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/">acquista-l-ritalin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-opana-online/">acquista-opana-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-vicodin-online/">acquista-vicodin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/">acquista-xanax-2mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/">acquistare-rohypnol-2mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/">acquistare-sibutramina-online</a>;
<a href="https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/">efedrina-hcl-in-polvere</a>;
<a href="https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/">sciroppo-di-metadone</a>;
<a href="https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/">tramadolo-hcl-200mg</a>;

 


<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/&quot; rel="dofollow">acquista-ozempic-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/&quot; rel="dofollow">acquista-victoza-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/&quot; rel="dofollow">acquista-mounjaro-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/&quot; rel="dofollow">acquista-mysimba-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/&quot; rel="dofollow">acquista-wegovy-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/&quot; rel="dofollow">acquistare-saxenda-6mg-ml-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/&quot; rel="dofollow">acquista-phentermine-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/&quot; rel="dofollow">acquistare-sibutramina-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/&quot; rel="dofollow">ephedrine-hcl-30mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/&quot; rel="dofollow">acquista-adderall-30mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/&quot; rel="dofollow">acquista-adipex-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/&quot; rel="dofollow">acquista-vyvanse-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/&quot; rel="dofollow">acquista-ossicodone-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/&quot; rel="dofollow">acquista-oxycontin-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/&quot; rel="dofollow">acquista-percocet-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/&quot; rel="dofollow">acquista-stilnox-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/&quot; rel="dofollow">acquista-suboxone-8mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/&quot; rel="dofollow">acquista-subutex-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/&quot; rel="dofollow">acquista-metadone</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/&quot; rel="dofollow">acquista-botox-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/&quot; rel="dofollow">acquista-adma-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/&quot; rel="dofollow">a-215-ossicodone-actavis</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/&quot; rel="dofollow">acquista-ativan-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/&quot; rel="dofollow">acquista-cerotti-al-fentanil</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/&quot; rel="dofollow">acquista-codeina-linctus-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/&quot; rel="dofollow">acquista-codeina-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/&quot; rel="dofollow">acquista-demerol-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/&quot; rel="dofollow">acquista-depalgo-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/&quot; rel="dofollow">acquista-diazepam-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/&quot; rel="dofollow">acquista-dilaudid-8mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/&quot; rel="dofollow">acquista-endocet-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/&quot; rel="dofollow">acquista-eroina-bianca</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/&quot; rel="dofollow">acquista-opana-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/&quot; rel="dofollow">acquista-vicodin-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/&quot; rel="dofollow">acquista-xanax-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/&quot; rel="dofollow">efedrina-hcl-in-polvere</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/&quot; rel="dofollow">sciroppo-di-metadone</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/&quot; rel="dofollow">tramadolo-hcl-200mg</a>

https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/


<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/&quot; rel="dofollow">acquista-ozempic-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/&quot; rel="dofollow">acquista-victoza-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/&quot; rel="dofollow">acquista-mounjaro-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/&quot; rel="dofollow">acquista-mysimba-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/&quot; rel="dofollow">acquista-wegovy-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/&quot; rel="dofollow">acquistare-saxenda-6mg-ml-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/&quot; rel="dofollow">acquista-phentermine-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/&quot; rel="dofollow">acquistare-sibutramina-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/&quot; rel="dofollow">ephedrine-hcl-30mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/&quot; rel="dofollow">acquista-adderall-30mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/&quot; rel="dofollow">acquista-adipex-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/&quot; rel="dofollow">acquista-vyvanse-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/&quot; rel="dofollow">acquista-ossicodone-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/&quot; rel="dofollow">acquista-oxycontin-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/&quot; rel="dofollow">acquista-percocet-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/&quot; rel="dofollow">acquista-stilnox-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/&quot; rel="dofollow">acquista-suboxone-8mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/&quot; rel="dofollow">acquista-subutex-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/&quot; rel="dofollow">acquista-metadone</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/&quot; rel="dofollow">acquista-botox-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/&quot; rel="dofollow">acquista-adma-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/&quot; rel="dofollow">a-215-ossicodone-actavis</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/&quot; rel="dofollow">acquista-ativan-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/&quot; rel="dofollow">acquista-cerotti-al-fentanil</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/&quot; rel="dofollow">acquista-codeina-linctus-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/&quot; rel="dofollow">acquista-codeina-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/&quot; rel="dofollow">acquista-demerol-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/&quot; rel="dofollow">acquista-depalgo-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/&quot; rel="dofollow">acquista-diazepam-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/&quot; rel="dofollow">acquista-dilaudid-8mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/&quot; rel="dofollow">acquista-endocet-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/&quot; rel="dofollow">acquista-eroina-bianca</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/&quot; rel="dofollow">acquista-opana-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/&quot; rel="dofollow">acquista-vicodin-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/&quot; rel="dofollow">acquista-xanax-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/&quot; rel="dofollow">efedrina-hcl-in-polvere</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/&quot; rel="dofollow">sciroppo-di-metadone</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/&quot; rel="dofollow">tramadolo-hcl-200mg</a>

Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
October 30, 2017 7:17 PM
Scoop.it!

Nutrition's Role In Performance Enhancement And Post Exercise Recovery

Nutrition's Role In Performance Enhancement And Post Exercise Recovery | Diet and Supplements | Scoop.it
Nutrition Abstract: A number of factors contribute to success in sport, and diet is a key component. An athlete’s dietary requirements depend on several aspects, including the sport, the athlete’s goals, the environment, and practical issues. The importance of individualized dietary advice has been increasingly recognized, including day-to-day dietary advice and specific advice before, during, and after training and/or competition. Athletes use a range of dietary strategies to improve performance, with maximizing glycogen stores a key strategy for many. Carbohydrate intake during exercise maintains high levels of carbohydrate oxidation, prevents hypoglycemia, and has a positive effect on the central nervous system. Recent research has focused on athletes training with low carbohydrate availability to enhance metabolic adaptations, but whether this leads to an improvement in performance is unclear. The benefits of protein intake throughout the day following exercise are now well recognized. Athletes should aim to maintain adequate levels of hydration, and they should minimize fluid losses during exercise to no more than 2% of their body weight. Supplement use is widespread in athletes, with recent interest in the beneficial effects of nitrate, beta-alanine, and vitamin D on performance. However, an unregulated supplement industry and inadvertent contamination of supplements with banned substances increases the risk of a positive doping result. Although the availability of nutrition information for athletes varies, athletes will bene t from the advice of a registered dietician or nutritionist.
 

Keywords: nutrition, diet, sport, athlete, supplements, hydration

Introduction To The Importance & Influence Of Nutrition On Exercise

Nutrition is increasingly recognized as a key component of optimal sporting performance, with both the science and practice of sports nutrition developing rapidly.1 Recent studies have found that a planned scientific nutritional strategy (consisting of fluid, carbohydrate, sodium, and caffeine) compared with a self-chosen nutritional strategy helped non-elite runners complete a marathon run faster2 and trained cyclists complete a time trial faster.3 Whereas training has the greatest potential to increase performance, it has been estimated that consumption of a carbohydrate–electrolyte drink or relatively low doses of caffeine may improve a 40 km cycling time trial performance by 32–42 and 55–84 seconds, respectively.4

 

Evidence supports a range of dietary strategies in enhancing sports performance. It is likely that combining several strategies will be of greater bene t than one strategy in isolation.5 Dietary strategies to enhance performance include optimizing intakes of macronutrients, micronutrients, and fluids, including their composition and spacing throughout the day. The importance of individualized or personalized dietary advice is becoming increasingly recognized,6 with dietary strategies varying according to the individual athlete’s sport, personal goals, and practicalities (eg, food preferences). “Athlete” includes individuals competing in a range of sport types, such as strength and power (eg, weight-lifting), team (eg, football), and endurance (eg, marathon running). The use of dietary supplements can enhance performance, provided these are used appropriately. This manuscript provides an overview of dietary strategies used by athletes, the efficacy of these strategies, availability of nutrition information to athletes, and risks associated with dietary supplement intake.

Review Of Diet Strategies Employed By Athletes

Maximizing Muscle Glycogen Stores Prior To Exercise

 

Carbohydrate loading aims to maximize an athlete’s muscle glycogen stores prior to endurance exercise lasting longer than 90 minutes. Benefits include delayed onset of fatigue (approximately 20%) and improvement in performance of 2%–3%.7 Initial protocols involved a depletion phase (3 days of intense training and low carbohydrate intake) followed by a loading phase (3 days of reduced training and high carbo- hydrate intake).8,9 Further research showed muscle glycogen concentrations could be enhanced to a similar level without the glycogen-depletion phase,10 and more recently, that 24 hours may be sufficient to maximize glycogen stores.11,12 Current recommendations suggest that for sustained or intermittent exercise longer than 90 minutes, athletes should consume 10–12 g of carbohydrate per kg of body mass (BM) per day in the 36–48 hours prior to exercise.13

 

There appears to be no advantage to increasing pre- exercise muscle glycogen content for moderate-intensity cycling or running of 60–90 minutes, as significant levels of glycogen remain in the muscle following exercise.7 For exercise shorter than 90 minutes, 7–12 g of carbohydrate/kg of BM should be consumed during the 24 hours preceding.13 Some14,15 but not all16 studies have shown enhanced performance of intermittent high-intensity exercise of 60–90 minutes with carbohydrate loading.

 

Carbohydrate eaten in the hours prior to exercise (com- pared with an overnight fast) has been shown to increase muscle glycogen stores and carbohydrate oxidation,17 extend cycle time to exhaustion,5 and improve exercise performance.5,18 Specific recommendations for exercise of longer than 60 minutes include 1–4 g of carbohydrate/kg of BM in the 1–4 hours prior.13 Most studies have not found improvements in performance from consuming low glycemic index (GI) foods prior to exercise.19 Any metabolic or performance effects from low GI foods appear to be attenuated when carbohydrate is consumed during exercise.20,21

Carbohydrate Intake During The Event

Carbohydrate ingestion has been shown to improve performance in events lasting approximately 1 hour.6 A growing body of evidence also demonstrates beneficial effects of a carbohydrate mouth rinse on performance.22 It is thought that receptors in the oral cavity signal to the central nervous system to positively modify motor output.23

 

In longer events, carbohydrate improves performance primarily by preventing hypoglycemia and maintaining high levels of carbohydrate oxidation.6 The rate of exogenous carbohydrate oxidation is limited by the small intestine’s ability to absorb carbohydrate.6 Glucose is absorbed by the sodium- dependent transporter (SGLT1), which becomes saturated with an intake of approximately 1 g/minute. The simultaneous ingestion of fructose (absorbed via glucose transporter 5 [GLUT5]), enables oxidation rates of approximately 1.3 g/minute,24 with performance benefits apparent in the third hour of exercise.6 Recommendations reflect this, with 90 g of carbohydrate from multiple sources recommended for events longer than 2.5 hours, and 60 g of carbohydrate from either single or multiple sources recommended for exercise of 2–3 hours’ duration (Table 1). For slower athletes exercising at a lower intensity, carbohydrate requirements will be less due to lower carbohydrate oxidation.6 Daily training with high carbohydrate availability has been shown to increase exogenous carbohydrate oxidation rates.25

The “Train-Low, Compete-High” Approach

The “train-low, compete-high” concept is training with low carbohydrate availability to promote adaptations such as enhanced activation of cell-signaling pathways, increased mitochondrial enzyme content and activity, enhanced lipid oxidation rates, and hence improved exercise capacity.26 However, there is no clear evidence that performance is improved with this approach.27 For example, when highly trained cyclists were separated into once-daily (train-high) or twice-daily (train-low) training sessions, increases in resting muscle glycogen content were seen in the low-carbohydrate- availability group, along with other selected training adaptations.28 However, performance in a 1-hour time trial after 3 weeks of training was no different between groups. Other research has produced similar results.29 Different strategies have been suggested (eg, training after an overnight fast, training twice per day, restricting carbohydrate during recovery),26 but further research is needed to establish optimal dietary periodization plans.27

Fat As A Fuel During Endurance Exercise

There has been a recent resurgence of interest in fat as a fuel, particularly for ultra endurance exercise. A high-carbohydrate strategy inhibits fat utilization during exercise,30 which may not be beneficial due to the abundance of energy stored in the body as fat. Creating an environment that optimizes fat oxidation potentially occurs when dietary carbohydrate is reduced to a level that promotes ketosis.31 However, this strategy may impair performance of high-intensity activity, by contributing to a reduction in pyruvate dehydrogenase activity and glycogenolysis. 32 The lack of performance benefits seen in studies investigating “high-fat” diets may be attributed to inadequate carbohydrate restriction and time for adaptation.31 Research into the performance effects of high fat diets continues.

Nutrition: Protein

While protein consumption prior to and during endurance and resistance exercise has been shown to enhance rates of muscle protein synthesis (MPS), a recent review found protein ingestion alongside carbohydrate during exercise does not improve time–trial performance when compared with the ingestion of adequate amounts of carbohydrate alone.33 

Fluid And Electrolytes

The purpose of fluid consumption during exercise is primarily to maintain hydration and thermoregulation, thereby benefiting performance. Evidence is emerging on increased risk of oxidative stress with dehydration.34 Fluid consumption prior to exercise is recommended to ensure that the athlete is well-hydrated prior to commencing exercise.35 In addition, carefully planned hyperhydration ( fluid overloading) prior to an event may reset fluid balance and increase fluid retention, and consequently improve heat tolerance.36 However, fluid overloading may increase the risk of hyponatremia 37 and impact negatively on performance due to feelings of fullness and the need to urinate.

 

Hydration requirements are closely linked to sweat loss, which is highly variable (0.5–2.0 L/hour) and dependent on type and duration of exercise, ambient temperature, and athletes’ individual characteristics.35 Sodium losses linked to high temperature can be substantial, and in events of long duration or in hot temperatures, sodium must be replaced along with fluid to reduce risk of hyponatremia. 35

 

It has long been suggested that fluid losses greater than 2% of BM can impair performance,35 but there is controversy over the recommendation that athletes maintain BM by fluid ingestion throughout an event.37 Well-trained athletes who “drink to thirst” have been found to lose as much as 3.1% of BM with no impairment of performance in ultra-endurance events.38 Ambient temperature is important, and a review illustrated that exercise performance was preserved if loss was restricted to 1.8% and 3.2% of BM in hot and temperate conditions, respectively.39

Dietary Supplementation: Nitrates, Beta-Alanine & Vitamin D

Performance supplements shown to enhance performance include caffeine, beetroot juice, beta-alanine (BA), creatine, and bicarbonate.40 Comprehensive reviews on other supplements including caffeine, creatine, and bicarbonate can be found elsewhere.41 In recent years, research has focused on the role of nitrate, BA, and vitamin D and performance. Nitrate is most commonly provided as sodium nitrate or beetroot juice.42 Dietary nitrates are reduced (in mouth and stomach) to nitrites, and then to nitric oxide. During exercise, nitric oxide potentially influences skeletal muscle function through regulation of blood ow and glucose homeostasis, as well as mitochondrial respiration.43 During endurance exercise, nitrate supplementation has been shown to increase exercise efficiency (4%–5% reduction in VO at a steady attenuate oxidative stress.42 Similarly, a 4.2% improvement in performance was shown in a test designed to simulate a football game.44

 

BA is a precursor of carnosine, which is thought to have a number of performance-enhancing functions including the reduction of acidosis, regulation of calcium, and antioxidant properties.45 Supplementation with BA has been shown to 2 state; 0.9% improvement in time trials), reduce fatigue, and augment intracellular carnosine concentration.45 A systematic review concluded that BA may increase power output and working capacity and decrease feelings of fatigue, but that there are still questions about safety. The authors suggest caution in the use of BA as an ergogenic aid.46

 

Vitamin D is essential for the maintenance of bone health and control of calcium homeostasis, but is also important for muscle strength,47,48 regulation of the immune system,49 and cardiovascular health.50 Thus inadequate vitamin D status has potential implications for the overall health of athletes and performance. A recent review found that the vitamin D status of most athletes reflects that of the population in their locality, with lower levels in winter, and athletes who train predominantly indoors are at greater risk of deficiency.51 There are no dietary vitamin D recommendations for athletes; however, for muscle function, bone health, and avoidance of respiratory infections, current evidence supports maintenance of serum 25-hydroxy vitamin D (circulating form) concentrations of 80–100 nmol/L.51

Diets Specific For Post Exercise

Recovery from a bout of exercise is integral to the athlete’s training regimen. Without adequate recovery of carbohydrate, protein, fluids, and electrolytes, beneficial adaptations and performance may be hampered.

Muscle Glycogen Synthesis

Consuming carbohydrates immediately post exercise to coincide with the initial rapid phase of glycogen synthesis has been used as a strategy to maximize rates of muscle glycogen synthesis. An early study found delaying feeding by 2 hours after glycogen-depleting cycling exercise reduced glycogen synthesis rates.52 However the importance of this early enhanced rate of glycogen synthesis has been questioned in the context of extended recovery periods with sufficient carbohydrate consumption. Enhancing the rate of glycogen synthesis with immediate carbohydrate consumption after exercise appears most relevant when the next exercise session is within 8 hours of the first.53,54 Feeding frequency is also irrelevant with extended recovery; by 24 hours post exercise, consumption of carbohydrate as four large meals or 16 small snacks had comparable effects on muscle glycogen storage.55

 

With less than 8 hours between exercise sessions, it is recommended that for maximal glycogen synthesis, 1.0–1.2 g/kg/hour is consumed for the first 4 hours, followed by resumption of daily carbohydrate requirements.13 Additional protein has been shown to enhance glycogen synthesis rates when carbohydrate intake is suboptimal.56 The consumption of moderate to high GI foods post exercise is recommended;13 however, when either a high-GI or low-GI meal was consumed after glycogen-depleting exercise, no performance differences were seen in a 5 km cycling time trial 3 hours later.57

Muscle Protein Synthesis

An acute bout of intense endurance or resistance exercise can induce a transient increase in protein turnover, and, until feeding, protein balance remains negative. Protein consumption after exercise enhances MPS and net protein balance,58 predominantly by increasing mitochondrial protein fraction with endurance training, and myofibrillar protein fraction with resistance training.59

 

Only a few studies have investigated the effect of timing of protein intake post exercise. No significant difference in MPS was observed over 4 hours post exercise when a mixture of essential amino acids and sucrose was fed 1 hour versus 3 hours after resistance exercise.60 Conversely, when a protein and carbohydrate supplement was provided immediately versus 3 hours after cycling exercise, leg protein synthesis increased threefold over 3 hours.61 A meta-analysis found timed post exercise protein intake becomes less important with longer recovery periods and adequate protein intake,62 at least for resistance training.

 

Dose–response studies suggest approximately 20 g of high-quality protein is sufficient to maximize MPS at rest,63 following resistance,63,64 and after high-intensity aerobic exercise.65 Rate of MPS has been found to approximately triple 45–90 minutes after protein consumption at rest, and then return to baseline levels, even with continued availability of circulating essential amino acids (termed the “muscle full” effect).66 Since exercise-induced protein synthesis is elevated for 24–48 hours following resistance exercise67and 24–28 hours following high-intensity aerobic exercise,68 and feeding protein post exercise has an additive effect,58,64 then multiple feedings over the day post exercise might maximize muscle growth. In fact, feeding 20 g of whey protein every 3 hours was subsequently found to maximally stimulate muscle myofibrillar protein synthesis following resistance exercise.69,70

 

In resistance training, where post exercise intake of protein was balanced by protein intake later in the day, increased adaptation of muscle hypertrophy resulted in equivocal strength performance effects.71,72 Most studies have not found a subsequent bene t to aerobic performance with post exercise protein consumption.73,74 However, in two well controlled studies in which post exercise protein intake was balanced by protein intake later in the day, improvements were seen in cycling time to exhaustion75 and in cycling sprint performance.76

Fluids And Electrolyte Balance

Fluid and electrolyte replacement after exercise can be achieved through resuming normal hydration practices. However, when euhydration is needed within 24 hours or substantial body weight has been lost (.5% of BM), a more structured response may be warranted to replace fluids and electrolytes.77

Availability Of Nutritional Information To Athletes At Varying Levels

The availability of nutrition information for athletes varies. Younger or recreational athletes are more likely to receive generalized nutritional information of poorer quality from individuals such as coaches.78 Elite athletes are more likely to have access to specialized sports-nutrition input from qualified professionals. A range of sports science and medicine support systems are in place in different countries to assist elite athletes,1 and nutrition is a key component of these services. Some countries have nutrition programs embedded within sports institutes (eg, Australia) or alternatively have National Olympic Committees that support nutrition programs (eg, United States of America).1 However, not all athletes at the elite level have access to sports-nutrition services. This may be due to financial constraints of the sport, geographical issues, and a lack of recognition of the value of a sports-nutrition service.78

 

Athletes eat several times per day, with snacks contributing to energy requirements.79 Dietary intake differs across sports, with endurance athletes more likely to achieve energy and carbohydrate requirements compared to athletes in weight-conscious sports.79 A review found daily intakes of carbohydrate were 7.6 g/kg and 5.7 g/kg of BM for male and female endurance athletes, respectively.80 Ten elite Kenyan runners met macronutrient recommendations but not guide- lines for fluid intake.81 A review of fluid strategies showed a wide variability of intake across sports, with several factors influencing intake, many outside the athlete’s control.82

 

Nutrition information may be delivered to athletes by a range of people (dietitians, nutritionists, medical practitioners, sports scientists, coaches, trainers) and from a variety of sources (nutrition education programs, sporting magazines, the media and Internet).83 Of concern is the provision of nutrition advice from outside various professional’s scope of practice. For example, in Australia 88% of registered exercise professionals provided nutrition advice, despite many not having adequate nutrition training.84 A study of Canadian high-performance athletes from 34 sports found physicians ranked eighth and dietitians, 16th as choice of source of dietary supplement information.85

Risks Of Contravening The Doping Regulations

Supplement use is widespread in athletes.86,87 For example, 87.5% of elite athletes in Australia used dietary supplements88 and 87% of Canadian high-performance athletes took dietary supplements within the past 6 months85 (Table 2). It is difficult to compare studies due to differences in the criteria used to define dietary supplements, variations in assessing supplement intake, and disparities in the populations studied.85

 

Athletes take supplements for many reasons, including for proposed performance benefits, for prevention or treatment of a nutrient deficiency, for convenience, or due to fear of “missing out” by not taking a particular supplement.41

 

The potential benefits (eg, improved performance) of taking a dietary supplement must outweigh the risks.86,87 There are few permitted dietary supplements available that have an ergogenic effect.87,89 Dietary supplementation cannot compensate for poor food choices.87 Other concerns include lack of efficacy, safety issues (toxicity, medical concerns), negative nutrient interactions, unpleasant side effects, ethical issues, financial expense, and lack of quality control.41,86,87 Of major concern, is the consumption of prohibited substances by the World Anti-Doping Agency (WADA).

 

Inadequate regulation in the supplement industry (com- pounded by widespread Internet sales) makes it difficult for athletes to choose supplements wisely.41,86,87 In 2000–2001, a study of 634 different supplements from 13 countries found that 94 (14.8%) contained undeclared steroids, banned by WADA.90 Many contaminated supplements were routinely used by athletes (eg, vitamin and mineral supplements).86 Several studies have confirmed these findings. 41,86,89

 

A positive drug test in an athlete can occur with even a minute quantity of a banned substance.41,87 WADA maintains a “strict liability” policy, whereby every athlete is responsible for any substance found in their body regardless of how it got there.41,86,87,89 The World Anti-Doping Code (January 1, 2015) does recognize the issue of contaminated supplements.91 Whereas the code upholds the principle of strict liability, athletes may receive a lesser ban if they can  show “no significant fault” to demonstrate they did not intend to cheat. The updated code imposes longer bans on those who cheat intentionally, includes athlete support personnel (eg, coaches, medical staff), and has an increased focus on anti-doping education.91,99

 

In an effort to educate athletes about sports-supplement use, the Australian Institute of Sport’s sports-supplement program categorizes supplements according to evidence of efficacy in performance and risk of doping outcome.40 Category A supplements have sound evidence for use and include sports foods, medical supplements, and performance supplements. Category D supplements should not be used by athletes, as they are banned or are at high risk for contamination. These include stimulants, pro-hormones and hormone boosters, growth hormone releasers, peptides, glycerol, and colostrum.40

Conclusion

Athletes are always looking for an edge to improve their performance, and there are a range of dietary strategies available. Nonetheless, dietary recommendations should be individualized for each athlete and their sport and provided by an appropriately qualified professional to ensure optimal performance. Dietary supplements should be used with caution and as part of an overall nutrition and performance plan.

Disclosure

The authors report no conflicts of interest in this work.

 

Kathryn L Beck1 Jasmine S Thomson2 Richard J Swift1 Pamela R von Hurst1

 

1School of Food and Nutrition, Massey institute of Food Science and Technology, College of Health, Massey University Albany, Auckland, 2School of Food and Nutrition, Massey institute of Food Science and Technology, College of Health, Massey University Manawatu, Palmerston North, New Zealand

 

References:

 

1. Burke LM, Meyer NL, Pearce J. National nutritional programs for the
2012 London Olympic Games: A systematic approach by three different
countries. In: van Loon LJC, Meeusen R, editors. Limits of Human
Endurance. Nestle Nutrition Institute Workshop Series, volume 76.
Vevey, Switzerland: Nestec Ltd; 2013:103–120.
2. Hansen EA, Emanuelsen A, Gertsen RM, Sørensen SSR. Improved
marathon performance by in-race nutritional strategy intervention.
Int J Sport Nutr Exerc Metab. 2014;24(6):645–655.
3. Hottenrott K, Hass E, Kraus M, Neumann G, Steiner M, Knechtle B.
A scientific nutrition strategy improves time trial performance by ≈6%
when compared with a self-chosen nutrition strategy in trained cyclists:
a randomized cross-over study. Appl Physiol Nutr Metab. 2012;
37(4):637–645.
4. Jeukendrup AE, Martin J. Improving cycling performance: how should
we spend our time and money. Sports Med. 2001;31(7):559–569.
5. Wright DA, Sherman WM, Dernbach AR. Carbohydrate feedings
before, during, or in combination improve cycling endurance
performance. J Appl Physiol (1985). 1991;71(3):1082–1088.
6. Jeukendrup A. A step towards personalized sports nutrition: carbohydrate
intake during exercise. Sports Med. 2014;44 Suppl 1:
S25–S33.
7. Hawley JA, Schabort EJ, Noakes TD, Dennis SC. Carbohydrateloading
and exercise performance. An update. Sports Med. 1997;24(2):
73–81.
8. Bergström J, Hermansen L, Hultman E, Saltin B. Diet, muscle glycogen
and physical performance. Acta Physiol Scand. 1967;71(2):140–150.
9. Karlsson J, Saltin B. Diet, muscle glycogen, and endurance performance.
J Appl Physiol. 1971;31(2):203–206.
10. Sherman WM, Costill DL, Fink WJ, Miller JM. Effect of exercise-diet
manipulation on muscle glycogen and its subsequent utilization during
performance. Int J Sports Med. 1981;2(2):114–118.
11. Bussau VA, Fairchild TJ, Rao A, Steele P, Fournier PA. Carbohydrate
loading in human muscle: an improved 1 day protocol. Eur J Appl
Physiol. 2002;87(3):290–295.
12. Fairchild TJ, Fletcher S, Steele P, Goodman C, Dawson B, Fournier PA.
Rapid carbohydrate loading after a short bout of near maximal-intensity
exercise. Med Sci Sports Exerc. 2002;34(6):980–986.
13. Burke LM, Hawley JA, Wong SH, Jeukendrup AE. Carbohydrates for
training and competition. J Sports Sci. 2011;29 Suppl 1:S17–S27.
14. Raman A, Macdermid PW, Mündel T, Mann M, Stannard SR. The
effects of carbohydrate loading 48 hours before a simulated squash
match. Int J Sport Nutr Exerc Metab. 2014;24(2):157–165.
15. Balsom PD, Wood K, Olsson P, Ekblom B. Carbohydrate intake and
multiple sprint sports: with special reference to football (soccer). Int J
Sports Med. 1999;20(1):48–52.
16. Abt G, Zhou S, Weatherby R. The effect of a high-carbohydrate diet
on the skill performance of midfield soccer players after intermittent
treadmill exercise. J Sci Med Sport. 1998;1(4):203–212.
17. Coyle EF, Coggan AR, Hemmert MK, Lowe RC, Walters TJ. Substrate
usage during prolonged exercise following a preexercise meal. J Appl
Physiol (1985). 1985;59(2):429–433.
18. Neufer PD, Costill DL, Flynn MG, Kirwan JP, Mitchell JB, Houmard J.
Improvements in exercise performance: effects of carbohydrate feedings
and diet. J Appl Physiol (1985). 1987;62(3):983–988.
19. Burke LM, Collier GR, Hargreaves M. Glycemic index – a new tool
in sport nutrition? Int J Sport Nutr. 1998;8(4):401–415.
20. Burke LM, Claassen A, Hawley JA, Noakes TD. Carbohydrate intake
during prolonged cycling minimizes effect of glycemic index of preexercise
meal. J Appl Physiol (1985). 1998;85(6):2220–2226.
21. Wong SH, Chan OW, Chen YJ, Hu HL, Lam CW, Chung PK. Effect of
preexercise glycemic-index meal on running when CHO-electrolyte
solution is consumed during exercise. Int J Sport Nutr Exerc Metab.
2009;19(3):222–242.
22. Burke LM, Maughan RJ. The Governor has a sweet tooth – mouth
sensing of nutrients to enhance sports performance. Eur J Sport Sci.
2015;15(1):29–40.
23. Gant N, Stinear CM, Byblow WD. Carbohydrate in the mouth immediately
facilitates motor output. Brain Res. 2010;1350:151–158.
24. Jentjens RL, Moseley L, Waring RH, Harding LK, Jeukendrup AE.
Oxidation of combined ingestion of glucose and fructose during
exercise. J Appl Physiol (1985). 2004;96(4):1277–1284.
25. Cox GR, Clark SA, Cox AJ, et al. Daily training with high carbohydrate
availability increases exogenous carbohydrate oxidation during endurance
cycling. J Appl Physiol (1985). 2010;109(1):126–134.
26. Bartlett JD, Hawley JA, Morton JP. Carbohydrate availability and
exercise training adaptation: too much of a good thing? Eur J Sport
Sci. 2015;15(1):3–12.
27. Burke LM. Fueling strategies to optimize performance: training high
or training low? Scand J Med Sci Sports. 2010;20 Suppl 2:48–58.
28. Yeo WK, Paton CD, Garnham AP, Burke LM, Carey AL, Hawley JA.
Skeletal muscle adaptation and performance responses to once a day
versus twice every second day endurance training regimens. J Appl
Physiol (1985). 2008;105(5):1462–1470.
29. Morton JP, Croft L, Bartlett JD, et al. Reduced carbohydrate availability
does not modulate training-induced heat shock protein adaptations but
does upregulate oxidative enzyme activity in human skeletal muscle.
J Appl Physiol (1985). 2009;106(5):1513–1521.
30. Horowitz JF, Mora-Rodriguez R, Byerley LO, Coyle EF. Lipolytic suppression
following carbohydrate ingestion limits fat oxidation during
exercise. Am J Physiol. 1997;273(4 Pt 1):E768–E775.
31. Volek JS, Noakes T, Phinney SD. Rethinking fat as a fuel for endurance
exercise. Eur J Sport Sci. 2015;15(1):13–20.
32. Stellingwerff T, Spriet LL, Watt MJ, et al. Decreased PDH activation
and glycogenolysis during exercise following fat adaptation
with carbohydrate restoration. Am J Physiol Endocrinol Metab.
2006;290(2):E380–E388.
33. van Loon LJ. Is there a need for protein ingestion during exercise?
Sports Med. 2014;44 Suppl 1:S105–S111.
34. Hillman AR, Turner MC, Peart DJ, et al. A comparison of hyperhydration
versus ad libitum fluid intake strategies on measures of
oxidative stress, thermoregulation, and performance. Res Sports Med.
2013;21(4):305–317.
35. Sawka MN, Burke LM, Eichner ER, Maughan RJ, Montain SJ,
Stachenfeld NS; American College of Sports Medicine. American
College of Sports Medicine position stand. Exercise and fluid
replacement. Med Sci Sports Exerc. 2007;39(2):377–390.
36. Kristal-Boneh E, Glusman JG, Shitrit R, Chaemovitz C, Cassuto Y.
Physical performance and heat tolerance after chronic water loading and
heat acclimation. Aviat Space Environ Med. 1995;66(8):733–738.
37. Noakes TD. Drinking guidelines for exercise: what evidence is there that
athletes should drink “as much as tolerable”, “to replace the weight lost
during exercise” or “ad libitum”? J Sports Sci. 2007;25(7):781–796.
38. Hoffman MD, Stuempfle KJ. Hydration strategies, weight change
and performance in a 161 km ultramarathon. Res Sports Med.
2014;22(3):213–225.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

A number of factors contribute to success in sport, and nutrition is a key component. An athlete’s dietary requirements. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

Shelby Daugherty's curator insight, March 18, 2021 1:54 PM

A lot of athletes struggle with nutrition in sports. This a lot of the times leads to performance enhancements pills being taken. When athletes aren't feeding their bodies with the nutrients it needs the body will not recover properly from workouts. If you are trying to bulk up but not doing it correctly, this also runs a problem. Everyone wants fast results. Taking enhancements can just hinder you. 

Lauren M's curator insight, June 3, 2022 9:07 AM

Running puts a lot of strain on your body, so learning how to properly fuel your body is essential if you want to run at your best. This article digs deeper into the topic of healthy nutrition. Meeting with a dietician or nutritionist is recommended if you want to understand more about what to eat, according to the article. When I was training for my half marathon, I visited with a nutritionist and we talked about the necessity of protein, carbs, and a variety of other topics!

Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
October 3, 2017 9:15 PM
Scoop.it!

Excessive Weight Gain, Obesity, And Cancer | El Paso, TX Chiropractor | 915-850-0900

Excessive Weight Gain, Obesity, And Cancer | El Paso, TX Chiropractor | 915-850-0900 | Diet and Supplements | Scoop.it

Opportunities For Clinical Intervention

Even though the effects of overweight and obesity on diabetes, cardiovascular disease, all-cause mortality, and other health outcomes are widely known, there is less awareness that overweight, obesity, and weight gain are associated with an increased risk of certain cancers. A recent review of more than 1000 studies concluded that sufficient evidence existed to link weight gain, overweight, and obesity with 13 cancers, including adenocarcinoma of the esophagus; cancers of the gastric cardia, colon and rectum, liver, gallbladder, pancreas, corpus uteri, ovary, kidney, and thyroid; postmenopausal female breast cancer; meningioma; and multiple myeloma.1 An 18-year follow-up of almost 93 000 women in the Nurses’ Health Study revealed a dose-response association of weight gain and obesity with several cancers.2

Obesity Increase

The prevalence of obesity in the United States has been increasing for almost 50 years. Currently, more than two-thirds of adults and almost one-third of children and adolescents are overweight or obese. Youths who are obese are more likely to be obese as adults, compounding their risk for health consequences such as cardiovascular disease, diabetes, and cancer. Trends in many of the health consequences of overweight and obesity (such as type 2 diabetes and coronary heart disease) also are increasing, coinciding with prior trends in rates of obesity. Furthermore, the sequelae of these diseases are related to the severity of obesity in a dose-response fashion.2 It is therefore not surprising that obesity accounts for a significant portion of health care costs.

Cancers

A report released on October 3, 2017, by the US Centers for Disease Control and Prevention assessed the incidence of the 13 cancers associated with overweight and obesity in 2014 and the trends in these cancers over the 10-year period from 2005 to 2014.3 In 2014, more than 630 000 people were diagnosed as having a cancer associated with overweight and obesity, comprising more than 55% of all cancers diagnosed among women and 24% of cancers among men. Most notable was the finding that cancers related to overweight and obesity were increasingly diagnosed among younger people.

 

From 2005 to 2014, there was a 1.4% annual increase in cancers related to overweight and obesity among individuals aged 20 to 49 years and a 0.4% increase in these cancers among individuals aged 50 to 64 years. For example, if cancer rates had stayed the same in 2014 as they were in 2005, there would have been 43 000 fewer cases of colorectal cancer but 33 000 more cases of other cancers related to overweight and obesity. Nearly half of all cancers in people younger than 65 years were associated with overweight and obesity. Overweight and obesity among younger people may exact a toll on individuals’ health earlier in their lifetimes.2 Given the time lag between exposure to cancer risk factors and cancer diagnosis, the high prevalence of overweight and obesity among adults, children, and adolescents may forecast additional increases in the incidence of cancers related to overweight and obesity.

Clinical Intervention

Since the release of the landmark 1964 surgeon general’s report on the health consequences of smoking, clinicians have counseled their patients to avoid tobacco and on methods to quit and provided referrals to effective programs to reduce their risk of chronic diseases including cancer. These efforts, coupled with comprehensive public health and policy approaches to reduce tobacco use, have been effective—cigarette smoking is at an all-time low. Similar efforts are warranted to prevent excessive weight gain and treat children, adolescents, and adults who are overweight or obese. Clinician referral to intense, multicomponent behavioral intervention programs to help patients with obesity lose weight can be an important starting point in improving a patient’s health and preventing diseases associatedwith obesity. The benefits of maintaining a healthy weight throughout life include improvements in a wide variety of health outcomes, including cancer. There is emerging but very preliminary data that some of these cancer benefits may be achieved following weight loss among people with overweight or obesity.4

The US Preventive Services Task Force (USPSTF)

The US Preventive Services Task Force (USPSTF) recommends screening for obesity and intensive behavioral interventions delivered over 12 to 16 visits for adults and 26 or more visits for children and adolescents with obesity.5,6 Measuring patients’ weight, height, and body mass index (BMI), consistent with USPSTF recommendations, and counseling patients about maintaining a healthy weight can establish a foundation for preventive care in clinical care settings. Scientific data continue to emerge about the negative health effects of weight gain, including an increased risk of cancer.1 Tracking patients’ weight over time can identify those who could benefit from counseling and referral early and help them avoid additional weight gain. Yet less than half of primary care physicians regularly assess the BMI of their adult, child, and adolescent patients. Encouraging discussions about weight management in multiple health care settings, including physicians’ offices, clinics, emergency departments, and hospitals, can provide multiple opportunities for patients and reinforce messages across contexts and care environments.

Weight Loss Programs

Implementation of clinical interventions, including screening, counseling, and referral, has major challenges. Since 2011, Medicare has covered behavioral counseling sessions for weight loss in primary care settings. However, the benefit has not been widely utilized.7 Whether the lack of utilization is a consequence of lack of clinician or patient knowledge or for other reasons remains uncertain. Few medical schools and residency programs provide adequate training in prevention and management of obesity or in understanding how to make referrals to such services. Obesity is a highly stigmatized condition; many clinicians find it difficult to initiate a conversation about obesity with patients, and some may inadvertently use alienating language when they do. Studies indicate that patients with obesity prefer the use of terms such as unhealthy weight or increased BMI rather

than overweight or obesity and improved nutrition and physical activity rather than diet and exercise.8 However, it is unknown if switching to these terms will lead to more effective behavioral counseling. Effective clinical decision support tools to measure BMI and guide physicians through referral and counseling interventions can provide clinicians needed support within the patient-clinician encounter. Inclusion of recently developed competencies for prevention and management of obesity into the curricula of health care professionals may improve their ability to deliver effective care. Because few primary care clinicians are trained in behavior change strategies like cognitive behavioral therapy or motivational interviewing, other trained health care professionals, such as nurses, pharmacists, psychologists, and dietitians could assist by providing counseling and appropriate referrals and help people manage their own health.

 

Achieving sustainable weight loss requires comprehensive strategies that support patients’ efforts to make significant lifestyle changes. The availability of clinical and community programs and services to which to refer patients is critically important. Although such programs are available in some communities, there are gaps in availability. Furthermore, even when these programs are available, enhancing linkages between clinical and community care could improve patients’ access. Linking community obesity prevention, weight management, and physical activity programs with clinical services can connect people to valuable prevention and intervention resources in the communities where they live, work, and play. Such linkages can give individuals the encouragement they need for the lifestyle changes that maintain or improve their health.

 

The high prevalence of overweight and obesity in the United States will continue to contribute to increases in health consequences related to obesity, including cancer. Nonetheless, cancer is not inevitable; it is possible that many cancers related to overweight and obesity could be prevented, and physicians have an important responsibility in educating patients and supporting patients’ efforts to lead healthy lifestyles. It is important for all health care professionals to emphasize that along with quitting or avoiding tobacco, achieving and maintaining a healthy weight are also important for reducing the risk of cancer.

Targeting Obesity

Article Information

 

Greta M. Massetti, PhD1; William H. Dietz, MD, PhD2; Lisa C. Richardson, MD, MPH1

 

Author Affiliations

 

Corresponding Author: Greta M. Massetti, PhD, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA 30341 (gmassetti@cdc.gov).

 

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflict of Interest. Dr Dietz reports receipt of scientific advisory board fees from Weight Watchers and consulting fees from RTI. No other disclosures were reported.

 

Disclaimer: The findings and conclusions in this report are those of the authors and not necessarily the official position of the Centers for Disease Control and Prevention.

 

References

 

1. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer—viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794-798. PubMed Article

 

2. Zheng Y, Manson JE, Yuan C, et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA. 2017;318(3):255-269. PubMed Article

 

3. Steele CB, Thomas CC, Henley SJ, et al. Vital Signs: Trends in Incidence of Cancers Related to Overweight and Obesity—United States, 2005-2014. October 3, 2017. https://www.cdc.gov/mmwr/volumes/66/wr/mm6639e1.htm?s_cid=mm6639e1_w.

 

4. Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes Obes Metab. 2011;13(12):1063-1072. PubMed Article

 

5. Grossman DC, Bibbins-Domingo K, Curry SJ, et al; US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(23):2417-2426. PubMed Article

 

6. US Preventive Services Task Force. Final Recommendation Statement: Obesity in Adults: Screening and Management. December 2016. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/obesity-in-adults-screening-and-management. Accessed September 21, 2017.

 

7. Batsis JA, Bynum JPW. Uptake of the centers for Medicare and Medicaid obesity benefit: 2012-2013. Obesity (Silver Spring). 2016;24(9):1983-1988. PubMed Article

 

8. Puhl R, Peterson JL, Luedicke J. Motivating or stigmatizing? public perceptions of weight-related language used by health providers. Int J Obes (Lond). 2013;37(4):612-619. PubMed Article

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

There is less awareness that overweight, obesity, and weight gain are associated with an increased risk of certain cancers. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
August 21, 2017 6:38 PM
Scoop.it!

The Common Benefits of a Ketogenic Diet | Nutrition Specialist | Call: 915-850-0900

The Common Benefits of a Ketogenic Diet | Nutrition Specialist | Call: 915-850-0900 | Diet and Supplements | Scoop.it

The benefits that come from a ketogenic diet are much like those of any strict low-carb diet. The effect may be greater since protein is significantly more restricted. This raises ketones more, and reduces insulin (the fat-storing hormone).

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

The advantages will be the most frequent ones. However there are many others that are potentially even more unexpected and, at least for some people, lifechanging. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
August 16, 2017 6:35 PM
Scoop.it!

Intermittent Fasting May Increase Quality of Life | Scientific Specialist | Call: 915-850-0900

Intermittent Fasting May Increase Quality of Life | Scientific Specialist | Call: 915-850-0900 | Diet and Supplements | Scoop.it

Although some studies have suggested that primates that eat less live longer, research concluded that restriction does not extend average life span in some species of monkeys. A section of the data confirms the idea that limiting food intake reduces the dangers of diseases common in older age and lengthens the period of life spent in good health, even if the research concludes that restriction does not help people live longer.

 

If only one could claim those advantages without being hungry all the time. In recent years researchers have concentrated on a strategy known as intermittent fasting as a promising option to continuous calorie restriction.

 

Intermittent fasting, including everything from regular multi-day fasts to skipping a meal or 2 on particular days of the week, may encourage a number of the identical health benefits that uninterrupted calorie restriction promises. The idea of intermittent fasting is palatable to people since somebody does not need to renounce the joys of eating. Studies suggest that rodents live as long as rats eating foods every moment consuming fewer calories overall than they would normally.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Studies have demonstrated that reducing typical calorie consumption, usually by 30 to 40 percent, extends life span by a third or more in many animals, including fruit flies, nematodes and rodents. But the jury remains out, when it comes to calorie restriction in primates and individuals. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
May 15, 2017 3:45 PM
Scoop.it!

The Ketogenic Diet & Athletes: An Interview With Ben Greenfield | El Paso Back Clinic® • 915-850-0900

The Ketogenic Diet & Athletes: An Interview With Ben Greenfield | El Paso Back Clinic® • 915-850-0900 | Diet and Supplements | Scoop.it


Conventional knowledge wants us to believe that athletes must eat a high carb diet in order to function at optimum levels. While many people believe this, nothing could be further from the truth. Ben Greenfield conducted extensive tests on himself to prove that it is possible to be a fat burning athlete, and that being a high carb athlete should be a thing of the past.


Ben’s analysis was very detailed and impressive: he had blood work, biopsies, urine and stool samples taken before the study began. He then walked on the treadmill for three hours and retook the blood work, biopsies the urine, and the stool samples, then analyzed the data. The study was called The Faster Study, and the data is available via PDF for those interested in looking at his findings and Ben’s write-up on the experience can be found here.
 
The Faster Study


When I asked Ben why he did the study, he said it was for his own selfish reasons. He said he was training for an Ironman triathlon at the time and wanted to go faster or at least maintain his speed for longer periods without experiencing the deleterious effects that chronically elevated blood sugar can cause. He also wanted to avoid the potentially unsettling effects that carbohydrates fermenting in your gut can cause.


Ben also had another incentive: he was diagnosed as having a 17% higher than normal risk for Type 2 diabetes. As a result, he needed to figure out a way to complete an Ironman triathlon without going the traditional route of fueling with gels, bars, and energy drinks.


I can attest that his theory works because I tried it myself: while on an 18 hour intermittent fast, I went on a 3 hour bike ride. By the time I got home, it was 22 or 23 hours before I’d eaten one bite of food, and to everyone’s surprise, I didn’t bonk. Everyone on the ride that day was a seasoned athlete and eating constantly. I was the only one not eating, yet had plenty of energy, even after 20 hours without food. Ben proved that in a laboratory and I successfully tested his hypothesis in a real life situation.


The Faster Diet


In preparation for his experiment, Ben followed a diet of 80 to 90% fat and 5 to 10% carbohydrates. His protein intake would vary depending on the day’s activities. For example, protein intake would be approximately 20% on days he’d run or do weight training. On average, the majority of his diet was fat based. He jokingly said he was banned from Italian restaurants during this time.


While on his high fat/low carb diet, Ben did two ironman triathlons that year (Ironman Canada and Ironman Hawaii.) He stresses that that a low carbohydrate diet does not mean a zero carbohydrate diet. Using Ironman triathlon as an example, participants may be out competing for ten or more hours. When passing someone the on the bike, a person may go from their normal race pace of 250 watts up to 400 watts for a few moments. This surge of energy being exerted can cause a pretty significant glycolytic shift, resulting in the body needing to burn through a high amount of carbohydrates.


Ben took in about a quarter of the amount of carbohydrates that he’d normally consume during the actual event, along with ample amounts of easy to digest proteins, amino acids, easy to digest fats, and medium chain triglycerides. After his triathlon season was completed, Ben added exogenous ketones to his diet in powder form to increase ketone levels. Ben admitted that he finds the ketones extremely beneficial and says he wish he’d known about them while training for previous triathlons. Personally, I have experimented with exogenous ketones in my own fat burning regime, after learning more about how they work during my interview with Dominic D’Agostino (watch the interview here.)


Study Findings


During that triathlon season, Ben conducted quite a few studies, with a few standing out in particular. In this test, a microbiome analysis was conducted to see how the gut differs between someone who follows a high-carbohydrate diet and someone who follows a high-fat diet.


Fat biopsies were taken both before and after exercise to see to see if his actual fat tissue make-up was any different. Tests were also conducted to see if there was any difference in the ability of his muscles to store carbohydrate and how quickly the muscle would burn through carbohydrates. A resting metabolic test was conducted, which is an analysis of how much fat and carbohydrate is burned at rest. And another measurement was taken to determine how many carbohydrates, fats, and calories are burned during exercise.


What makes these tests interesting is even though most physiology textbooks claim that the average person will burn about 1.0 grams of fat per minute during exercise, the athletes who followed a ketogenic or low-carbohydrate diet for close to 12 month were experiencing fat oxidation values of closer to 1.5 to 1.8 grams of fat per minute. This is significantly higher than what experts expected.


Not only is there a glycogen sparing effect that’s occurring, but there’s also some pretty significant health implications: fewer free radicals are being created, there is less fermentation in the gut, and fluctuations in blood sugar are noticeably reduced.
Initially, there was some confusion pertaining to this study because it was called “ The Faster Study.” Critics would say Ben wasn’t going any faster on the high fat/low carb diet than those on the high carb diet. What they neglected to understand was the purpose of the study wasn’t to go faster than those on high carb diets. Instead, the goal was to maintain similar speeds while limiting (and possibly eliminating) the chronic fluctuations and elevations of blood sugar.


Ben’s thought process behind the study was simple: If he could go just as fast by eliminating sugars, why not do it? If he slowed down or felt his energy levels being depleted, he’d be forced to ask himself the following questions as an endurance athlete:

 

  • What kind of balance did he want between health and performance?
  • How many years of his life was he willing to sacrifice in exchange for going just a little bit faster?
  • How much pressure was he willing to put on his joints?
  • How much gut distress was he willing to endure?
  • As it turns out, Ben could go just as fast on a carbohydrate-limited diet.


Go Just as Fast, Live Longer


While people are focused on getting faster, the ultimate goal should be to go just as fast and live longer doing it. Unfortunately, many high-carb athletes have a wide assortment of health problems, which can range from joint problems to life threatening emergencies such as heart attacks. Many of them are dying prematurely and don’t realize a contributing factor to their ailments is the high carb diet they had been following for years. Ironically, many athletes are thin but show evidence of degenerative disease indicating years of inflammation and oxidative stress caused by repeated glucose and insulin spikes. We know this damage is oxidative, is harmful to the cells, and causes premature aging.


There are many studies with research illustrating how endurance sports increase oxidation and aging, but I believe as more research is done this belief will change. Studies by Ben and others show that a fat-adapted endurance athlete does not have the same levels of oxidative stress as high carb endurance athletes. At age 50, I have 8% body fat and can exercise for hours without ingesting carbohydrates because, like Ben, I’m very efficient at fat burning.


I firmly believe Ben’s study proves that people who are efficient at fat burning can burn well over one gram of fat per minute of exercise, whereas before it was believed one gram (or less) was a more realistic number. It should be noted that in order to burn that much fat, a person has to be fat adapted. It’s impossible to accomplish this level of fat burning on a high-carbohydrate diet (read more on how to get fat-adapted here: Part 1 and Part 2.)


Fat Adaption: A trick to Accelerate the Process


Becoming an efficient fat burner takes time. Many of the athletes that Ben coaches have been on a high fat diet for twelve months or more. While the greatest benefits aren’t felt for several months, a person can experience lower blood sugar levels and less oxidation within a few short weeks of starting a high fat diet. However, in order to achieve the mitochondrial density necessary for producing a lot of ATP on a high-fat diet while exercising, a person will need to follow a high-fat diet for at least a year.


It can take anywhere from 6 months to 2 years for a person to become fully efficient at burning fat. While some may balk at how long it can take, it’s not long when compared to the time it may take to become proficient in a sport, learning to play a musical instrument, or getting a college degree.


Adjusting to a high fat diet takes time and patience. To accelerate the process, one can choose to eat within a compressed time window, a strategy known as intermittent fasting. Intermittent fasts can range from 14-24 hours with just liquids being consumed. Intermittent fasting can be a challenge for beginners as the body begins to adapt, but becomes easier with each subsequent fast. I intermittent fast daily and must say it’s been the great contributor to my overall cellular health.


Some side effects beginners may experience while intermittent fasting the first few times may include the following

 

  • Fatigue
  • Nausea
  • Vomiting
  • Diarrhea
  • Headaches
  • Lack of focus
  • Bad breath
  • Lethargy
  • Joint pain
  • Minor depression


These side effects are normal as the body eliminates various toxins. Drinking pure water helps to alleviate some side effects and quickly remove them from the body via urination. Staying focused on the long term is key when embarking on these changes.


Occasionally, I will receive emails from my clients or the doctors of my clients, telling me they are keto-adapted, but they’re not burning fat, they don’t notice any significant changes in their bodies, and they haven’t lost any weight. I explain how this is normal, and the body has to adjust. It takes time for the body to realize it is not starving and that it can begin to burn its own fat for energy. Using my wife as an example, it was almost a year before she was able to use her fat storage for energy. Now, she’s an efficient fat burner and finds it much easier to stay lean.


Not All Fat is the Same


An important aspect of being efficient at fat burning is the type of high fat diet you follow. A plant-rich, ketogenic diet not only limits oxidation and free radical production, but it also causes an increase in stable energy sources due to high fiber content. Having high levels of plant-based chlorophylls in the bloodstream also has the potential to increase ATP production beyond what we fully understand in nutrition science.


Ben encounters many people who follow the Bulletproof Coffee type of approach:

 

  • Three cups of coffee with grass-fed butter and MCT oil during the day
  • Coconut milk with some coconut flakes and some chocolate stevia
  • Fatty grass-fed steak for dinner
  • Macadamia nuts for a snack


The problem with this type of diet is there’s very little plant matter eaten, and plants are an integral part of a healthy high fat diet.


Ben Greenfield’s Diet


Ben eats an astonishing 20 to 25 servings of plants per day. He has an enormous backyard garden and eats kale, butter lettuce, bok choy, mustard greens, cilantro, parsley, and tomatoes daily. He says these foods do not count towards his total daily carbohydrate intake, and that eating a high-fat diet does not mean that you’re not eating plants. It’s the opposite. “I eat a lot of plants, a lot of fiber, and it makes a night-and-day difference.”


In order to get 20-25 servings Ben eats huge salads and drinks nutrient dense smoothies. He’ll drink one or two large smoothies a day, using a powerful blender that blends everything from the pit of an avocado to an entire bunch of kale. A sample smoothie includes the following ingredients:

 

  • Six to eight different plants (both wild plants and herbs)
  • Traditional plants like cucumbers or avocados
  • Coconut milk
  • Good fats
  • Seeds
  • Nuts


Lunch. Lunch is a salad in an enormous bowl filled exclusively with vegetables. Ben will spend 30 to 60 minutes chewing each bite 20 to 25 times and “eating lunch like a cow while I go through emails and things like that during lunch.”


Dinner. Another big salad.


Snack. Snacks are normally smaller versions of the smoothie he had for breakfast.


He stresses that his salads are extremely large and he prefers thicker smoothies: “If you were to see the size of my salads and the size of my smoothies, you would be shocked. You’d think I would be morbidly obese, but if you dig in and you look at it, it’s really just mostly plant volume. That’s generally what I do, salads and smoothies. I make them so thick I need to eat them with a spoon because I really like to chew my food. Yeah, I’m a smoothie and a salad guy.”


He goes on to say “When I look over the blood and bile markers of people following a high-fat diet, a lot of times I see really high triglycerides and really low HDL, which is often what you’ll see in someone who is eating a ton of animal fats without many plants or without much fiber. I’ll see a lot of CO2 and really low chloride levels, an indicator of a net acidic state, and a lot of biomarkers that aren’t necessarily favorable and that can be a result of a high-fat diet done improperly. I think that’s one important thing to bear in mind, too, is that you don’t want to necessarily eschew plant intake and vegetable intake; you just want to ensure that those are accompanied primarily by healthy fats and oils rather than accompanied by high amounts of protein and starches.”


When it comes to good fats, Ben prefers the following:

 

  • Full-fat coconut milk
  • Avocados and avocado oil
  • Olives
  • Extra virgin olive oil
  • Macadamia nuts
  • Almonds
  • Walnuts
  • Pumpkin seeds
  • Chia seeds
  • Bone broth
  • MCT oil (during exercise)
  • Coconut oil (added to smoothies)


Animal fats are eaten sparingly. He’ll eat a grass-fed steak and wild fish a couple of times a week. He also likes pemmican, which comes in a tube that he can snack on while flying or if he needs a quick snack on the go.


When Ben was a bodybuilder, he would aim for 200 grams of protein per day but now only consumes between 100 to 120 grams. Currently, he weighs about 180 pounds and consumes between 0.5 and .8 grams of protein per pound of body weight. He feels this is the amount is sufficient to avoid any loss of muscle.


Ben says he has excellent colonic health. Since he started the high fat diet four years ago, he doesn’t have the fermentation, gas, bloating, or constant gas that many endurance athletes have. He also believes the high fat diet offers a lower risk for things like small intestine bacterial overgrowth (SIBO) and fermentation in the gut.


Diet Variation


In addition to eating a variety of plant based foods, an important eating concept that I have written about is something I like to call “diet variation,” which is basically emulating what our ancestors have done: They were forced into different diet variations seasonally, and in some instances, weekly.


When we look at the Hunza people as an example, they were relying mostly on plant food in the summers to survive. During the cold winter months, vegetables and fruits were scarce or nonexistent, and as a result, they were forced to eat higher-fat foods (meats and animal fats). Over time we can see a pattern: there would be long stretches where their diet consisted mostly of vegetables (summer,) then extended periods of time where their diet was mainly meat products (winter.) This type of seasonal eating created a variation in their diet they had little control over. Today, we have the ability to vary our diet at all times, which can work for us and against us.


I go into ketosis every summer and eat more good fats and protein than I do in the winter, when I eat more healthy carbs. Like Ben, I’m very fat adapted, yet still able to stay in ketosis while eating a lot of plants in my diet. I intermittent fast in the morning and by the afternoon I’m burning high ketones.


One of the popular diet trends these days is the Paleo Diet, where a person is instructed to eat large amounts of protein. Quite frankly, I am not a fan of this diet. I have read many studies on high-protein diets and feel they are not healthy. Eating too much protein can cause weight gain, extra body fat, increased stress on the kidneys, dehydration and other health issues.


If you include the dangers of eating grain fed beef instead of the healthier grass fed beef, we can clearly see how the Paleo Diet could be a recipe for disaster. I tell people as a general rule, eating protein that is equivalent to half your body weight (considering that you’re not morbidly obese) is usually safe and practical. Athletes like Ben (and those who do a lot of strenuous physical exercise) can consume more protein than the average person and utilize it safely. These individuals may require 0.7 to 0.8 grams of protein per day, while the average person only needs .55 grams per day.


Fasting


Ben goes on a 24 hour fast once a month, just to “clean things out a little bit.” He will start the fast Saturday at lunchtime end it at lunchtime on Sunday. Or, he’ll skip dinner on Saturday night and won’t eat again until dinner on Sunday. He’ll drink water, coffee and tea primarily during the fast, and kombucha on occasion. He also goes on a 12-16-hour intermittent fast daily. The majority of the fast is overnight where he’ll finish dinner around 7:00 or 8:00 p.m. and eat breakfast sometime 9 and 10:30 a.m. During the daily fast, Ben will perform a few low-level exercises in the morning: yoga, foam rolling, or mobility work are exercises of choice.


In addition to daily intermittent fasting, Ben believes a likely factor that helps him to stay lean and maintain a low body fat percentage is taking cold showers. He likes to do one of the following daily:

 

  • Fast, perform a low intensity exercises then take cold shower or…
  • Fast, sit in a sauna for a few minutes, followed immediately with a cold shower.


Ben’s Exercise Regimen


Ben is active all day, but in an unconventional way:


“I generally am active all day long. Today, while I’m writing, doing consults, and reading emails, I’ll walk somewhere in the range of three to five miles at a low intensity like I am right now. When I get up in the morning, I’ll generally spend 20 to 30 minutes doing some deep-tissue work and some mobility work, some foam roller, and some band work for traction on my joints. By the time I get to the end of the day, I’ve been mildly physically active for six to eight hours at just very low-level intensity.


“At the end of the day, I’ll throw in 30 to 60 minutes of a hard workout. That might be a tennis match. It might be kickboxing or jujitsu. It might be some kind of an obstacle course workout with sandbags, and kettlebells, and things like that. It might be a swim. It varies quite a bit, but generally it’s 30 to 60 minutes of something hard in the afternoon to the early evening, then up until that point, low-level physical activity all day long. It’s just tough to quantify because I’m always moving. As far as a formal workout, it comes out to about 30 to 60 minutes a day. We’re talking about a workout where the average heart rate is very close to maximum heart rate, so like a puke-fest style workout. That’s pretty draining from an energy standpoint. Generally, for me to do daily—exceeding 16-hour fasts daily—that gets tough.”


What’s Next For Ben?


Ben is an outdoorsman and wants to experiment with living on the land:


“I’d like to look into more of an ancestral application, a more practical application. I would like to look a little bit more into persistence hunting, something closer to where I live where I’d be going after elk or moose or something like that, preferably in the snow where tracking is a little bit easier, but seeing if it’s doable.


“A five to eight day hunt is realistically what you’re looking at with a bow, or with a spear, or with a close-range weapon, and seeing if it’s possible to actually go and get your own food in the absence of food, just to begin to get people thinking about the state that we live in, the culture that we live in where food is just constantly readily available. What would happen if we didn’t have food but we had to figure out a way to feed ourselves?”


Ben also shares the outdoor life with his children: One day week in the summers, they can only eat the plants they find outside in the garden until dinner. As part of their childhood, he wants them to learn how to take care of themselves. They can use the stove and the blender, stuff like that, but they can’t use ingredients from the pantry, or from the refrigerator. It’s all based on plants.


While many people may think this way of thinking and living is extreme, Ben believes more people can benefit from it if they stay open minded and give it a try:


“I would like to get people more aware of that type of practice because it really goes quite handily with the things that we’ve talked about—fasting and ketosis, and denial of modern food sources and starches and instead just learning how to take care of yourself. I think that there’s a lot of lessons to be had from a health and survival standpoint, and so plant foraging, spreading our message, as well as the potential of seeing the persistence hunting in the absence of any significant sources of calories, to be able to take what allows one to, say, do an Ironman Triathlon with very little calorie intake and then turn that into a more practical level like going out and getting your own meat and stuff. Again, without carrying a bunch of power-bars out with you, I think that’d be a cool little adventure to embark upon.”


A Life of Fitness


Ben believes fitness is a lifestyle, and everyone can incorporate fitness into their daily activities:

 

  • If you work in a traditional office setting, put a kettlebell underneath your desk.
  • Get one of these stools that you lean back on rather than sitting down.
  • Every time that you go to the bathroom have a rule that you’ve got to do 50 air squats.


“Start to work in those little things throughout the day. You’d be surprise at how fit you can stay and how prepared you can be for a big event without necessarily neglecting your family, your friends, hobbies, or work.”


Ben Greenfield is an inspiration. His research on high fat diets is sure to revolutionize the way athletes view diet and endurance exercise as a whole.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Ben Greenfield conducted extensive tests on himself to prove that it is possible to be a fat burning athlete.  For Answers to any questions you may have please call Dr. Jimenez at 

915-850-0900

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
January 18, 2018 4:03 PM
Scoop.it!

Nutraceutical Supplements, Nutrition: And Treatment Of Hypertension

Nutraceutical Supplements, Nutrition: And Treatment Of Hypertension | Diet and Supplements | Scoop.it

 

Abstract:

 

Vascular biology, endothelial and vascular smooth muscle and cardiac dysfunction play a primary role in the initiation and perpetuation of hypertension, cardiovascular disease and target organ damage. Nutrientgene interactions and epigenetics are predominant factors in promoting beneficial or detrimental effects in cardiovascular health and hypertension. Macronutrients and micronutrients can prevent, control and treat hypertension through numerous mechanisms related to vascular biology. Oxidative stress, inflammation and autoimmune dysfunction initiate and propagate hypertension and cardiovascular disease. There is a role for the selected use of single and component nutraceutical supplements, vitamins, antioxidants and minerals in the treatment of hypertension based on scientifically controlled studies which complement optimal nutrition, coupled with other lifestyle modifications.

 

Key words: Hypertension; Nutrition; Nutritional supplements;
Cardiovascular disease; Vascular biology

 

Core tip: Vascular biology and endothelial dysfunction play a primary roles in hypertension and subsequent cardiovascular disease. Micronutrients, macronutrients and optimal nutrition and nutritional supplements can prevent, control and treat hypertension through numerous mechanisms related to vascular biology. These treatments are complementary to drug therapy. Oxidative
stress, inflammation and autoimmune dysfunction initiate and propagate hypertension and cardiovascular disease. There is a role for the selected use of single and component nutraceutical supplements, vitamins, antioxidants and minerals in the treatment of hypertension based on scientifically controlled studies which complement optimal nutrition, coupled with other lifestyle modifications.

Nutraceutical Introduction:

 

 

Vascular disease is a balance between vascular injury and repair (Figure 1). The endothelium is in a strategic location between the blood and the vascular smooth muscle and secretes various substances to maintain vascular homeostasis and health (Figures 2 and 3). Various insults that damage the endothelium, lead to endothelial dysfunction (ED) and may induce hypertension and other cardiovascular diseases. Hypertension may be a hemodynamic marker of injured endothelium and vascular smooth muscle related to finite responses of inflammation, oxidative stress and immune dysfunction of the arteries leading to ED, vascular and cardiac smooth muscle dysfunction, loss of arterial elasticity with reduced arterial compliance and increased systemic vascular resistance. Hypertension is a consequence of the interaction of genetics and environment. Macronutrients and micronutrients are crucial in the regulation of blood pressure (BP) and subsequent target organ damage (TOD). Nutrient-gene interactions, subsequent gene expression, epigenetics, oxidative stress, inflammation and autoimmune vascular dysfunction have positive or negative influences on vascular biology in humans. Endothelial activation with ED and vascular smooth muscle dysfunction (VSMD) initiate and perpetuate essential hypertension.

 

 

 

 

Macronutrient and micronutrient deficiencies are very common in the general population and may be even more common in patients with hypertension and cardiovascular disease due to genetics, environmental causes and prescription drug use. These deficiencies will have an enormous impact on present and future cardiovascular health outcomes such as hypertension, myocardial infarction (MI), stroke and renal disease. The diagnosis and treatment of these nutrient deficiencies will reduce BP
and improve vascular health, ED, vascular biology and cardiovascular events.

EPIDEMIOLOGY

Epidemiology underscores the etiologic role of diet and associated nutrient intake in hypertension. The transition from the Paleolithic diet to our modern diet has produced
an epidemic of nutritionally-related diseases (Table 1). Hypertension, atherosclerosis, coronary heart disease (CHD), MI, congestive heart failure (CHF), cerebrovascular accidents (CVA), renal disease, type 2 diabetes mellitus (T2DM), metabolic syndrome (MS) and obesity are some of these diseases[1,2]. Table 1 contrasts intake of nutrients involved in BP regulation during the Paleolithic Era and modern time. Evolution from a pre-agricultural, hunter-gatherer milieu to an agricultural, refrigeration society has imposed an unnatural and unhealthful nutritional selection process. In sum, diet has changed more than our genetics can adapt.

 

 

 

The human genetic makeup is 99.9% that of our Paleolithic ancestors, yet our nutritional, vitamin and mineral intakes are vastly different[3]. The macronutrient and micronutrient variations, oxidative stress from radical oxygen species (ROS) and radical nitrogen species (RNS) and inflammatory mediators such as cell adhesion molecules (CAMs), cytokines, signaling molecules and autoimmune vascular dysfunction of T cells and B cells, contribute to the higher incidence of hypertension and other cardiovascular diseases through complex nutrient-gene interactions, epigenetic and nutrient-caveolae interactions and nutrient reactions with pattern recognition receptors [toll like receptors (TLR) and nod like receptors] in the endothelium[4-9] (Figure 4). Reduction in nitric oxidebioavailability, increase in angiotensin Ⅱ and endothelin coupled with endothelial activation initiate the vascular and cardiac dysfunction and hypertension. Poor nutrition, coupled with obesity and a sedentary lifestyle have resulted in an exponential increase in nutritionally-related
diseases. In particular, the high Na+/K+ ratio of modern diets has contributed to hypertension, CVA, CHD, MI, CHF and renal disease[3,10] as have the relatively low intake
of omega-3 PUFA, increase in omega-6 PUFA, saturated fat and trans fatty acids[11].

 

PATHOPHYSIOLOGY

Vascular biology assumes a pivotal role in the initiation and perpetuation of hypertension and cardiovascular TOD[1]. Oxidative stress (ROS and RNS), inflammation (increased expression of redox-sensitive proinflammatory genes, CAMs and recruitment migration and infiltration of circulating cells) and autoimmune vascular dysfunction (T cells and B cells) are the primary pathophysiologic and functional mechanisms that induce vascular disease[1,12-14] (Figure 5). All three of these are closely inter-related and establish a deadly combination that leads to ED, vascular smooth muscle and cardiac dysfunction, hypertension, vascular disease, atherosclerosis and CVD. Hypertension is not a disease but is the correct and chronically dysregulated response with an exaggerated outcome of the infinite insults to the blood vessel with subsequent environmental-genetic expression patterns and downstream disturbances in which the vascular system is the innocent bystander. This becomes a maladaptive vascular response that was initially intended to provide vascular defense to the endothelial insults (Figure 6)[1,13-15]. Hypertension is a vasculopathy characterized by ED, structural remodeling, vascular inflammation, increased arterial stiffness, reduced distensibility and loss of elasticity[13]. These insults are biomechanical (BP, pulse pressure, blood flow, oscillatory flow, turbulence, augmentation, pulse wave velocity and reflected waves) and biohumoral or biochemical which includes all the non-mechanical causes such as metabolic, endocrine, nutritional, toxic, infectious and other etiologies[1] (Figure 4). In addition to the very well established connections for endocrine and nutritional causes of hypertension, toxins and infections also increase BP[16-20]. Various toxins such as polychlorinated biphenyls, mercury, lead, cadmium, arsenic and iron also increase BP and CVD[16,17].

 

 

 

 

 

Numerous microbial organisms have been implicated in hypertension and CHD[18-20]. All of these insults lead to impaired microvascular structure and function which manifests clinically as hypertension[12-14]. The level of BP may not give an accurate indication of the microvascular involvement and impairment in hypertension. Hypertensive patients have abnormal microvasculature in the form of inward eutrophic remodeling of the small resistance arteries leading to impaired vasodilatory capacity, increased vascular resistance, increased media to lumen ratio, decreased maximal organ perfusion and reduced flow reserve, especially in the heart with decreased coronary flow reserve[12-14]. Significant functional then structural microvascular impairment occurs even before the BP begins to rise in normotensive offspring of hypertensive parents evidenced by ED, impaired vasodilation, forearm vascular resistance, diastolic dysfunction, increased left ventricular mass index, increased septal and posterior wall thickness and left ventricular hypertrophy[12,15]. Thus, the cellular processes underlying the vascular perturbations constitute a vascular phenotype of hypertension that may be determined by early life programming and imprinting which is compounded by vascular aging[12-14].

Oxidative Stress

Oxidative stress, with an imbalance between ROS and RNS and the anti-oxidant defense mechanisms, contributes to the etiology of hypertension in animals[10] and humans[11,12]. Radical oxygen species and RNS are generated by multiple cellular sources, including nicotinamide adenine dinucleotide phosphate hydrase (NADPH) oxidase, mitochondria, xanthine oxidase, uncoupled endotheliumderived nitric oxide (NO) synthase (U-eNOS), cyclooxygenase and lipo-oxygenase[11]. Superoxide anion is the predominant ROS species produced by these tissues, which neutralizes NO and also leads to downstream production of other ROS (Figure 3). Hypertensive patients have impaired endogenous and exogenous anti-oxidant defense mechanisms[21], an increased plasma oxidative stress and an exaggerated oxidative stress response to various stimuli[21,22]. Hypertensive subjects also have lower plasma ferric reducing ability of plasma, lower vitamin C levels and increased plasma 8-isoprostanes, which correlate with both systolic and diastolic BP. Various singlenucleotide polymorphisms (SNP’s) in genes that codify for anti-oxidant enzymes are directly related to hypertension[23]. These include NADPH oxidase, xanthine oxidase, superoxide dismutase 3 (SOD 3), catalase, glutathione peroxidase 1 (GPx 1) and thioredoxin. Antioxidant deficiency and excess free radical production have been implicated in human hypertension in numerous epidemiologic, observational and interventional studies (Table 2)[21,22,24]. Radical oxygen species directly damage endothelial cells, degrade NO, influence eicosanoid metabolism, oxidize LDL, lipids, proteins, carbohydrates, DNA and organic molecules, increase catecholamines, damage the genetic machinery, influence gene expression and transcription factors[1,21,22,25,26]. The inter-relations of neurohormonal systems, oxidative stress and cardiovascular disease are shown in Figures 6 and 7. The increased oxidative stress, inflammation and autoimmune vascular dysfunction in human hypertension results from a combination of increased generation of ROS and RNS, an exacerbated response to ROS and RNS and a decreased antioxidant reserve[24-29]. Increased oxidative stress in the rostral ventrolateral medulla (RVLM) enhances glutamatergic excitatory inputs and attenuates GABA-ergic inhibitory inputs to the RVLM which contributes to increased sympathetic nervous system (SNS) activity from the paraventricular nucleus[30]. Activation of the AT1R in the RVLM increases NADPH oxidase and increases oxidative stress and superoxide anion, increases SNS outflow causing an imbalance of SNS/PNS activity with elevation of BP, increased heart rate and alterations in heart rate variability and heart rate recovery time, which can be blocked by AT1R blockers[30,31].

 

 

 

Inflammation

The link between inflammation and hypertension has been suggested in both cross-sectional and longitudinal studies[32]. Increases in high sensitivity C-reactive protein (HS-CRP) as well as other inflammatory cytokines such as interleukin-1B, (IL-1B), IL-6, tumor necrosis alpha (TNF-α) and chronic leukocytosis occur in hypertension and hypertensive- related TOD, such as increased carotid IMT[33]. HS-CRP predicts future CV events[32,33]. Elevated HS-CRP is both a risk marker and risk factor for hypertension and CVD[34,35]. Increases in HS-CRP of over 3 μg/ml may increase BP in just a few days that is directly proportional to the increase in HS-CRP[34,35]. Nitric oxide and eNOS are inhibited by HS-CRP[34,35]. The AT2R, which normally counterbalances AT1R, is down regulated by HS-CRP[34,35]. Angiotensin Ⅱ (A-Ⅱ) upregulates many of the cytokines, especially IL-6, CAMs and chemokines by activating nuclear factor Kappa B (NFκb) leading to vasoconstriction. These events, along with the increases in oxidative stress and endothelin-1, elevate BP[32].

Autoimmune Dysfunction

Innate and adaptive immune responses are linked to hypertension and hypertension-induced CVD through at least three mechanisms: cytokine production, central nervous system stimulation and renal damage. This includes salt-sensitive hypertension with increased renal inflammation as a result of T cell imbalance, dysregulation of CD4+ and CD8+ lymphocytes and chronic leukocytosis with increased neutrophils and reduced lymphocytes[36-38]. Leukocytosis, especially increased neutrophils and decreased lymphocyte count increase BP in Blacks by 6/2 mmHg in the highest vs the lowest tertile[38]. Macrophages and various T-cell subtypes regulate BP, invade the arterial
wall, activate TLRs and induce autoimmune vascular damage[38,39]. Angiotensin Ⅱ activates immune cells (T cells, macrophages and dendritic cells) and promotes cell infiltration into target organs[39]. CD4+ T lymphocytes express AT1R and PPAR gamma receptors, and release TNF-α, interferon and interleukins within the vascular wall when activated[39] (Figure 5). IL-17 produced by T cells may play a pivotal role in the genesis of hypertension caused by Angiotensin Ⅱ[39]. Hypertensive patients have significantly higher TLR 4 mRNA in monocytes compared to normal[40]. Intensive reduction in BP to systolic BP (SBP) less than 130 mmHg vs SBP to only 140 mmHg lowers the TLR 4 more[40]. A-Ⅱ activates the TLR expression leading to inflammation and activation of the innate immune system. When TLR 4 is activated there is downstream macrophage activation, migration, increase metalloproteinase 9, vascular remodeling, collagen accumulation in the artery, LVH and cardiac fibrosis[40]. The autonomic nervous system is critical in either increasing
or decreasing immune dysfunction and inflammation[41]. Efferent cholinergic anti inflammatory pathways via the vagal nerve innervate the spleen, nicotine acetylcholine receptor subunits and cytokine producing immune cells to influence vasoconstriction and BP[41]. Local CNS inflammation or ischemia may mediate vascular inflammation and hypertension[39].

 

Aldosterone is associated with increased adaptive immunity and autoimmune responses with CD4+ T cell activation and Th 17 polarization with increased IL 17, TGF-β and TNF-α which modulate over 30 inflammatory genes[42,43]. Increased serum aldosterone is an independent risk factor for CVD and CHD through non-hemodynamic effects as well as through increased BP[42,43]. Blockade of mineralocorticoid receptors in the heart, brain, blood vessels and immune cells reduces CV risk even with the persistence of hypertension[42,43].

TREATMENT

Many of the natural compounds in food, certain nutraceutical supplements, vitamins, antioxidants or minerals function in a similar fashion to a specific class of antihypertensive drugs. Although the potency of these natural compounds may be less than the antihypertensive drug, when used in combination with other nutrients and nutraceutical supplements, the antihypertensive effect is additive or synergistic. Table 3 summarizes these natural compounds into the major antihypertensive drug classes such as diuretics, beta blockers, central alpha agonists, direct vasodilators, calcium channel blockers (CCB’s), angiotensin converting enzyme inhibitors (ACEI’s), angiotensin receptor blockers (ARB’s) and direct renin inhibitors (DRI).

Dietary Approaches To Stop Hypertension Diets

The Dietary Approaches to Stop Hypertension (DASH) Ⅰand Ⅱ diets conclusively demonstrated significant reductions in BP in borderline and stageⅠhypertensive patients[44,45]. In DASHⅠuntreated hypertensive subjects with SBP < 160 mmHg and DBP 80-95 mmHg were placed on one of three diets for 4 wk, control diet, fruit and vegetable diet (F + V) and combined diet that added F + V and low fat dairy[44]. DASH Ⅱ added progressive sodium restriction in each group[45]. The control diet consisted of sodium at 3 g/d, potassium, magnesium and calcium at 25% of the US average, macronutrients at US average of 4 servings per day, a sodium/potassium ratio of 1.7 and fiber at 9 g/d. The F + V diet increased the potassium, magnesium and calcium to 75%, macronutrients to greater than the US average, a sodium potassium ratio of 0.7, 31 g of fiber and 8.5 servings of fruits and vegetables per day. The combined diet was similar to the F + V diet but added low fat dairy. At 2 wk the BP was decreased by 10.7/5.2 mmHg in the hypertensive patients in DASHⅠand 11.5/6.8 mmHg in the hypertensive patients in DASH Ⅱ. These reductions persisted as long as the patients were on the diet. The DASH diet increases plasma renin activity (PRA) and serum aldosterone levels in response to the BP reductions[46,47]. The mean increase in PRA was 37 ng/ml per day[47]. There was an associated of response with the G46A polymorphism of beta 2 adrenergic receptor. The A allele of G46A had a greater BP reduction and blunted PRA and aldosterone. The arachidonic acid (AA) genotype had the best response and the GG genotype had no response. Adding an ARB, ACEI or DRI improved BP response to the DASH diet in the GG group due to blockade of the increase in PRA. A low sodium DASH diet decreases oxidative stress (urine F2-isoprostanes), improves vascular function (augmentation index) and lowers BP in salt sensitive subjects[48]. In addition, plasma nitrite increased and pulse wave velocity decreased at week two on the DASH diet[49].

Sodium (Na+) Reduction

The average sodium intake in the US is 5000 mg/d with some areas of the country consuming 15000-20000 mg/d[50]. However, the minimal requirement for sodium is probably about 500 mg/d[50]. Epidemiologic, observational and controlled clinical trials demonstrate that an increased sodium intake is associated with higher BP as well as increased risk for CVD, CVA, LVH, CHD, MI, renal insufficiency, proteinuria and over activity of the SNS[1,50]. A reduction in sodium intake in hypertensive patients, especially the salt sensitive patients, will significantly lower BP by 4-6/2-3 mmHg that is proportional to the degree of sodium restriction and may prevent or delay hypertension in high risk patients and reduce future CV events[51-53].

 

Salt sensitivity (≥ 10% increase in MAP with salt loading) occurs in about 51% of hypertensive patients and is a key factor in determining the cardiovascular, cerebrovascular, renal and BP responses to dietary salt intake[54]. Cardiovascular events are more common in the salt sensitive patients than in salt resistant ones, independent of BP[55]. An increased sodium intake has a direct positive correlation with BP and the risk of CVA and CHD[56]. The risk is independent of BP for CVA with a relative risk of 1.04 to 1.25 from the lowest to the highest quartile[56]. In addition, patients will convert to a nondipping BP pattern with increases in nocturnal BP as the sodium intake increases[56].

 

Increased sodium intake has a direct adverse effect on endothelial cells[57-61]. Sodium promotes cutaneous lymphangiogenesis, increases endothelial cell stiffness, reduces size, surface area, volume, cytoskeleton, deformability and pliability, reduces eNOS and NO production, increases asymmetric dimethyl arginine (ADMA), oxidative stress and TGF-β. All of these abnormal vascular responses are increased in the presence of aldosterone[57-61]. These changes occur independent of BP and may be partially counteract by dietary potassium[57-61]. The endothelial cells act as vascular salt sensors[62]. Endothelial cells are targets for aldosterone which activate epithelial sodium channels (ENaCs) and have a negative effects on release of NO and on endothelial function. The mechanical stiffness of the cell plasma membrane and the submembranous actin network (endothelial glcyocalyx) (“shell”) serve as a “firewall” to protect the endothelial cells and are regulated by serum sodium, potassium and aldosterone within the physiologic range[62]. Changes in shear-stress-dependent activity of the endothelial NO synthase located in the caveolae regulate the viscosity in this “shell”[62]. High plasma sodium gelates the shell of the endothelial cell, whereas the shell is fluidized by high potassium. These communications between extracellular ions and intracellular enzymes occur at the plasma membrane barrier, whereas 90% of the total cell mass remains uninvolved in these changes. Blockade of the ENaC with spironolactone (100%) or amiloride (84%) minimizes or stop many of these vascular endothelial responses and increase NO[58,63]. Nitric oxide release follows endothelial nanomechanics and not vice versa and membrane depolarization decreases vascular endothelial cell stiffness which improves flow mediated nitric-oxide dependent vasodilation[64,65]. In the presence of vascular inflammation and increased HS-CRP, the effects of aldosterone on the ENaC is enhanced further increasing vascular stiffness and BP[66]. High sodium intake also abolishes the AT2Rmediated vasodilation immediately with complete abolition of endothelial vasodilation (EDV) within 30 d[67]. Thus, it has become clear that increased dietary sodium has adverse effects on the vascular system, BP and CVD by altering the endothelial glycocalyx, which is a negatively charged biopolymer that lines the blood vessels and serves as a protective barrier against sodium overload, increased sodium permeability and sodium-induced TOD[68]. Certain SNP’s of salt inducible kinaseⅠwhich alter Na+ /K+ ATPase, determine sodium induced hypertension and LVH[69].

 

The sodium intake per day in hypertensive patients should be between 1500 to 2000 mg. Sodium restriction improves BP reduction in those on patients that are on pharmacologic treatment and the decrease in BP is additive with restriction of refined carbohydrates[70,71]. Reducing dietary sodium intake may reduce damage to the brain, heart, kidney and vasculature through mechanisms dependent on the small BP reduction as well as those independent of the decreased BP[72-75].

 

A balance of sodium with other nutrients, especially potassium, magnesium and calcium is important, not only in reducing and controlling BP, but also in decreasing cardiovascular and cerebrovascular events[3,72,73]. An increase in the sodium to potassium ratio is associated with significantly increased risk of CVD and all-cause mortality[72]. The Yanomamo Indians consume and excrete only 1 meq of sodium in 24 h and consume and excrete 152 meq of potassium in 24 h[73]. The Na+ to K+ ratio is 1/152 and is associated with elevated PRA, but BP does not increase with age. At age 50 the average BP in the Yanomamo is 100-108/64-69 mmHg[73].

Potassium

The average U.S. dietary intake of potassium (K+ ) is 45 mmol/d with a potassium to sodium (K+ /Na+ ) ratio of less than 1:2[10,74]. The recommended intake of K+ is 4700 mg/d (120 mmol) with a K+ /Na+ ratio of about 4-5 to 1[10,74]. Numerous epidemiologic, observational and clinical trials have demonstrated a significant reduction in BP with increased dietary K+ intake in both normotensive and hypertensive patients[10,74,76]. The average BP reduction with a K+ supplementation of 60 to 120 mmol/d is 4.4/2.5 mmHg in hypertensive patients but may be as much as 8/4.1 mmHg with 120 mmol/d (4700 mg)[10,74,76,77]. In hypertensive patients, the linear doseresponse relationship is 1.0 mmHg reduction in SBP and 0.52 mmHg reduction in diastolic BP per 0.6 g/d increase in dietary potassium intake that is independent of baseline dietary potassium ingestion[10]. The response depends on race (black > white), sodium, magnesium and calcium intake[10]. Those on a higher sodium intake have a greater reduction in BP with potassium[10]. Alteration of the K+ /Na+ ratio to a higher level is important for both antihypertensive as well as cardiovascular and cerebrovascular effects[10,77]. High potassium intake reduces the incidence of cardiovascular (CHD, MI) and CVA independent of the BP reduction[10,74,76,77]. There are also reductions in CHF, LVH, diabetes mellitus and cardiac arrhythmias[10]. If the serum potassium is less than 4.0 meq/dL, there is an increased risk of CVD mortality, ventricular tachycardia, ventricular fibrillation and CHF[10]. Red blood cell potassium is a better indication of total body stores and CVD risk than is serum potassium[10]. Gu et al[77] found that potassium supplementation at 60 mmol of KCl per day for 12 wk significantly reduced SBP -5.0 mmHg (range -2.13 to -7.88 mmHg) (p < 0.001) in 150 Chinese men and women aged 35 to 64 years.

 

Potassium increases natriuresis, modulates baroreflex sensitivity, vasodilates, decreases the sensitivity to catecholamines and Angiotensin Ⅱ, increases sodium potassium ATPase and DNA synthesis in the vascular smooth muscle cells and decreases SNS activity in cells with improved vascular function[10]. In addition, potassium increases bradykinin and urinary kallikrein, decreases NADPH oxidase, which lowers oxidative stress and inflammation, improves insulin sensitivity, decreases ADMA, reduces intracellular sodium and lowers production of TGF-β[10].

 

Each 1000 mg increase in potassium intake per day reduces all cause mortality by approximately 20%. Potassium intake of 4.7 g/d is estimated to decrease CVA by 8% to 15% and MI by 6%-11%[10]. Numerous SNP’s such as nuclear receptor subfamily 3 group C, angiotensin Ⅱ type receptor and hydroxysteroid 11 beta dehydrogenase (HSD11B1 and B2) determine an individual’s response to dietary potassium intake[78]. Each 1000 mg decrease in sodium intake per day will decrease all cause mortality by 20%[10,73]. A recent analysis suggested a dose related response to CVA with urinary potassium excretion[79]. There was a RRR of CVA of 23% at 1.5-1.99 g, 27% at 2.0-2.49 g, 29% at 2.5-3 g and 32% over 3 g/d of potassium urinary excretion[79]. The recommended daily dietary intake for patients with hypertension is 4.7 to 5.0 g of potassium and less than 1500 mg of sodium[10]. Potassium in food or from supplementation should be reduced or used with caution in those patients with renal impairment or those on medications that increase renal potassium retention such as ACEI, ARB, DRI and serum aldosterone receptor antagonists[10].

Magnesium

A high dietary intake of magnesium of at least 500-1000 mg/d reduces BP in most of the reported epidemiologic, observational and clinical trials, but the results are less consistent than those seen with Na+ and K+[74,80]. In most epidemiologic studies, there is an inverse relationship between dietary magnesium intake and BP[74,80,81]. A study of 60 essential hypertensive subjects given magnesium supplements showed a significant reduction in BP over an eight week period documented by 24 h ambulatory BP, home and office blood BP[74,80,81]. The maximum reduction in clinical trials has been 5.6/2.8 mmHg but some studies have shown no change in BP[82]. The combination of high potassium and low sodium intake with increased magnesium intake had additive anti-hypertensive effects[82]. Magnesium also increases the effectiveness of all anti-hypertensive drug classe[82].

 

Magnesium competes with Na+ for binding sites on vascular smooth muscle and acts as a direct vasodilator, like a CCB. Magnesium increases prostaglandin E (PGE), regulates intracellular calcium, sodium, potassium and pH, increases nitric oxide, improves endothelial function, reduces oxLDL, reduces HS-CRP, TBxA2, A-Ⅱ, and norepinephrine. Magnesium also improves insulin resistance, glucose and MS, binds in a necessary-cooperative manner with potassium, inducing EDV and BP reduction, reduces CVD and cardiac arrhythmias, decreases carotid IMT, lowers cholesterol, lowers cytokine production, inhibits nuclear factor Kb, reduces oxidative stress and inhibits platelet aggregation to reduce thrombosis[74,80-86].

 

Magnesium is an essential co-factor for the delta6-desaturase enzyme that is the rate-limiting step for conversion of linoleic acid (LA) to gamma linolenic acid (GLA)[74,80,81,83-85] needed for synthesis of the vasodilator and platelet inhibitor PGE1. Altered TRPM7 channels, which are the transporter for magnesium occur in many hypertensive patients[83].

 

A meta-analysis of 241378 patients with 6477 strokes showed an inverse relationship of dietary magnesium to the incidence of ischemic stroke[84]. For each 100 mg of dietary magnesium intake, ischemic stroke was decreased by 8%. The proposed mechanism include inhibition of ischemia induced glutamate release, NMDA receptor blockade, CCB actions, mitochondrial calcium buffering, decrease in ATP depletion and vasodilation of the cerebral arteries[84]. A meta-analysis showed reductions in BP of 3-4/2-3 mmHg in 22 trials of 1173 patients[87].

 

Intracellular level of magnesium (RBC) is more indicative of total body stores and should be measured in conjunction with serum and urinary magnesium[83]. Magnesium may be supplemented in doses of 500 to 1000 mg/d. Magnesium formulations chelated to an amino acid may improve absorption and decrease the incidence of diarrhea[82]. Adding taurine at 1000 to 2000 mg/d will enhance the anti-hypertensive effects of magnesium[82]. Magnesium supplements should be avoided or used with caution in patients with known renal insufficiency or in those taking medications that induce magnesium retention[82].

Calcium

Population studies show a link between hypertension and calcium[88], but clinical trials that administered calcium supplements to patients have shown inconsistent effects on BP[88]. The heterogeneous responses to calcium supplementation have been explained by Resnick[89]. This is the “ionic hypothesis”[89] of hypertension, cardiovascular disease and associated metabolic, functional and structural disorders. Calcium supplementation is not recommended at this time as an effective means to reduce BP.

Zinc

Low serum zinc levels in observational studies correlate with hypertension as well as CHD, type Ⅱ DM, hyperlipidemia, elevated lipoprotein a [Lp(a)], increased 2 h post prandial plasma insulin levels and insulin resistance[90,91]. Zinc is transported into cardiac and vascular muscle and other tissues by metallothionein[92]. Genetic deficiencies of metallothionein with intramuscular zinc deficiencies may lead to increased oxidative stress, mitochondrial dysfunction, cardiomyocyte dysfunction and apoptosis with subsequent myocardial fibrosis, abnormal cardiac remodeling, heart disease, heart failure, or hypertension[92]. Intracellular calcium increases oxidative stress which is reduced by zinc[92]. Bergomi et al[93] evaluated Zinc (Zn++) status in 60 hypertensive subjects compared to 60 normotensive control subjects. An inverse correlation of BP and serum Zn++ was observed. The BP was also inversely correlated to a Zn++ dependent enzyme-lysyl oxidase activity. Zn++ inhibits gene expression and transcription through NF-κb and activated protein-1 and is an important cofactor for SOD[90,92]. These effects plus those on insulin resistance, membrane ion exchange, RAAS and SNS effects may account for Zn++ antihypertensive effects[90,92]. Zinc intake should be 50 mg/d[1].

Protein

Observational and epidemiologic studies demonstrate a consistent association between a high protein intake and a reduction in BP and incident BP[94,95]. The protein source is an important factor in the BP effect; animal protein being less effective than non-animal or plant protein, especially almonds[94-97]. In the Inter-Salt Study of over 10000 subjects, those with a dietary protein intake 30% above the mean had a lower BP by 3.0/2.5 mmHg compared to those that were 30% below the mean (81 vs 44 g/d)[94]. However, lean or wild animal protein with less saturated fat and more essential omega-3 fatty acids may reduce BP, lipids and CHD risk[94,97]. A meta-analysis confirmed these findings and also suggested that hypertensive patients and the elderly have the greatest BP reduction with protein intake[95]. Another meta-analysis of 40 trials with 3277 patients found reductions in BP of 1.76/1.15 mmHg compared to carbohydrate intake (p < 0.001)[98]. Both vegetable and animal protein significantly and equally reduced BP at 2.27/1.26 mmHg and 2.54/0.95 mmHg respectively[98]. Increased dietary protein intake is inversely associated with risk for stroke in women with hypertension[99]. A randomized cross-over study in 352 adults with pre-hypertension and stageⅠhypertension found a significant reduction in SBP of 2.0 mmHg with soy protein and 2.3 mmHg with milk protein compared to a high glycemic index diet over each of the 8 wk treatment periods[100]. There was a non-significant reduction in DBP. Another RDB parallel study over 4 wk of 94 subjects with prehypertension and stageⅠhypertension found significant reductions on office BP of 4.9/2.7 mmHg in those given a combination of 25% protein intake vs the control group given 15% protein in an isocaloric manner[101]. The protein consisted of 20% pea, 20% soy, 30% egg and 30% milk-protein isolate[101]. The daily recommended intake of protein from all sources is 1.0 to 1.5 g/kg body weight, varying with exercise level, age, renal function and other factors[1,70,71].

 

Fermented milk supplemented with whey protein concentrate significantly reduces BP in human studies[102-106]. Administration of 20 g/d of hydrolyzed whey protein supplement rich in bioactive peptides significantly reduced BP over 6 wk by 8.0 ± 3.2 mmHg in SBP and 5.5 ± 2.1 mm in diastolic BP[103]. Milk peptides which contain both caseins and whey proteins are a rich source of ACEI peptides. Val-Pro-Pro and Ile-Pro-Pro given at 5 to 60 mg/d have variable reductions in BP with an average decrease in pooled studies of about 1.28-4.8/0.59-2.2 mmHg[71,100,104-107]. However several recent meta-analysis did not show significant reductions in BP in humans[106,108]. Powdered fermented milk with Lactobacillus helveticus given at 12 g/d significantly lowered BP by 11.2/6.5 mmHg in 4 wk in one study[104]. Milk peptides are beneficial in treating MS[109]. A dose response study showed insignificant reductions in BP[110]. The clinical response is attributed to fermented milk’s active peptides which inhibit ACE.

 

Pins et al[111] administered 20 g of hydrolyzed whey protein to 56 hypertensive subjects and noted a BP reduction of 11/7 mmHg compared to controls at one week that was sustained throughout the study. Whey protein is effective in improving lipids, insulin resistance, glucose, arterial stiffness and BP[112]. These data indicate that the whey protein must be hydrolyzed in order to exhibit an antihypertensive effect, and the maximum BP response is dose dependent.

 

Bovine casein-derived peptides and whey protein-derived peptides exhibit ACEI activity[102-111]. These components include B-caseins, B-lg fractions, B2-microglobulin and serum albumin[102-104,111]. The enzymatic hydrolysis of whey protein isolates releases ACEI peptides.

 

Marine collagen peptides (MCPs) from deep sea fish have anti-hypertensive activity[113-115]. A double-blind placebo controlled trial in 100 hypertensive subjects with diabetes who received MCPs twice a day for 3 mo had significant reductions in DBP and mean arterial pressure[113]. Bonito protein (Sarda Orientalis), from the tuna and mackerel family has natural ACEI inhibitory peptides and reduces BP 10.2/7 mmHg at 1.5 g/d[114,116].

 

Sardine muscle protein, which contains Valyl-Tyrosine (VAL-TYR), significantly lowers BP in hypertensive subjects[117]. Kawasaki et al[117] treated 29 hypertensive subjects with 3 mg of VAL-TYR sardine muscle concentrated extract for four wk and lowered BP 9.7/5.3 mmHg (p < 0.05). Levels of A-Ⅰincreased as serum A-Ⅱ and aldosterone decreased indicating that VAL-TYR is a natural ACEI. A similar study with a vegetable drink with sardine protein hydrolysates significantly lowered BP by 8/5 mmHg in 13 wk[118].

 

Soy protein lowers BP in hypertensive patients in most studies[100,119-127]. Soy protein intake was significantly and inversely associated with both SBP and DBP in 45694 Chinese women consuming 25 g/d or more of soy protein over 3 years and the association increased with age[119]. The SBP reduction was 1.9 to 4.9 mm lower and the DBP 0.9 to 2.2 mmHg lower[119]. However, randomized clinical trials and meta-analysis have shown mixed results on BP with no change in BP to reductions of 7% to 10 % for SBP and DBP[121-125]. The recent meta-analysis of 27 trials found a significant reduction in BP of 2.21/1.44 mmHg[120]. Some studies suggest improvement in endothelial function, improved arterial compliance, reduction in HS-CRP and inflammation, ACEI activity, reduction in sympathetic tone, diuretic action and reduction in both oxidative stress and aldosterone levels[125-127]. Fermented soy at about 25 g/d is recommended.

 

In addition to ACEI effects, protein intake may also alter catecholamine responses and induce a natriuretic effect[117,118]. Low protein intake coupled with low omega 3 fatty acid intake may contribute to hypertension in animal models[128]. The optimal protein intake, depending on level of activity, renal function, stress and other factors, is about 1.0 to 1.5 g/kg per day[1].

Amino Acids And Related Compounds

L-arginine: L-arginine and endogenous methylarginines are the primary precursors for the production of NO, which has numerous beneficial cardiovascular effects, mediated through conversion of L-arginine to NO by eNOS. Patients with hypertension, hyperlipidemia, diabetes mellitus and atherosclerosis have increased levels of HSCRP and inflammation, increased microalbumin, low levels of apelin (stimulates NO in the endothelium), increased levels of arginase (breaks down arginine) and elevated serum levels of ADMA, which inactivates NO[129-133].

 

Under normal physiological conditions, intracellular arginine levels far exceed the Km [Michaelis Menton constant(MMC)] of eNOS which is less than 5 μmol[134]. However, endogenous NO formation is dependent on extracellular arginine concentration[134]. The intracellular concentrations of L-arginine are 0.1-3.8 mmol/L in endothelial cells while the plasma concentration of arginine is 80-120 μmol/L which is about 20-25 times greater than the MMC[135,136]. Despite this, cellular NO formation depends on exogenous L-arginine and this is the arginine paradox. Renal arginine regulates BP and blocks the formation of endothelin, reduces renal sodium reabsorption and is a potent antioxidant[134]. The NO production in endothelial cells is closely coupled to cellular arginine uptake indicating that arginine transport mechanisms play a major role in the regulation of NO-dependent function. Exogenous arginine can increase renal vascular and tubular NO bioavailability and influence renal perfusion, function and BP[132]. Molecular eNOS uncoupling may occur in the absence of tetrahydrobiopterin which stabilizes eNOS, which leads to production of ROS[135].

 

Human studies in hypertensive and normotensive subjects of parenteral and oral administrations of L-arginine demonstrate an antihypertensive effect as well as improvement in coronary artery blood flow and peripheral blood flow in PAD[129,136-140]. The BP decreased by 6.2/6.8 mmHg on 10 g/d of L-arginine when provided as a supplement or though natural foods to a group of hypertensive subjects[136]. Arginine produces a statistically and biologically significant decrease in BP and improved metabolic effect in normotensive and hypertensive humans that is similar in magnitude to that seen in the DASHⅠdiet[136]. Arginine given at 4 g/d also significantly lowered BP in women with gestational hypertension without proteinuria, reduced the need for anti-hypertensive therapy, decreased maternal and neonatal complications and prolonged the pregnancy[137,138]. The combination of arginine (1200 mg/d) and N-acetyl cysteine (NAC) (600 mg bid) administered over 6 mo to hypertensive patients with type 2 diabetes, lowered SBP and DBP (p < 0.05), increased HDL-C, decreased LDL-C and oxLDL, reduced HSCRP, ICAM, VCAM, PAI-Ⅰ, fibrinogen and IMT[139]. A study of 54 hypertensive subjects given arginine 4 g three times per day for four weeks had significant reductions in 24 h ABM[140]. A meta-analysis of 11 trials with 383 subjects administered arginine 4-24 g/d found average reduction in BP of 5.39/2.66 mmHg (p < 0.001) in 4 wk[141]. Although these doses of L-arginine appear to be safe, no long term studies in humans have been published at this time and there are concerns of a pro-oxidative effect or even an increase in mortality in patients who may have severely dysfunctional endothelium, advanced atherosclerosis, CHD, ACS or MI[142]. In addition to the arginine-NO path, there exists an nitrate/nitrite pathway that is related to dietary nitrates from vegetables, beetroot juice and the DASH diet that are converted to nitrites by symbiotic, salivary, GI and oral bacteria[143]. Administration of beetroot juice or extract at 500 mg/d will increase nitrites and lower BP, improve endothelial function, increase cerebral, coronary and peripheral blood flow[143].

 

L-carnitine and acetyl -L-carnitine: L-carnitine is a nitrogenous constituent of muscle primarily involved in the oxidation of fatty acids in mammals. Animal studies indicate that carnitine has both systemic anti-hypertensive effects as well as anti-oxidant effects in the heart by upregulation of eNOS and PPAR gamma, inhibition of RAAS, modulation of NF-κB and down regulation of NOX2, NOX4, TGF-β and CTGF that reduces cardiac fibrosis[144,145]. Endothelial function, NO and oxidative defense are improved while oxidative stress and BP are reduced[144-147]. Human studies on the effects of L-carnitine and acetyl-L-carnitine are limited, with minimal to no change in BP[148-153]. In patients with MS, acetyl-L-carnitine at one gram bid over 8 wk, improved dysglycemia and reduced SBP by 7-9 mmHg, but diastolic BP was significantly decreased only in those with higher glucose[151]. Low carnitine levels are associated with a nondipping BP pattern in Type 2 DM[153]. Carnitine has antioxidant and antiinflammatory effects and may be useful in the treatment of essential hypertension, type Ⅱ DM with hypertension, hyperlipidemia, cardiac arrhythmias, CHF and cardiac ischemic syndromes[1,149,150,153]. Doses of 2-3 g twice per day are recommended.

 

Taurine: Taurine is a sulfonic beta-amino acid that is considered a conditionally-essential amino acid, which is not utilized in protein synthesis, but is found free or in simple peptides with its highest concentration in the brain, retina and myocardium[154]. In cardiomyocytes, it represents about 50% of the free amino acids and has a role of an osmoregulator, inotropic factor and antihypertensive agent[155].

 

Human studies have noted that essential hypertensive subjects have reduced urinary taurine as well as other sulfur amino acids[1,154,155]. Taurine lowers BP, SVR and HR, decreases arrhythmias, CHF symptoms and SNS activity, increases urinary sodium and water excretion, increases atrial natriuretic factor, improves insulin resistance, increases NO and improves endothelial function. Taurine also decreases A-Ⅱ, PRA, aldosterone, SNS activity, plasma norepinephrine, plasma and urinary epinephrine, lowers homocysteine, improves insulin sensitivity, kinins and acetyl choline responsiveness, decreases intracellular calcium and sodium, lowers response to beta receptors and has antioxidant, anti-atherosclerotic and anti-inflammatory activities, decreases IMT and arterial stiffness and may protect from risk of CHD[1,154-160]. A lower urinary taurine is associated with increased risk of hypertension and CVD[160,161]. A study of 31 Japanese males with essential hypertension placed on an exercise program for 10 wk showed a 26% increase in taurine levels and a 287% increase in cysteine levels. The BP reduction of 14.8/6.6 mmHg was proportional to increases in serum taurine and reductions in plasma norepinephrine[162]. Fujita et al[155] demonstrated a reduction in BP of 9/4.1 mmHg (p < 0.05) in 19 hypertension subjects given 6 g of taurine for 7 d. Taurine has numerous beneficial effects on the cardiovascular system and BP[156]. The recommended dose of taurine is 2 to 3 g/d at which no adverse effects are noted, but higher doses up to 6 g/d may be needed to reduce BP significantly[1,70,71,154-162].

Omega-3 Fats

The omega-3 fatty acids found in cold water fish, fish oils, flax, flax seed, flax oil and nuts lower BP in observational, epidemiologic and in prospective clinical trials[163-173]. The findings are strengthened by a dose-related response in hypertension as well as a relationship to the specific concomitant diseases associated with hypertension[163-173].

 

Studies indicate that DHA at 2 g/d reduces BP and heart rate[163,173]. The average reduction in BP is 8/5 mmHg and heart rate falls about 6 beats/min usually in about 6 wk[1,70,71,91-175]. Fish oil at 4-9 g/d or combination of DHA and EPA at 3-5 g/d will also reduce BP[1,168-173]. However, formation of EPA and ultimately DHA from ALA is decreased in the presence of high LA (the essential omega-6 fatty acid), saturated fats, trans fatty acids, alcohol, several nutrient deficiencies (magnesium, vitamin B6) and aging, all of which inhibit the desaturase enzymes[163]. Eating cold water fish three times per week may be as effective as high dose fish oil in reducing BP in hypertensive patients, and the protein in the fish may also have antihypertensive effects[1,163]. In patients with chronic kidney disease 4 g of omega 3 fatty acids reduced BP measured with 24 h ABM over 8 wk by 3.3/2.9 mmHg compared to placebo (p < 0.0001)[167].

 

The ideal ratio of omega-6 FA to omega-3 FA is between 1:1 to 1:4 with a polyunsaturated to saturated fat ratio greater than 1.5 to 2:0[2]. Omega 3 fatty acids increase eNOS and nitric oxide, improve endothelial function, improve insulin sensitivity, reduce calcium influx, suppress ACE activity and improve parasympathetic tone[1,163-171]. The omega-6 FA family includes LA, GLA, dihomo-GLA and AA which do not usually lower BP significantly, but may prevent increases in BP induced by saturated fats[176]. GLA may block stress-induced hypertension by increasing PGE1 and PGI2, reducing aldosterone levels, reducing adrenal AT1R density and affinity[175].

 

The omega-3 FA have a multitude of other cardiovascular consequences which modulates BP such as increases in eNOS and nitric oxide, improvement in ED, reduction in plasma nor-epinephrine and increase in paraSNS tone, suppression of ACE activity and improvement in insulin resistance[176]. The recommended daily dose is 3000 to 5000 mg/d of combined DHA and EPA in a ratio of 3 parts EPA to 2 parts DHA and about 50% of this dose as GLA combined with gamma/delta tocopherol at 100 mg per gram of DHA and EPA to get the omega 3 index to 8% or higher to reduce BP and provide optimal cardioprotection[177]. DHA is more effective than EPA for reducing BP and should be given at 2 g/d if administered alone[163,173].

Omega-9 Fats

Olive oil is rich in the omega-9 monounsaturated fat (MUFA) oleic acid, which has been associated with BP and lipid reduction in Mediterranean and other diets[178-180]. Olive oil and MUFAs have shown consistent reductions in BP in most clinical studies in humans[178-190]. In one study, the SBP fell 8 mmHg (p ≤ 0.05) and the DBP fell 6 mmHg (p ≤ 0.01) in both clinic and 24 h ambulatory BP monitoring in the MUFA treated subjects compared to the PUFA treated subjects[178]. In addition, the need for antihypertensive medications was reduced by 48% in the MUFA group vs 4% in the omega-6 PUFA group (p < 0.005). Extra virgin olive oil (EVOO) was more effective than sunflower oil in lowering SBP in a group of 31 elderly hypertensive patients in a double blind randomized crossover study[187]. The SBP was 136 mmHg in the EVOO treated subjects vs 150 mmHg in the sunflower treated group (p < 0.01). Olive oil also reduces BP in hypertensive diabetic subjects[188]. It is the high oleic acid content in olive oil that reduces BP[180]. In stageⅠhypertensive patients, oleuropein-olive leaf (Olea Eurpoaea) extract 500 mg bid for 8 wk reduced BP 11.5/4.8 mmHg which was similar to captopril 25 mg bid[189]. Olea Eupopea L aqueous extract administered to 12 patients with hypertension at 400 mg qid for 3 mo significantly reduced BP (p < 0.001)[181]. Olive oil intake in the EPIC study of 20343 subjects was inversely associated with both systolic and diastolic BP[182]. In the SUN study of 6863 subjects, BP was inversely associated with olive oil consumption, but only in men[183]. In a study of 40 hypertensive monozygotic twins, olive leaf extract demonstrated a dose response reduction in BP at doses of 500 to 1000 mg/d in 8 wk compared to placebo[184]. The low dose groups decreased BP 3/1 mmHg and the high dose 11/4 mmHg[184]. A double blind, randomized, crossover dietary intervention study over 4 mo using polyphenol rich olive oil 30 mg/d decreased BP in the study group by 7.91/6.65 mmHg and improved endothelial function[185]. The ADMA levels, oxLDL and HS-CRP were reduced in the olive oil group. Plasma nitrites and nitrates increased and hyperemic area after ischemia improved in the treated group. Olive oil inhibits the AT1R receptor, exerts L-type calcium channel antagonist effects and improves wave reflections and augmentation index[191-193].

 

EVOO is also contains lipid-soluble phytonutrients such as polyphenols. Approximately 5 mg of phenols are found in 10 g of EVOO[178,186]. About 4 tablespoons of EVOO is equal to 40 g of EVOO which is the amount required to get significant reductions in BP.

 

Fiber

The clinical trials with various types of fiber to reduce BP have been inconsistent[194,195]. Soluble fiber, guar gum, guava, psyllium and oat bran may reduce BP and reduce the need for antihypertensive medications in hypertensive subjects, diabetic subjects and hypertensive-diabetic subjects[1,70,71,194,195]. The average reduction in BP is about 7.5/5.5 mmHg on 40 to 50 g/d of a mixed fiber. There is improvement in insulin sensitivity, endothelial function, reduction in SNS activity and increase in renal sodium loss[1,70,71,194].

Vitamin C

Vitamin C is a potent water-soluble electron-donor. At physiologic levels it is an antioxidant although at supraphysiologic doses such as those achieved with intravenous vitamin C it donates electrons to different enzymes which results in pro-oxidative effects. At physiologic doses vitamin C recycles vitamin E, improves ED and produces a diuresis[196]. Dietary intake of vitamin C and plasma ascorbate concentration in humans is inversely correlated to SBP, DBP and heart rate[196-210].

 

An evaluation of published clinical trials indicate that vitamin C dosing at 250 mg twice daily will significantly lower SBP 5-7 mmHg and diastolic BP 2-4 mmHg over 8 wk[196-210]. Vitamin C will induce a sodium water diuresis, improve arterial compliance, improve endothelial function, increase nitric oxide and PGI2, decrease adrenal steroid production, improve sympathovagal balance, increase RBC Na/K ATPase, increase SOD, improve aortic elasticity and compliance, improve flow mediated vasodilation, decrease pulse wave velocity and augmentation index, increase cyclic GMP, activate potassium channels, reduce cytosolic calcium and reduce serum aldehydes[208]. Vitamin C prevents ED induced by an oral glucose load. Vitamin C enhances the efficacy of amlodipine, decreases the binding affinity of the AT 1 receptor for angiotensin Ⅱ by disrupting the ATR1 disulfide bridges and enhances the anti-hypertensive effects of medications in the elderly with refractory hypertension[1,70,71,200-205]. In elderly patients with refractory hypertension already on maximum pharmacologic therapy, 600 mg of vitamin C daily lowered the BP by 20/16 mmHg[205]. The lower the initial ascorbate serum level, the better is the BP response. A serum level of 100 μmol/L is recommended[1,70,71]. The SBP and 24 ABM show the most significant reductions with chronic oral administration of Vitamin C[200-205]. Block et al[206] in an elegant depletion-repletion study of vitamin C demonstrated an inverse correlation of plasma ascorbate levels, SBP and DBP. In a meta-analysis of thirteen clinical trials with 284 patients, vitamin C at 500 mg/d over 6 wk reduced SBP 3.9 mmHg and DBP 2.1 mmHg[207]. Hypertensive subjects were found to have significantly lower plasma ascorbate levels compared to normotensive subjects (40 μmol/L vs 57 μmol/L respectively)[211], and plasma ascorbate is inversely correlated with BP even in healthy, normotensive individuals[206].

Vitamin E

Most studies have not shown reductions in BP with most forms of tocopherols or tocotrienols[1,70,71]. Patients with T2DM and controlled hypertension (130/76 mmHg) on prescription medications with an average BP of 136/76 mmHg were administered mixed tocopherols containing 60% gamma, 25% delta and 15% alpha tocopherols[212]. The BP actually increased by 6.8/3.6 mmHg in the study patients (p < 0.0001) but was less compared to the increase with alpha tocopherol of 7/5.3 mmHg (p < 0.0001). This may be a reflection of drug interactions with tocopherols via cytochrome P 450 (3A4 and 4F2) and reduction in the serum levels of the pharmacologic treatments that were simultaneously being given[212]. Gamma tocopherol may have natriuretic effects by inhibition of the 70pS potassium channel in the thick ascending limb of the loop of Henle and lower BP[213]. Both alpha and gamma tocopherol improve insulin sensitivity and enhance adiponectin expression via PPAR gamma dependent processes, which have the potential to lower BP and serum glucose[214]. If vitamin E has an antihypertensive effect, it is probably small and may be limited to untreated hypertensive patients or those with known vascular disease or other concomitant problems such as diabetes or hyperlipidemia.

 

Vitamin D

Vitamin D3 may have an independent and direct role in the regulation of BP and insulin metabolism[215-225]. Vitamin D influences BP by its effects on calcium-phosphate metabolism, RAA system, immune system, control of endocrine glands and ED[216]. If the Vitamin D level is below 30 ng/ml the circulating PRA levels are higher which increases angiotensin Ⅱ, increases BP and blunts plasma renal blood flow[221]. The lower the level of Vitamin D, the greater the risk of hypertension, with the lowest quartile of serum Vitamin D having a 52% incidence of hypertension and the highest quartile having a 20% incidence[221]. Vitamin D3 markedly suppresses renin transcription by a VDR-mediated mechanism via the JGA apparatus. Its role in electrolytes, volume and BP homeostasis indicates that Vitamin D3 is important in amelioration of hypertension. Vitamin D lower ADMA, suppresses pro-inflammatory cytokines such as TNF-α, increases nitric oxide, improves endothelial function and arterial elasticity, decreases vascular smooth muscle hypertrophy, regulates electrolytes and blood volume, increases insulin sensitivity, reduces free fatty acid concentration, regulates the expression of the natriuretic peptide receptor and lowers HS-CRP[217-219,221].

 

The hypotensive effect of vitamin D was inversely related to the pretreatment serum levels of 1,25(OH)2D3 and additive to antihypertensive medications. Pfeifer et al[225] showed that short-term supplementation with vitamin D3 and calcium is more effective in reducing SBP than calcium alone. In a group of 148 women with low 25(OH)2D3 levels, the administration of 1200 mg calcium plus 800 IU of vitamin D3 reduced SBP 9.3% more (p < 0.02) compared to 1200 mg of calcium alone. The HR fell 5.4% (p = 0.02), but DBP was not changed. The range in BP reduction was 3.6/3.1 to 13.1/7.2 mmHg. The reduction in BP is related to the pretreatment level of vitamin D3, the dose of vitamin D3 and serum level of vitamin D3, but BP is reduced only in hypertensive patients. Although vitamin D deficiency is associated with hypertension in observational studies, randomized clinical trials and their meta-analysis have yielded inconclusive results[223]. In addition, vitamin D receptor gene polymorphisms may effect the risk of hypertension in men[224]. A 25 hydroxyvitamin D level of 60 ng/ml is recommended.

 

Vitamin B6 (Pyridoxine)

Low serum vitamin B6 (pyridoxine) levels are associated with hypertension in humans[226]. One human study by Aybak et al[227] proved that high dose vitamin B6 at 5 mg/kg per day for 4 wk significantly lowered BP by 14/10 mmHg. Pyridoxine (vitamin B6) is a cofactor in neurotransmitter and hormone synthesis in the central nervous system(norepinephrine, epinephrine, serotonin, GABA and kynurenine), increases cysteine synthesis to neutralize aldehydes, enhances the production of glutathione, blocks calcium channels, improves insulin resistance, decreases central sympathetic tone and reduces end organ responsiveness to glucocorticoids and mineralocorticoids[1,70,71,228,229]. Vitamin B6 is reduced with chronic diuretic therapy and heme pyrollactams. Vitamin B6 thus has similar action to central alpha agonists, diuretics and CCB’s. The recommended dose is 200 mg/d orally.

 

Flavonoids

Over 4000 naturally occurring flavonoids have been identified in such diverse substances as fruits, vegetables, red wine, tea, soy and licorice[230]. Flavonoids (flavonols, flavones and isoflavones) are potent free radical scavengers that inhibit lipid peroxidation, prevent atherosclerosi

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

El Paso, TX. Nutraceutical There is a role for the selected use of single and component nutraceutical supplements, vitamins, antioxidants and minerals in the treatment of hypertension which complement optimal nutrition, coupled with other lifestyle modifications. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

good health's curator insight, January 15, 2024 12:12 PM

Acquista Online La Prescrizione Di Perdita Di Peso
Crediamo che i farmaci a volte possano essere molto urgenti da assumere. Se hai urgente bisogno di farmaci, possiamo anche fornirti una consegna espressa,


https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/

https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://globalefarmacia.com/Prodotto/acquista-metadone/
https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/


<a href="https://globalefarmacia.com/Prodotto/acquista-ozempic-online/">acquista-ozempic-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-victoza-online/">acquista-victoza-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/">acquista-mounjaro-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-mysimba-online/">acquista-mysimba-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-wegovy-online/">acquista-wegovy-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/">acquistare-saxenda-6mg-ml-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-phentermine-online/">acquista-phentermine-online</a>;
<a href="https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/">ephedrine-hcl-30mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/">acquista-ossicodone-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/">acquista-oxycontin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-percocet-online/">acquista-percocet-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-stilnox-online/">acquista-stilnox-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/">acquista-suboxone-8mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-subutex-online/">acquista-subutex-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-metadone/">acquista-metadone</a>;
<a href="https://globalefarmacia.com/Prodotto/buy-vyvanse-online/">buy-vyvanse-online</a>;
<a href="https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/">a-215-ossicodone-actavis</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/">acquista-adderall-30mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adipex-online/">acquista-adipex-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adma-online/">acquista-adma-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-ativan-online/">acquista-ativan-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-botox-online/">acquista-botox-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/">acquista-cerotti-al-fentanil</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/">acquista-codeina-linctus-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-codeina-online/">ta-codeina-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-demerol-online/">acquista-demerol-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-depalgo-online/">acquista-depalgo-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-diazepam-online/">acquista-diazepam-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/">acquista-dilaudid-8mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-endocet-online/">acquista-endocet-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/">acquista-eroina-bianca</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/">acquista-l-ritalin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-opana-online/">acquista-opana-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-vicodin-online/">acquista-vicodin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/">acquista-xanax-2mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/">acquistare-rohypnol-2mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/">acquistare-sibutramina-online</a>;
<a href="https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/">efedrina-hcl-in-polvere</a>;
<a href="https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/">sciroppo-di-metadone</a>;
<a href="https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/">tramadolo-hcl-200mg</a>;

 


<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/&quot; rel="dofollow">acquista-ozempic-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/&quot; rel="dofollow">acquista-victoza-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/&quot; rel="dofollow">acquista-mounjaro-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/&quot; rel="dofollow">acquista-mysimba-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/&quot; rel="dofollow">acquista-wegovy-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/&quot; rel="dofollow">acquistare-saxenda-6mg-ml-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/&quot; rel="dofollow">acquista-phentermine-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/&quot; rel="dofollow">acquistare-sibutramina-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/&quot; rel="dofollow">ephedrine-hcl-30mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/&quot; rel="dofollow">acquista-adderall-30mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/&quot; rel="dofollow">acquista-adipex-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/&quot; rel="dofollow">acquista-vyvanse-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/&quot; rel="dofollow">acquista-ossicodone-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/&quot; rel="dofollow">acquista-oxycontin-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/&quot; rel="dofollow">acquista-percocet-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/&quot; rel="dofollow">acquista-stilnox-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/&quot; rel="dofollow">acquista-suboxone-8mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/&quot; rel="dofollow">acquista-subutex-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/&quot; rel="dofollow">acquista-metadone</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/&quot; rel="dofollow">acquista-botox-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/&quot; rel="dofollow">acquista-adma-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/&quot; rel="dofollow">a-215-ossicodone-actavis</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/&quot; rel="dofollow">acquista-ativan-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/&quot; rel="dofollow">acquista-cerotti-al-fentanil</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/&quot; rel="dofollow">acquista-codeina-linctus-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/&quot; rel="dofollow">acquista-codeina-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/&quot; rel="dofollow">acquista-demerol-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/&quot; rel="dofollow">acquista-depalgo-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/&quot; rel="dofollow">acquista-diazepam-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/&quot; rel="dofollow">acquista-dilaudid-8mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/&quot; rel="dofollow">acquista-endocet-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/&quot; rel="dofollow">acquista-eroina-bianca</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/&quot; rel="dofollow">acquista-opana-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/&quot; rel="dofollow">acquista-vicodin-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/&quot; rel="dofollow">acquista-xanax-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/&quot; rel="dofollow">efedrina-hcl-in-polvere</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/&quot; rel="dofollow">sciroppo-di-metadone</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/&quot; rel="dofollow">tramadolo-hcl-200mg</a>

https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/


<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/&quot; rel="dofollow">acquista-ozempic-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/&quot; rel="dofollow">acquista-victoza-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/&quot; rel="dofollow">acquista-mounjaro-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/&quot; rel="dofollow">acquista-mysimba-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/&quot; rel="dofollow">acquista-wegovy-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/&quot; rel="dofollow">acquistare-saxenda-6mg-ml-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/&quot; rel="dofollow">acquista-phentermine-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/&quot; rel="dofollow">acquistare-sibutramina-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/&quot; rel="dofollow">ephedrine-hcl-30mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/&quot; rel="dofollow">acquista-adderall-30mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/&quot; rel="dofollow">acquista-adipex-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/&quot; rel="dofollow">acquista-vyvanse-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/&quot; rel="dofollow">acquista-ossicodone-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/&quot; rel="dofollow">acquista-oxycontin-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/&quot; rel="dofollow">acquista-percocet-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/&quot; rel="dofollow">acquista-stilnox-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/&quot; rel="dofollow">acquista-suboxone-8mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/&quot; rel="dofollow">acquista-subutex-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/&quot; rel="dofollow">acquista-metadone</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/&quot; rel="dofollow">acquista-botox-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/&quot; rel="dofollow">acquista-adma-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/&quot; rel="dofollow">a-215-ossicodone-actavis</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/&quot; rel="dofollow">acquista-ativan-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/&quot; rel="dofollow">acquista-cerotti-al-fentanil</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/&quot; rel="dofollow">acquista-codeina-linctus-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/&quot; rel="dofollow">acquista-codeina-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/&quot; rel="dofollow">acquista-demerol-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/&quot; rel="dofollow">acquista-depalgo-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/&quot; rel="dofollow">acquista-diazepam-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/&quot; rel="dofollow">acquista-dilaudid-8mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/&quot; rel="dofollow">acquista-endocet-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/&quot; rel="dofollow">acquista-eroina-bianca</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/&quot; rel="dofollow">acquista-opana-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/&quot; rel="dofollow">acquista-vicodin-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/&quot; rel="dofollow">acquista-xanax-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/&quot; rel="dofollow">efedrina-hcl-in-polvere</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/&quot; rel="dofollow">sciroppo-di-metadone</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/&quot; rel="dofollow">tramadolo-hcl-200mg</a>

Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 21, 2017 6:15 PM
Scoop.it!

Heart Health Benefits of Coenzyme Q10 | El Paso, TX Chiropractor | Call: 915-850-0900

Heart Health Benefits of Coenzyme Q10 | El Paso, TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

There’s also evidence that CoQ10 might have “important protective heart health effects” that might help prevent CVD, the world’s leading cause of death, reports a recent study published in Cardiovascular Pharmacology: Open Access. As these are fascinating findings, messaging to individuals around CoQ10, especially in the popular media, is frequently confusing, resulting in less than optimum results and inadequate supplement option. Here’s a guide to the most recent discoveries about the heart health benefits of CoQ10 and how to make smart choices in selecting supplements.

 

What is Coenzyme Q10?

 

Found in almost every cell of the body, Coenzyme Q10 is a fat-soluble, vitamin-like substance that helps convert food into energy. A potent antioxidant that protects against harm from toxic free radicals, CoQ10 is naturally created by the human body and can also be found in many foods, with high levels found in organ meats, like liver or kidneys; as well as in sardines, mackerel, chicken, cauliflower, broccoli and asparagus.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Researchers report that Coenzyme Q10 may have important benefits for those who have cardiovascular disease, or CVD, from reducing the risk of repeated heart attacks and improving outcomes in patients with heart failure, to reducing high blood pressure, or BP, and helping combat side ramifications of cholesterol-lowering statins. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 14, 2017 6:40 PM
Scoop.it!

Effects of Pycnogenol in Cardiovascular Disease | El Paso TX Chiropractor | Call: 915-850-0900

Effects of Pycnogenol in Cardiovascular Disease | El Paso TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

Pycnogenol, a pine bark extract that you may have never heard of, may be a fundamental ingredient which can give your general well-being a boost. In fact, Dr. Russell Blaylock, author of The Blaylock Wellness Report, believes it ought to be a part of everybody’s health regimen, especially when it comes to it’s benefits towards cardiovascular disease.

 

Pycnogenol is a patented form of pine bark extract made using the bark of the maritime pine that grows in France. Pine bark extract contains procyanidins, a form of catechins, similiar to those found in green tea, cocoa, and grape seed extract. Pycnogenol also has a unique combination of powerful antioxidant components in addition to procyanidins, including bioflavonoids and phenolic acids, that neutralize disease-causing free radicals in the body. Furthermore, this form of pine bark extract is believed to increase skin elasticity as well as reduce both oxidative stress and collagen degradation, reducing the effects of aging.

 

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

A balanced diet provides humans with a variety of compounds necessary to sustain the complex systems and functions of the body, however, some foods and/or supplements can provide more health benefits than the basic nutrition.While the list of beneficial substances is growing, one substance has gained more recognition when it comes to preventing and treating cardiovascular disease: pycnogenol. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 12, 2017 6:17 PM
Scoop.it!

Can Flavonoids Reduce Cardiovascular Disease? El Paso TX Chiropractor | Call: 915-850-0900

Can Flavonoids Reduce Cardiovascular Disease? El Paso TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

Epidemiological studies, clinical trials and basic science has found an inverse correlation between flavonoid intake and a decreased mortality from the prevalence of stroke and coronary heart disease, including the improvement of hypertension and cardiovascular disease risks.

 

More than 4000 naturally occurring flavonoids have been identified, including fruits, vegetables, red wine, tea, soy and licorice. Flavonoids (flavonols, flavones and isoflavones) are potent free radical scavengers that inhibit lipid peroxidation, prevent atherosclerosis, promote vascular relaxation and also have anti-hypertensive properties. Along with reducing stroke and providing effects which reduce mortality and CHD morbidity, as mentioned.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Diets high in flavonoids have been associated with a way of life, as it’s often a part of many nutritional recommendations from healthcare professionals associated with the prevention of cardiovascular diseases. However, the identification of beneficial effects from flavonoids and flavonoid-rich foods has become a challenging area to discuss. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
December 8, 2017 6:30 PM
Scoop.it!

Essential Vitamin Intake for Cardiovascular Disease | El Paso TX Chiropractor | Call: 915-850-0900

Essential Vitamin Intake for Cardiovascular Disease | El Paso TX Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

The American Heart Association’s Dietary Guidelines can help with weight control as well as provide a high nutrient density to meet all nutritional needs. As reviewed in the first AHA Science Advisory, epidemiological and population studies reported that some vitamins, such as vitamin C, vitamin E, vitamin D and vitamin B6 (pyridoxine), may beneficially affect cardiovascular disease. Reducing the overall risk of cardiovascular disease can be achieved by the long-term consumption of dietary patterns consistent with the AHA Dietary Guidelines. Vitamin C, vitamin E, vitamin D and vitamin B6 (pyridoxine), each perform a specific function in the prevention and improvement of CVD.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Periodic AHA Dietary Guidelines support a dietary pattern that promotes the consumption of fruits, vegetables, whole grains, low-fat or nonfat dairy products, fish, legumes, poultry, and lean meats. An improper nutrition consisting of foods rich in saturated and trans fats, can raise the human body’s “bad” cholesterol levels, increasing the risk of cardiovascular disease. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
November 8, 2017 9:24 PM
Scoop.it!

Can A Gluten Free Diet Relieve Joint Pain? | Dr. Alex Jimenez D.C.

Can A Gluten Free Diet Relieve Joint Pain? | Dr. Alex Jimenez D.C. | Diet and Supplements | Scoop.it

Gluten Free: During a visit to my orthopedist I made a confession: “I stopped eating gluten and—this might sound a little crazy, but—a lot of my joint pain disappeared.

 

She smiled broadly and said, “You’re not the first person to say that.”

 

See How Gluten Can Cause Joint Pain

 

Giving up gluten may be difficult, but it could lead to less joint pain.  Learn more: What Are Anti-Inflammatory Foods?[

 

I stopped eating gluten because couple of friends suggested it might relieve some unexplained symptoms I was experiencing, like fatigue and mild joint pain. I had strong doubts, but my primary care doctor and I had run out of ideas (I was waiting to see a specialist), so I figured I had nothing to lose.

 

See Rheumatoid Arthritis and Fatigue

 

Within a week of going on a gluten-free diet, my fatigue, joint pain, and many other symptoms disappeared.

The Connection Between Gluten & Joint Pain

It turns out, researchers have long known that people with autoimmune forms of arthritis, such as rheumatoid 

arthritis and psoriatic arthritis, are at higher risk for celiac disease,1, 2 an autoimmune disorder triggered by gluten.

 

See Inflammatory Arthritis

 

More recently, medical experts have begun to acknowledge the connection between gluten and joint pain described as non-pathologic (unrelated to disease).

 

Both my orthopedist and primary care provider agree that my gluten-free diet is probably keeping my joint pain and other symptoms of inflammation in check.

 

See An Anti-Inflammatory Diet for Arthritis 

Wait, Don’t Go Gluten Free Yet…

Before you throw away your pasta and cereal in search of joint pain relief, consider these factors:

 

  • Going gluten free isn’t for everyone. 
    Whole grains are a recommended part of a healthy diet. No research suggests everyone should start eating a gluten free diet. But for people experiencing painful joint inflammation, eliminating gluten and other “pro-inflammatory” foods may be one treatment approach to consider.

 

See The Ins and Outs of an Anti-Inflammatory Diet

 

  • Food products labeled “gluten free” aren’t necessarily healthy. 
    It’s almost always better to eat whole foods as opposed to processed foods that are gluten-free, but still full of sugar or saturated fats. For example, skip the gluten-free sugar cereal and make yourself a bowl of gluten-free oatmeal or a fruit smoothie for breakfast.
  • Eating a gluten-free diet isn’t a magic bullet. 
    Adopting other healthy habits, such as making time for exercise, is essential to eliminating joint pain.

 

See Managing RA Fatigue Through Diet and Exercise

 

  • A health professional can help.It’s always a good idea to tell yourdoctor about lifestyle changes, including achange in diet. A doctor may refer you to a registered dietician who can recommend certain foods, helping ensure you get enough nutrients and fiber in your gluten-free diet.

 

See Arthritis Treatment Specialists

 

  • You might experience gluten withdrawal.Many people report that their inflammatory symptoms initially got worse after starting their gluten free diet. This withdrawal stage can last days or even weeks, so you may not want to go gluten free right before a big event, like a vacation, holiday, or the start of a newjob.

 

No single treatment or lifestyle habit can eliminate the symptoms of arthritis, but going gluten-free may be an option worth trying as part of your overall treatment plan.

 

By Jennifer Flynn

Learn More

Turmeric and Curcumin for Arthritis

 

Dietary Supplements for Treating Arthritis

 

References

  1. Rath, L. The Connection Between Gluten and Arthritis. The Arthritis Foundation. http://www.arthritis.org/living-with-arthritis/arthritis-diet/anti-infla...Accessed August 20, 2015.
  2. Barton SH, Murray JA. Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am. 2008;37(2):411-28, vii.
Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

El Paso, TX No single treatment or lifestyle habit can eliminate the symptoms of arthritis, but gluten free may be an option worth trying. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
November 2, 2017 9:14 PM
Scoop.it!

Turmeric Root Side Effects | El Paso, TX Chiropractor

Turmeric Root Side Effects | El Paso, TX Chiropractor | Diet and Supplements | Scoop.it

Turmeric: Let us ease your mind a bit. As with any dietary supplement, there are right ways to take turmeric root that could best benefit your health. We review things to keep in mind to limit any potential side effects. 

Potential Benefits Of Turmeric Root 

The compound that gives turmeric root its signature bright yellow hue is also the compound that packs the potential health benefits punch: curcumin. Curcumin – and therefore turmeric root – is believed to provide some pretty attractive health benefits, including support of joint and muscle comfort, promotion of healthy aging of the brain, support of a healthy digestive tract, and maintenance of healthy cholesterol levels already in the normal range.

 

But that doesn’t mean that taking 10 turmeric root supplement capsules at once would give you 10 times the potential benefit. Quite the opposite. There are right – and wrong – ways to consume the supplement in an effort to reduce possible side effects.

Avoiding Turmeric Root Side Effects

According to MentalHealthDaily.com, if you’re supplementing with turmeric root, especially at high doses, it is possible that you may encounter some unwanted side effects at one point or another. The two most common side effects associated are diarrhea and nausea. High on the list of possible side effects are also:

 

  • Thinning of the blood. Some research shows that curcumin may have anticoagulant effects which can slow blood clotting. If you’re already taking a blood thinner, speak to your doctor about your desire to add a turmeric root supplement, and discontinue use at least two weeks before any surgery.
  • Some estimates indicate that one in four turmeric root users will notice an increase in bloating and passing gas. To reduce the likelihood of experiencing this particular side effect, consider a dose less than 6 grams per day, and avoid taking your supplement on an empty stomach.
  • Low blood sugar. Especially in those with health concerns related to blood glucose, turmeric root supplements may yield this unwanted effect. Some experts believe that the curcumin may even act to amplify pre-existing blood sugar issues.

 

Less common side effects may also include facial flushing, fever, headaches, skin rash and even low testosterone.

 

But as with any supplement or medication, remember that the severity and number of side effects you experience is likely subject to a variety of causes and factors. Keep in mind that some individuals may not experience any side effects at all.

Recommendations And Dosages

As with all medications and supplements, we encourage you to consult with your healthcare professional before adding a turmeric root supplement to your regimen. He or she can personalize dosing recommendations for you based on your desired outcomes and other factors – like other medications and supplements you are taking. That said, WebMD.com offers a few general guidelines for using turmeric and avoiding possible side effects:

 

  • This root is likely safe when applied to the skin appropriately for up to eight months.
  • It should only be considered as a mouthwash for short-term use.
  • For high cholesterol levels: 1.4 grams of turmeric extract in two divided doses each day for three months has been used for those 15 years or older.

Let’s Get Technical

While there are still many studies to be done and results to be reported, BCM-95 – a highly-absorbent form of curcumin, which is the active ingredient in turmeric root – has been clinically proven to help temporarily relieve minor pain. When used at a dosage of 2 grams per day, volunteers participated in the study without any mild adverse reactions. To try BCM-95 out for yourself, we recommend CuraMed and other daily supplements from Terry Naturally. And as always, we’re proud to provide you with free shipping anywhere in the U.S.

 

by Theresa Groskopp, CN in Health Challenges, Health Tips, Nutrition Supplements

 

 

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Dietary supplements, there are right ways to take turmeric that could best benefit your health & to limit any turmeric root side effects. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
October 31, 2017 5:55 PM
Scoop.it!

The Role Of Epigenetic's In Obesity And Metabolic Disease

The Role Of Epigenetic's In Obesity And Metabolic Disease | Diet and Supplements | Scoop.it

Epigenetic Abstract:

The increased prevalence of obesity and related comorbidities is a major public health problem. While genetic factors undoubtedly play a role in determining individual susceptibility to weight gain and obesity, the identified genetic variants only explain part of the variation. This has led to growing interest in understanding the potential role of epigenetics as a mediator of gene-environment interactions underlying the development of obesity and its associated comorbidities. Initial evidence in support of a role of epigenetics in obesity and type 2 diabetes mellitus (T2DM) was mainly provided by animal studies, which reported epigenetic changes in key metabolically important tissues following high-fat feeding and epigenetic differences between lean and obese animals and by human studies which showed epigenetic changes in obesity and T2DM candidate genes in obese/diabetic individuals. More recently, advances in epigenetic methodologies and the reduced cost of epigenome-wide association studies (EWAS) have led to a rapid expansion of studies in human populations. These studies have also reported epigenetic differences between obese/T2DM adults and healthy controls and epigenetic changes in association with nutritional, weight loss, and exercise interventions. There is also increasing evidence from both human and animal studies that the relationship between perinatal nutritional exposures and later risk of obesity and T2DM may be mediated by epigenetic changes in the offspring. The aim of this review is to summarize the most recent developments in this rapidly moving field, with a particular focus on human EWAS and studies investigating the impact of nutritional and lifestyle factors (both pre- and postnatal) on the epigenome and their relationship to metabolic health outcomes. The difficulties in distinguishing consequence from causality in these studies and the critical role of animal models for testing causal relationships and providing insight into underlying mechanisms are also addressed. In summary, the area of epigenetics and metabolic health has seen rapid developments in a short space of time. While the outcomes to date are promising, studies are ongoing, and the next decade promises to be a time of productive research into the complex interactions between the genome, epigenome, and environment as they relate to metabolic disease.

 

Keywords: Epigenetics, DNA methylation, Obesity, Type 2 diabetes, Developmental programming

Introduction

Obesity is a complex, multifactorial disease, and better understanding of the mechanisms underlying the interactions between lifestyle, environment, and genetics is critical for developing effective strategies for prevention and treatment [1].

 

In a society where energy-dense food is plentiful and the need for physical activity is low, there is a wide variation in individuals’ susceptibility to develop obesity and metabolic health problems. Estimates of the role of heredity in this variation are in the range of 40–70 %, and while large genome-wide association studies (GWAS) have identified a number of genetic loci associated with obesity risk, the ~100 most common genetic variants only account for a few percent of variance in obesity [2, 3]. Genome-wide estimates are higher, accounting for ~20 % of the variation [3]; however, a large portion of the heritability remains unexplained.

 

Recently, attention has turned to investigating the role of epigenetic changes in the etiology of obesity. It has been argued that the epigenome may represent the mechanistic link between genetic variants and environmental factors in determining obesity risk and could help explain the “missing heritability.” The first human epigenetic studies were small and only investigated a limited number of loci. While this generally resulted in poor reproducibility, some of these early findings, for instance the relationship between PGC1A methylation and type 2 diabetes mellitus (T2DM) [4] and others as discussed in van Dijk et al. [5], have been replicated in later studies. Recent advances and increased affordability of high- throughput technologies now allow for large-scale epigenome wide association studies (EWAS) and integration of different layers of genomic information to explore the complex interactions between the genotype, epigenome, transcriptome, and the environment [6–9]. These studies are still in their infancy, but the results thus far have shown promise in helping to explain the variation in obesity susceptibility.

 

There is increasing evidence that obesity has develop mental origins, as exposure to a suboptimal nutrient supply before birth or in early infancy is associated with an increased risk of obesity and metabolic disease in later life [10–13]. Initially, animal studies demonstrated that a range of early life nutritional exposures, especially those experienced early in gestation, could induce epigenetic changes in key metabolic tissues of the offspring that persisted after birth and result in permanent alterations in gene function [13–17]. Evidence is emerging to support the existence of the same mechanism in humans. This has led to a search for epigenetic marks present early in life that predict later risk of metabolic disease, and studies to determine whether epigenetic programming of metabolic disease could be prevented or reversed in later life.

 

This review provides an update of our previous systematic review of studies on epigenetics and obesity in humans [5]. Our previous review showcased the promising outcomes of initial studies, including the first potential epigenetic marks for obesity that could be detected at birth (e.g., RXRA) [18]. However, it also highlighted the limited reproducibility of the findings and the lack of larger scale longitudinal investigations. The current review focuses on recent developments in this rapidly moving field and, in particular, on human EWAS and studies investigating the impact of (pre- and postnatal) nutritional and lifestyle factors on the epigenome and the emerging role of epigenetics in the pathology of obesity. We also address the difficulties in identifying causality in these studies and the importance of animal models in providing insight into mechanisms.

Review

Epigenetic Changes In Animal Models Of Obesity

Animal models provide unique opportunities for highly controlled studies that provide mechanistic insight into the role of specific epigenetic marks, both as indicators of current metabolic status and as predictors of the future risk of obesity and metabolic disease. A particularly important aspect of animal studies is that they allow for the assessment of epigenetic changes within target tissues, including the liver and hypothalamus, which is much more difficult in humans. Moreover, the ability to harvest large quantities of fresh tissue makes it possible to assess multiple chromatin marks as well as DNA methylation. Some of these epigenetic modifications either alone or in combination may be responsive to environmental programming. In animal models, it is also possible to study multiple generations of offspring and thus enable differentiation between trans-generational and intergenerational transmission of obesity risk mediated by epigenetic memory of parental nutritional status, which cannot be easily distinguished in human studies. We use the former term for meiotic transmission of risk in the absence of continued exposure while the latter primarily entails direct transmission of risk through metabolic reprogramming of the fetus or gametes.

 

Animal studies have played a critical role in our current understanding of the role of epigenetics in the developmental origins of obesity and T2DM. Both increased and decreased maternal nutrition during pregnancy have been associated with increased fat deposition in offspring of most mammalian species studied to date (reviewed in [11, 13–15, 19]). Maternal nutrition during pregnancy not only has potential for direct effects on the fetus, it also may directly impact the developing oocytes of female fetuses and primordial germ cells of male fetuses and therefore could impact both the off- spring and grand-offspring. Hence, multigenerational data are usually required to differentiate between maternal intergenerational and trans-generational transmission mechanisms.

 

Table 1 summarizes a variety of animal models that have been used to provide evidence of metabolic and epigenetic changes in offspring associated with the parental plane of nutrition. It also contains information pertaining to studies identifying altered epigenetic marks in adult individuals who undergo direct nutritional challenges. The table is structured by suggested risk transmission type.

(i) Epigenetic Changes In Offspring Associated With Maternal Nutrition During Gestation

Maternal nutritional supplementation, undernutrition, and over nutrition during pregnancy can alter fat deposition and energy homeostasis in offspring [11, 13–15, 19]. Associated with these effects in the offspring are changes in DNA methylation, histone post-translational modifications, and gene expression for several target genes, especially genes regulating fatty acid metabolism and insulin signaling [16, 17, 20–30]. The diversity of animal models used in these studies and the common metabolic pathways impacted suggest an evolutionarily conserved adaptive response mediated by epigenetic modification. However, few of the specific identified genes and epigenetic changes have been cross-validated in related studies, and large-scale genome-wide investigations have typically not been applied. A major hindrance to comparison of these studies is the different develop mental windows subjected to nutritional challenge, which may cause considerably different outcomes. Proof that the epigenetic changes are causal rather than being associated with offspring phenotypic changes is also required. This will necessitate the identification of a parental nutritionally induced epigenetic “memory” response that precedes development of the altered phenotype in offspring.

(ii)Effects Of Paternal Nutrition On Offspring Epigenetic Marks

Emerging studies have demonstrated that paternal plane of nutrition can impact offspring fat deposition and epigenetic marks [31–34]. One recent investigation using mice has demonstrated that paternal pre-diabetes leads to increased susceptibility to diabetes in F1 offspring with associated changes in pancreatic gene expression and DNA methylation linked to insulin signaling [35]. Importantly, there was an overlap of these epigenetic changes in pancreatic islets and sperm suggesting germ line inheritance. However, most of these studies, although intriguing in their implications, are limited in the genomic scale of investigation and frequently show weak and somewhat transient epigenetic alterations associated with mild metabolic phenotypes in offspring.

(iii)Potential Trans-generational Epigenetic Changes Promoting Fat Deposition In Offspring

Stable transmission of epigenetic information across multiple generations is well described in plant systems and C. elegans, but its significance in mammals is still much debated [36, 37]. An epigenetic basis for grand- parental transmission of phenotypes in response to dietary exposures has been well established, including in livestock species [31]. The most influential studies demonstrating effects of epigenetic transmission impacting offspring phenotype have used the example of the viable yellow agouti (Avy) mouse [38]. In this mouse, an insertion of a retrotransposon upstream of the agouti gene causes its constitutive expression and consequent yellow coat color and adult onset obesity. Maternal transmission through the germ line results in DNA methylation mediated silencing of agouti expression resulting in wild-type coat color and lean phenotype of the offspring [39, 40]. Importantly, subsequent studies in these mice demonstrated that maternal exposure to methyl donors causes a shift in coat color [41]. One study has reported transmission of a phenotype to the F3 generation and alterations in expression of large number of genes in response to protein restriction in F0 [42]; however, alterations in expression were highly variable and a direct link to epigenetic changes was not identified in this system.

(iv) Direct Exposure Of Individuals To Excess Nutrition In Postnatal Life

While many studies have identified diet-associated epigenetic changes in animal models using candidate site-specific regions, there have been few genome-wide analyses undertaken. A recent study focussed on determining the direct epigenetic impact of high-fat diets/ diet-induced obesity in adult mice using genome-wide gene expression and DNA methylation analyses [43]. This study identified 232 differentially methylated regions (DMRs) in adipocytes from control and high-fat fed mice. Importantly, the corresponding human regions for the murine DMRs were also differentially methylated in adipose tissue from a population of obese and lean humans, thereby highlighting the remarkable evolutionary conservation of these regions. This result emphasizes the likely importance of the identified DMRs in regulating energy homeostasis in mammals.

Human Studies

 

Drawing on the evidence from animal studies and with the increasing availability of affordable tools for genome- wide analysis, there has been a rapid expansion of epigenome studies in humans. These studies have mostly focused on the identification of site-specific differences in DNA methylation that are associated with metabolic phenotypes.

 

A key question is the extent to which epigenetic modifications contribute to the development of the metabolic phenotype, rather than simply being a con- sequence of it (Fig. 1). Epigenetic programming could contribute to obesity development, as well as playing a role in consequent risk of cardiovascular and metabolic problems. In human studies, it is difficult to prove causality [44], but inferences can be made from a number of lines of evidence:

 

(i) Genetic association studies. Genetic polymorphisms that are associated with an increased risk of developing particular conditions are a priori linked to the causative genes. The presence of differential methylation in such regions infers functional relevance of these epigenetic changes in controlling expression of the proximal gene(s). There are strong cis-acting genetic effects underpinning much epigenetic variation [7, 45], and in population-based studies, methods that use genetic surrogates to infer a causal or mediating role of epigenome differences have been applied [7, 46–48]. The use of familial genetic information can also lead to the identification of potentially causative candidate regions showing phenotype-related differential methylation [49].

 

(ii)Timing of epigenetic changes. The presence of an epigenetic mark prior to development of a phenotype is an essential feature associated with causality. Conversely, the presence of a mark in association with obesity, but not before its development, can be used to exclude causality but would not exclude a possible role in subsequent obesity-related pathology.

 

(iii)Plausible inference of mechanism. This refers to epigenetic changes that are associated with altered expression of genes with an established role in regulating the phenotype of interest. One such example is the association of methylation at two CpG sites at the CPT1A gene with circulating triglyceride levels [50]. CPT1A encodes carnitine palmitoyltransferase 1A, an enzyme with a central role in fatty acid metabolism, and this is strongly indicative that differential methylation of this gene may be causally related to the alterations in plasma triglyceride concentrations.

Epigenome-Wide Association Studies: Identifying Epigenetic Biomarkers Of Metabolic Health

A number of recent investigations have focused on exploring associations between obesity/metabolic diseases and DNA methylation across the genome (Table 2). The largest published EWAS so far, including a total of 5465 individuals, identified 37 methylation sites in blood that were associated with body mass index (BMI), including sites in CPT1A, ABCG1, and SREBF1 [51]. Another large-scale study showed consistent associations between BMI and methylation in HIF3A in whole blood and adipose tissue [52], a finding which was also partially replicated in other studies [9, 51]. Other recently reported associations between obesity-related measures and DNA methylation include (i) DNA methylation differences between lean and obese individuals in LY86 in blood leukocytes [53]; (ii) associations between PGC1A promoter methylation in whole blood of children and adiposity 5 years later [54]; (iii) associations between waist-hip ratio and ADRB3 methylation in blood [55]; and (iv) associations between BMI, body fat distribution measures, and multiple DNA methylation sites in adipose tissue [9, 56]. EWAS have also shown associations between DNA methylation sites and blood lipids [55, 57–59], serum metabolites [60], insulin resistance [9, 61], and T2DM [48, 62, 63] (Table 2).

 

From these studies, altered methylation of PGC1A, HIF3A, ABCG1, and CPT1A and the previously described RXRA [18] have emerged as biomarkers associated with, or perhaps predictive of, metabolic health that are also plausible candidates for a role in development of metabolic disease.

Interaction Between Genotype And The Epigenome

Epigenetic variation is highly influenced by the underlying genetic variation, with genotype estimated to explain ~20–40 % of the variation [6, 8]. Recently, a number of studies have begun to integrate methylome and genotype data to identify methylation quantitative trait loci (meQTL) associated with disease phenotypes. For instance, in adipose tissue, an meQTL overlapping with a BMI genetic risk locus has been identified in an enhancer element upstream of ADCY3 [8]. Other studies have also identified overlaps between known obesity and T2DM risk loci and DMRs associated with obesity and T2DM [43, 48, 62]. Methylation of a number of such DMRs was also modulated by high-fat feeding in mice [43] and weight loss in humans [64]. These results identify an intriguing link between genetic variations linked with disease susceptibility and their association with regions of the genome that undergo epigenetic modifications in response to nutritional challenges, implying a causal relationship. The close connection between genetic and epigenetic variation may signify their essential roles in generating individual variation [65, 66]. However, while these findings suggest that DNA methylation may be a mediator of genetic effects, it is also important to consider that both genetic and epigenetic processes could act independently on the same genes. Twin studies [8, 63, 67] can provide important insights and indicate that inter-individual differences in levels of DNA methylation arise predominantly from non-shared environment and stochastic influences, minimally from shared environmental effects, but also with a significant impact of genetic variation.

The Impact Of The Prenatal And Postnatal Environment On The Epigenome

Prenatal environment: Two recently published studies made use of human populations that experienced “natural” variations in nutrient supply to study the impact of maternal nutrition before or during pregnancy on DNA methylation in the offspring [68, 69]. The first study used a Gambian mother-child cohort to show that both seasonal variations in maternal methyl donor intake during pregnancy and maternal pre-pregnancy BMI were associated with altered methylation in the infants [69]. The second study utilized adult offspring from the Dutch Hunger Winter cohort to investigate the effect of prenatal exposure to an acute period of severe maternal undernutrition on DNA methylation of genes involved in growth and metabolism in adulthood [68]. The results highlighted the importance of the timing of the exposure in its impact on the epigenome, since significant epigenetic effects were only identified in individuals exposed to famine during early gestation. Importantly, the epigenetic changes occurred in conjunction with increased BMI; however, it was not possible to establish in this study whether these changes were present earlier in life or a consequence of the higher BMI.

 

Other recent studies have provided evidence that prenatal over-nutrition and an obese or diabetic maternal environment are also associated with DNA methylation changes in genes related to embryonic development, growth, and metabolic disease in the offspring [70–73].

 

While human data are scarce, there are indications that paternal obesity can lead to altered methylation of imprinted genes in the newborn [74], an effect thought to be mediated via epigenetic changes acquired during spermatogenesis.

 

Postnatal environment: The epigenome is established de novo during embryonic development, and therefore, the prenatal environment most likely has the most significant impact on the epigenome. However, it is now clear that changes do occur in the “mature” epigenome under the influence of a range of conditions, including aging, exposure to toxins, and dietary alterations. For example, changes in DNA methylation in numerous genes in skeletal muscle and PGC1A in adipose tissue have been demonstrated in response to a high-fat diet [75, 76]. Interventions to lose body fat mass have also been associated with changes in DNA methylation. Studies have reported that the DNA methylation profiles of adipose tissue [43, 64], peripheral blood mononuclear cells [77], and muscle tissue [78] in formerly obese patients become more similar to the profiles of lean subjects following weight loss. Weight loss surgery also partially reversed non-alcoholic fatty liver disease-associated methylation changes in liver [79] and in another study led to hypomethylation of multiple obesity candidate genes, with more pronounced effects in subcutaneous compared to omental (visceral) fat [64]. Accumulating evidence suggests that exercise interventions can also influence DNA methylation. Most of these studies have been conducted in lean individuals [80–82], but one exercise study in obese T2DM subjects also demonstrated changes in DNA methylation, including in genes involved in fatty acid and glucose transport [83]. Epigenetic changes also occur with aging, and recent data suggest a role of obesity in augmenting them [9, 84, 85]. Obesity accelerated the epigenetic age of liver tissue, but in contrast to the findings described above, this effect was not reversible after weight loss [84].

 

Collectively, the evidence in support of the capacity to modulate the epigenome in adults suggests that there may be the potential to intervene in postnatal life to modulate or reverse adverse epigenetic programming.

Effect Sizes And Differences Between Tissue Types

DNA methylation changes associated with obesity or induced by diet or lifestyle interventions and weight loss are generally modest (<15 %), although this varies depending on the phenotype and tissue studied. For instance, changes greater than 20 % have been reported in adipose tissue after weight loss [64] and associations between HIF3A methylation and BMI in adipose tissue were more pronounced than in blood [52].

 

The biological relevance of relatively small methylation changes has been questioned. However, in tissues consisting of a mixture of cell types, a small change in DNA methylation may actually reflect a significant change in a specific cell fraction. Integration of epigenome data with transcriptome and other epigenetic data, such as histone modifications, is important, since small DNA methylation changes might reflect larger changes in chromatin structure and could be associated with broader changes in gene expression. The genomic context should also be considered; small changes within a regulatory element such as a promotor, enhancer, or insulator may have functional significance. In this regard, DMRs for obesity, as well as regions affected by prenatal famine exposure and meQTL for metabolic trait loci have been observed to overlap enhancer elements [8, 43, 68]. There is evidence that DNA methylation in famine-associated regions could indeed affect enhancer activity [68], supporting a role of nutrition-induced methylation changes in gene regulation.

 

A major limitation in many human studies is that epigenetic marks are often assessed in peripheral blood, rather than in metabolically relevant tissues (Fig. 2). The heterogeneity of blood is an issue, since different cell populations have distinct epigenetic signatures, but algorithms have been developed to estimate the cellular composition to overcome this problem [86]. Perhaps more importantly, epigenetic marks in blood cells may not necessarily report the status of the tissues of primary interest. Despite this, recent studies have provided clear evidence of a relationship between epigenetic marks in blood cells and BMI. In the case of HIF3A for which the level of methylation (beta-value) in the study population ranged from 0.14–0.52, a 10 % increase in methylation was associated with a BMI increase of 7.8 % [52]. Likewise, a 10 % difference in PGC1A methylation may predict up to 12 % difference in fat mass [54].

Conclusions

The study of the role of epigenetics in obesity and metabolic disease has expanded rapidly in recent years, and evidence is accumulating of a link between epigenetic modifications and metabolic health outcomes in humans. Potential epigenetic biomarkers associated with obesity and metabolic health have also emerged from recent studies. The validation of epigenetic marks in multiple cohorts, the fact that several marks are found in genes with a plausible function in obesity and T2DM development, as well as the overlap of epigenetic marks with known obesity and T2DM genetic loci strengthens the evidence that these associations are real. Causality has so far been difficult to establish; however, regardless of whether the associations are causal, the identified epigenetic marks may still be relevant as biomarkers for obesity and metabolic disease risk.

 

Effect sizes in easily accessible tissues such as blood are small but do seem reproducible despite variation in ethnicity, tissue type, and analysis methods [51]. Also, even small DNA methylation changes may have biological significance. An integrative “omics” approach will be crucial in further unraveling the complex interactions between the epigenome, transcriptome, genome, and metabolic health. Longitudinal studies, ideally spanning multiple generations, are essential to establishing causal relationships. We can expect more such studies in the future, but this will take time.

 

While animal studies continue to demonstrate an effect of early life nutritional exposure on the epigenome and metabolic health of the offspring, human data are still limited. However, recent studies have provided clear evidence that exposure to suboptimal nutrition during specific periods of prenatal development is associated with methylation changes in the offspring and therefore have the potential to influence adult phenotype. Animal studies will be important to verify human findings in a more controlled setting, help determine whether the identified methylation changes have any impact on metabolic health, and unravel the mechanisms underlying this intergenerational/transgenerational epigenetic regulation. The identification of causal mechanisms underlying metabolic memory responses, the mode of transmission of the phenotypic effects into successive generations, the degree of impact and stability of the transmitted trait, and the identification of an overarching and unifying evolutionary context also remain important questions to be addressed. The latter is often encapsulated by the predictive adaptive response hypothesis, i.e., a response to a future anticipated environment that increases fitness of the population. However, this hypothesis has increasingly been questioned as there is limited evidence for increased fitness later in life [87].

 

In summary, outcomes are promising, as the epigenetic changes are linked with adult metabolic health and they act as a mediator between altered prenatal nutrition and subsequent increased risk of poor metabolic health outcomes. New epigenetic marks have been identified that are associated with measures of metabolic health. Integration of different layers of genomic information has added further support to causal relationships, and there have been further studies showing effects of pre- and postnatal environment on the epigenome and health. While many important questions remain, recent methodological advances have enabled the types of large-scale population-based studies that will be required to address the knowledge gaps. The next decade promises to be a period of major activity in this important research area.

 

Susan J. van Dijk1, Ross L. Tellam2, Janna L. Morrison3, Beverly S. Muhlhausler4,5† and Peter L. Molloy1*†

 

Competing interests

The authors declare that they have no competing interests.

 

Authors’ contributions
All authors contributed to the drafting and critical revision of the manuscript, and all authors read and approved the final manuscript.

 

Authors’ information
Beverly S. Muhlhausler and Peter L. Molloy are joint last authors.

 

Acknowledgements

This work has been supported by a grant from the Science and Industry Endowment Fund (Grant RP03-064). JLM and BSM are supported by the National Health and Medical Research Council Career Development Fellowships (JLM, APP1066916; BSM, APP1004211). We thank Lance Macaulay and Sue Mitchell for critical reading and comments on the manuscript.

 

Author details

1CSIRO Food and Nutrition Flagship, PO Box 52, North Ryde, NSW 1670, Australia. 2CSIRO Agriculture Flagship, 306 Carmody Road, St Lucia, QLD 4067, Australia. 3Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia 4FOODplus Research Centre, Waite Campus, The University of Adelaide, PMB 1, Glen Osmond, SA 5064, Australia. 5Women’s and Children’s Health Research Institute, 72 King William Road, North Adelaide, SA 5006, Australia.

 

References:

1. WHO. WHO | Overweight and obesity. http://www.who.int/gho/ncd/<br />
risk_factors/overweight/en/index.html. Accessed 29 January 2015.<br />
2. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery.<br />
Am J Hum Genet. 2012;90:7–24.<br />
3. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic<br />
studies of body mass index yield new insights for obesity biology. Nature.<br />
2015;518:197–206.<br />
4. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, et al.<br />
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and<br />
effect on insulin secretion. Diabetologia. 2008;51:615–22.<br />
5. Van Dijk SJ, Molloy PL, Varinli H, Morrison JL, Muhlhausler BS. Epigenetics<br />
and human obesity. Int J Obes (Lond). 2015;39:85–97.<br />
6. Teh AL, Pan H, Chen L, Ong M-L, Dogra S, Wong J, et al. The effect of<br />
genotype and in utero environment on interindividual variation in neonate<br />
DNA methylomes. Genome Res. 2014;24:1064–74.<br />
7. Olsson AH, Volkov P, Bacos K, Dayeh T, Hall E, Nilsson EA, et al. Genomewide<br />
associations between genetic and epigenetic variation influence<br />
mRNA expression and insulin secretion in human pancreatic islets. PLoS<br />
Genet. 2014;10:e1004735.<br />
8. Grundberg E, Meduri E, Sandling JK, Hedman AK, Keildson S, Buil A, et al.<br />
Global analysis of DNA methylation variation in adipose tissue from twins<br />
reveals links to disease-associated variants in distal regulatory elements.<br />
Am J Hum Genet. 2013;93:876–90.<br />
9. Ronn T, Volkov P, Gillberg L, Kokosar M, Perfilyev A, Jacobsen AL, et al.<br />
Impact of age, BMI and HbA1c levels on the genome-wide DNA<br />
methylation and mRNA expression patterns in human adipose tissue<br />
and identification of epigenetic biomarkers in blood. Hum Mol Genet.<br />
2015;24:3792–813.<br />
10. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental<br />
origins hypothesis. Annu Rev Nutr. 2007;27:363–88.<br />
11. McMillen IC, Rattanatray L, Duffield JA, Morrison JL, MacLaughlin SM, Gentili<br />
S, et al. The early origins of later obesity: pathways and mechanisms. Adv<br />
Exp Med Biol. 2009;646:71–81.<br />
12. Ravelli A, van der Meulen J, Michels R, Osmond C, Barker D, Hales C, et al.<br />
Glucose tolerance in adults after prenatal exposure to famine. Lancet.<br />
1998;351:173–7.<br />
13. McMillen IC, MacLaughlin SM, Muhlhausler BS, Gentili S, Duffield JL,<br />
Morrison JL. Developmental origins of adult health and disease: the role of<br />
periconceptional and foetal nutrition. Basic Clin Pharmacol Toxicol.<br />
2008;102:82–9.<br />
14. Zhang S, Rattanatray L, McMillen IC, Suter CM, Morrison JL. Periconceptional<br />
nutrition and the early programming of a life of obesity or adversity. Prog<br />
Biophys Mol Biol. 2011;106:307–14.<br />
15. Bouret S, Levin BE, Ozanne SE. Gene-environment interactions controlling<br />
energy and glucose homeostasis and the developmental origins of obesity.<br />
Physiol Rev. 2015;95:47–82.<br />
16. Borengasser SJ, Zhong Y, Kang P, Lindsey F, Ronis MJ, Badger TM, et al.<br />
Maternal obesity enhances white adipose tissue differentiation and alters<br />
genome-scale DNA methylation in male rat offspring. Endocrinology.<br />
2013;154:4113–25.<br />
17. Gluckman PD, Lillycrop KA, Vickers MH, Pleasants AB, Phillips ES, Beedle AS,<br />
et al. Metabolic plasticity during mammalian development is directionally<br />
dependent on early nutritional status. Proc Natl Acad Sci U S A.<br />
2007;104:12796–800.<br />
18. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C,<br />
et al. Epigenetic gene promoter methylation at birth is associated with<br />
child’s later adiposity. Diabetes. 2011;60:1528–34.<br />
19. McMillen IC, Adam CL, Muhlhausler BS. Early origins of obesity:<br />
programming the appetite regulatory system. J Physiol. 2005;565(Pt 1):9–17.<br />
20. Begum G, Stevens A, Smith EB, Connor K, Challis JR, Bloomfield F, et al.<br />
Epigenetic changes in fetal hypothalamic energy regulating pathways are<br />
associated with maternal undernutrition and twinning. FASEB J.<br />
2012;26:1694–703.<br />
21. Ge ZJ, Liang QX, Hou Y, Han ZM, Schatten H, Sun QY, et al. Maternal obesity<br />
and diabetes may cause DNA methylation alteration in the spermatozoa of<br />
offspring in mice. Reprod Biol Endocrinol. 2014;12:29.<br />
22. Jousse C, Parry L, Lambert-Langlais S, Maurin AC, Averous J, Bruhat A, et al.<br />
Perinatal undernutrition affects the methylation and expression of the leptin<br />
gene in adults: implication for the understanding of metabolic syndrome.<br />
FASEB J. 2011;25:3271–8.<br />
23. Lan X, Cretney EC, Kropp J, Khateeb K, Berg MA, Penagaricano F, et al.<br />
Maternal diet during pregnancy induces gene expression and DNA<br />
methylation changes in fetal tissues in sheep. Front Genet. 2013;4:49.<br />
24. Li CC, Young PE, Maloney CA, Eaton SA, Cowley MJ, Buckland ME, et al.<br />
Maternal obesity and diabetes induces latent metabolic defects and<br />
widespread epigenetic changes in isogenic mice. Epigenetics. 2013;8:602–11.<br />
25. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC. Dietary protein<br />
restriction of pregnant rats induces and folic acid supplementation prevents<br />
epigenetic modification of hepatic gene expression in the offspring. J Nutr.<br />
2005;135:1382–6.<br />
26. Radford EJ, Ito M, Shi H, Corish JA, Yamazawa K, Isganaitis E, et al. In utero<br />
effects. In utero undernourishment perturbs the adult sperm methylome<br />
and intergenerational metabolism. Science. 2014;345(80):1255903.<br />
27. Suter M, Bocock P, Showalter L, Hu M, Shope C, McKnight R, et al.<br />
Epigenomics: maternal high-fat diet exposure in utero disrupts<br />
peripheral circadian gene expression in nonhuman primates. FASEB J.<br />
2011;25:714–26.<br />
28. Suter MA, Ma J, Vuguin PM, Hartil K, Fiallo A, Harris RA, et al. In utero<br />
exposure to a maternal high-fat diet alters the epigenetic histone code in a<br />
murine model. Am J Obs Gynecol. 2014;210:463 e1–463 e11.<br />
29. Tosh DN, Fu Q, Callaway CW, McKnight RA, McMillen IC, Ross MG, et al.<br />
Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1<br />
mRNA expression and histone structure in rapid vs. delayed postnatal<br />
catch-up growth. Am J Physiol Gastrointest Liver Physiol.<br />
2010;299:G1023–9.<br />
30. Sandovici I, Smith NH, Nitert MD, Ackers-Johnson M, Uribe-Lewis S, Ito Y,<br />
et al. Maternal diet and aging alter the epigenetic control of a promoterenhancer<br />
interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl<br />
Acad Sci U S A. 2011;108:5449–54.<br />
31. Braunschweig M, Jagannathan V, Gutzwiller A, Bee G. Investigations on<br />
transgenerational epigenetic response down the male line in F2 pigs. PLoS<br />
One. 2012;7, e30583.<br />
32. Carone BR, Fauquier L, Habib N, Shea JM, Hart CE, Li R, et al. Paternally<br />
induced transgenerational environmental reprogramming of metabolic<br />
gene expression in mammals. Cell. 2010;143:1084–96.<br />
33. Ost A, Lempradl A, Casas E, Weigert M, Tiko T, Deniz M, et al. Paternal diet<br />
defines offspring chromatin state and intergenerational obesity. Cell.<br />
2014;159:1352–64.<br />
34. Martínez D, Pentinat T, Ribó S, Daviaud C, Bloks VW, Cebrià J, et al. In utero<br />
undernutrition in male mice programs liver lipid metabolism in the secondgeneration<br />
offspring involving altered Lxra DNA methylation. Cell Metab.<br />
2014;19:941–51.<br />
35. Wei Y, Yang C-R, Wei Y-P, Zhao Z-A, Hou Y, Schatten H, et al. Paternally<br />
induced transgenerational inheritance of susceptibility to diabetes in<br />
mammals. Proc Natl Acad Sci U S A. 2014;111:1873–8.<br />
36. Grossniklaus U, Kelly WG, Kelly B, Ferguson-Smith AC, Pembrey M, Lindquist<br />
S. Transgenerational epigenetic inheritance: how important is it? Nat Rev<br />
Genet. 2013;14:228–35.<br />
37. Pembrey M, Saffery R, Bygren LO. Human transgenerational responses to<br />
early-life experience: potential impact on development, health and<br />
biomedical research. J Med Genet. 2014;51:563–72.<br />
38. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl<br />
supplements affect agouti gene expression in Avy/a mice. FASEB J.<br />
1998;12:949–57.<br />
39. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility.<br />
Nat Rev Genet. 2007;8:253–62.<br />
40. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. Epigenetic inheritance at<br />
the agouti locus in the mouse. Nat Genet. 1999;23:314–8.<br />
41. Cropley JE, Suter CM, Beckman KB, Martin DI. Germ-line epigenetic<br />
modification of the murine A vy allele by nutritional supplementation. Proc<br />
Natl Acad Sci U S A. 2006;103:17308–12.<br />
42. Hoile SP, Lillycrop KA, Thomas NA, Hanson MA, Burdge GC. Dietary protein<br />
restriction during F0 pregnancy in rats induces transgenerational changes in<br />
the hepatic transcriptome in female offspring. PLoS One. 2011;6, e21668.<br />
43. Multhaup ML, Seldin MM, Jaffe AE, Lei X, Kirchner H, Mondal P, et al. Mousehuman<br />
experimental epigenetic analysis unmasks dietary targets and<br />
genetic liability for diabetic phenotypes. Cell Metab. 2015;21:138–49.<br />
44. Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I, et al.<br />
Recommendations for the design and analysis of epigenome-wide<br />
association studies. Nat Methods. 2013;10:949–55.<br />
45. Dayeh TA, Olsson AH, Volkov P, Almgren P, Rönn T, Ling C. Identification of<br />
CpG-SNPs associated with type 2 diabetes and differential DNA methylation<br />
in human pancreatic islets. Diabetologia. 2013;56:1036–46.<br />
46. Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a<br />
strategy for establishing the causal role of epigenetic processes in pathways<br />
to disease. Int J Epidemiol. 2012;41:161–76.<br />
47. Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, et al.<br />
Epigenome-wide association data implicate DNA methylation as an<br />
intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol.<br />
2013;31:142–7.<br />
48. Yuan W, Xia Y, Bell CG, Yet I, Ferreira T, Ward KJ, et al. An integrated<br />
epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic<br />
twins. Nat Commun. 2014;5:5719.<br />
49. Nitert MD, Dayeh T, Volkov P, Elgzyri T, Hall E, Nilsson E, et al. Impact of an<br />
exercise intervention on DNA methylation in skeletal muscle from firstdegree<br />
relatives of patients with type 2 diabetes. Diabetes. 2012;61:3322–32.<br />
50. Gagnon F, Aïssi D, Carrié A, Morange P-E, Trégouët D-A. Robust validation of<br />
methylation levels association at CPT1A locus with lipid plasma levels.<br />
J Lipid Res. 2014;55:1189–91.<br />
51. Demerath EW, Guan W, Grove ML, Aslibekyan S, Mendelson M, Zhou Y-H,<br />
et al. Epigenome-wide association atudy (EWAS) of BMI, BMI change, and<br />
waist circumference in African American adults identifies multiple replicated<br />
loci. Hum Mol Genet. 2015:ddv161–.<br />
52. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, et al. DNA<br />
methylation and body-mass index: a genome-wide analysis. Lancet.<br />
2014;6736:1–9.<br />
53. Su S, Zhu H, Xu X, Wang X, Dong Y, Kapuku G, et al. DNA methylation of<br />
the LY86 gene is associated with obesity, insulin resistance, and<br />
inflammation. Twin Res Hum Genet. 2014;17:183–91.<br />
54. Clarke-Harris R, Wilkin TJ, Hosking J, Pinkney J, Jeffery AN, Metcalf BS, et al.<br />
PGC1α promoter methylation in blood at 5–7 years predicts adiposity from<br />
9 to 14 years (EarlyBird 50). Diabetes. 2014;63:2528–37.<br />
55. Guay S-P, Brisson D, Lamarche B, Biron S, Lescelleur O, Biertho L, et al.<br />
ADRB3 gene promoter DNA methylation in blood and visceral adipose<br />
tissue is associated with metabolic disturbances in men. Epigenomics.<br />
2014;6:33–43.<br />
56. Agha G, Houseman EA, Kelsey KT, Eaton CB, Buka SL, Loucks EB. Adiposity is<br />
associated with DNA methylation profile in adipose tissue. Int J Epidemiol.<br />
2014:1–11.<br />
57. Irvin MR, Zhi D, Joehanes R, Mendelson M, Aslibekyan S, Claas SA, et al.<br />
Epigenome-wide association study of fasting blood lipids in the genetics of<br />
lipid-lowering drugs and diet network study. Circulation. 2014;130:565–72.<br />
58. Frazier-Wood AC, Aslibekyan S, Absher DM, Hopkins PN, Sha J, Tsai MY, et al.<br />
Methylation at CPT1A locus is associated with lipoprotein subfraction<br />
profiles. J Lipid Res. 2014;55:1324–30.<br />
59. Pfeifferm L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. DNA<br />
methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc<br />
Genet. 2015.<br />
60. Petersen A-K, Zeilinger S, Kastenmüller G, Römisch-Margl W, Brugger M, Peters<br />
A, et al. Epigenetics meets metabolomics: an epigenome-wide association<br />
study with blood serum metabolic traits. Hum Mol Genet. 2014;23:534–45.<br />
61. Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al. Epigenomewide<br />
association study of fasting measures of glucose, insulin, and HOMA-IR<br />
in the genetics of lipid lowering drugs and diet network study. Diabetes.<br />
2014;63:801–7.<br />
62. Dayeh T, Volkov P, Salö S, Hall E, Nilsson E, Olsson AH, et al. Genome-wide<br />
DNA methylation analysis of human pancreatic islets from type 2 diabetic<br />
and non-diabetic donors identifies candidate genes that influence insulin<br />
secretion. PLoS Genet. 2014;10, e1004160.<br />
63. Nilsson E, Jansson PA, Perfilyev A, Volkov P, Pedersen M, Svensson MK, et al.<br />
Altered DNA methylation and differential expression of genes influencing<br />
metabolism and inflammation in adipose tissue from subjects with type 2<br />
diabetes. Diabetes. 2014;63:2962–76.<br />
64. Benton MC, Johnstone A, Eccles D, Harmon B, Hayes MT, Lea RA, et al. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight<br />
loss. Gene. 2015;16:1–21.<br />
65. Bateson P, Gluckman P. Plasticity and robustness in development and<br />
evolution. Int J Epidemiol. 2012;41:219–23.<br />
66. Feinberg AP, Irizarry RA, Feinberg AP, Irizarry RA. Evolution in health and<br />
medicine Sackler colloquium: stochastic epigenetic variation as a driving<br />
force of development, evolutionary adaptation, and disease. Proc Natl Acad<br />
Sci U S A. 2010;107(Suppl):1757–64.<br />
67. Martino D, Loke YJ, Gordon L, Ollikainen M, Cruickshank MN, Saffery R, et al.<br />
Longitudinal, genome-scale analysis of DNA methylation in twins from birth<br />
to 18 months of age reveals rapid epigenetic change in early life and pairspecific<br />
effects of discordance. Genome Biol. 2013;14:R42.<br />
68. Tobi EW, Goeman JJ, Monajemi R, Gu H, Putter H, Zhang Y, et al. DNA<br />
methylation signatures link prenatal famine exposure to growth and<br />
metabolism. Nat Commun. 2014;5:5592.<br />
69. Dominguez-Salas P, Moore SE, Baker MS, Bergen AW, Cox SE, Dyer RA, et al.<br />
Maternal nutrition at conception modulates DNA methylation of human<br />
metastable epialleles. Nat Commun. 2014;5:3746.<br />
70. Quilter CR, Cooper WN, Cliffe KM, Skinner BM, Prentice PM, Nelson L, et al.<br />
Impact on offspring methylation patterns of maternal gestational diabetes<br />
mellitus and intrauterine growth restraint suggest common genes and<br />
pathways linked to subsequent type 2 diabetes risk. FASEB J. 2014:1–12.<br />
71. Morales E, Groom A, Lawlor DA, Relton CL. DNA methylation signatures in<br />
cord blood associated with maternal gestational weight gain: results from<br />
the ALSPAC cohort. BMC Res Notes. 2014;7:278.<br />
72. Ruchat SM, Houde AA, Voisin G, St-Pierre J, Perron P, Baillargeon JP, et al.<br />
Gestational diabetes mellitus epigenetically affects genes predominantly<br />
involved in metabolic diseases. Epigenetics. 2013;8:935–43.<br />
73. Liu X, Chen Q, Tsai H-J, Wang G, Hong X, Zhou Y, et al. Maternal<br />
preconception body mass index and offspring cord blood DNA<br />
methylation: exploration of early life origins of disease. Environ Mol<br />
Mutagen. 2014;55:223–30.<br />
74. Soubry A, Murphy SK, Wang F, Huang Z, Vidal AC, Fuemmeler BF, et al.<br />
Newborns of obese parents have altered DNA methylation patterns at<br />
imprinted genes. Int J Obes (Lond). 2015;39:650–7.<br />
75. Jacobsen SC, Brøns C, Bork-Jensen J, Ribel-Madsen R, Yang B, Lara E, et al.<br />
Effects of short-term high-fat overfeeding on genome-wide DNA<br />
methylation in the skeletal muscle of healthy young men. Diabetologia.<br />
2012;55:3341–9.<br />
76. Gillberg L, Jacobsen SC, Rönn T, Brøns C, Vaag A. PPARGC1A DNA<br />
methylation in subcutaneous adipose tissue in low birth weight subjects–<br />
impact of 5 days of high-fat overfeeding. Metabolism. 2014;63:263–71.<br />
77. Huang Y-T, Maccani JZJ, Hawley NL, Wing RR, Kelsey KT, McCaffery JM.<br />
Epigenetic patterns in successful weight loss maintainers: a pilot study. Int J<br />
Obes (Lond). 2015;39:865–8.<br />
78. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A, Näslund E,<br />
Zierath JR. Weight loss after gastric bypass surgery in human obesity<br />
remodels promoter methylation. Cell Rep. 2013:1–8.<br />
79. Ahrens M, Ammerpohl O, von Schönfels W, Kolarova J, Bens S, Itzel T, et al.<br />
DNA methylation analysis in nonalcoholic fatty liver disease suggests<br />
distinct disease-specific and remodeling signatures after bariatric surgery.<br />
Cell Metab. 2013;18:296–302.<br />
80. Voisin S, Eynon N, Yan X, Bishop DJ. Exercise training and DNA methylation<br />
in humans. Acta Physiol (Oxf). 2014;213:39–59.<br />
81. Lindholm ME, Marabita F, Gomez-Cabrero D, Rundqvist H, Ekström TJ,<br />
Tegnér J, et al. An integrative analysis reveals coordinated reprogramming<br />
of the epigenome and the transcriptome in human skeletal muscle after<br />
training. Epigenetics. 2014;9:1557–69.<br />
82. Denham J, O’Brien BJ, Marques FZ, Charchar FJ. Changes in the leukocyte<br />
methylome and its effect on cardiovascular related genes after exercise.<br />
J Appl Physiol. 2014:jap.00878.2014.<br />
83. Rowlands DS, Page RA, Sukala WR, Giri M, Ghimbovschi SD, Hayat I, et al.<br />
Multi-omic integrated networks connect DNA methylation and miRNA with<br />
skeletal muscle plasticity to chronic exercise in type 2 diabetic obesity.<br />
Physiol Genomics. 2014;46:747–65.<br />
84. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M,<br />
et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad<br />
Sci. 2014;111:15538–43.<br />
85. Almén MS, Nilsson EK, Jacobsson JA, Kalnina I, Klovins J, Fredriksson R, et al.<br />
Genome-wide analysis reveals DNA methylation markers that vary with<br />
both age and obesity. Gene. 2014.;548:61–7<br />
86. Houseman EA, Molitor J, Marsit CJ. Reference-free cell mixture adjustments<br />
in analysis of DNA methylation data. Bioinformatics. 2014;30:1431–9.<br />
87. Wells JC. A critical appraisal of the predictive adaptive response hypothesis.<br />
Int J Epidemiol. 2012;41:229–35.<br />
88. Williams-Wyss O, Zhang S, MacLaughlin SM, Kleemann D, Walker SK, Suter<br />
CM, et al. Embryo number and periconceptional undernutrition in the<br />
sheep have differential effects on adrenal epigenotype, growth, and<br />
development. Am J Physiol Endocrinol Metab. 2014;307:E141–50.<br />
89. Zhang S, Rattanatray L, Morrison JL, Nicholas LM, Lie S, McMillen IC.<br />
Maternal obesity and the early origins of childhood obesity: weighing up<br />
the benefits and costs of maternal weight loss in the periconceptional<br />
period for the offspring. Exp Diabetes Res. 2011;2011:585749.<br />
90. Zhang S, Williams-Wyss O, MacLaughlin SM, Walker SK, Kleemann DO, Suter<br />
CM, et al. Maternal undernutrition during the first week after conception<br />
results in decreased expression of glucocorticoid receptor mRNA in the<br />
absence of GR exon 17 hypermethylation in the fetal pituitary in late<br />
gestation. J Dev Orig Heal Dis. 2013;4:391–401.<br />
91. Lie S, Morrison JL, Williams-Wyss O, Suter CM, Humphreys DT, Ozanne SE,<br />
et al. Periconceptional undernutrition programs changes in insulin-signaling<br />
molecules and microRNAs in skeletal muscle in singleton and twin fetal<br />
sheep. Biol Reprod. 2014;90:5.<br />
92. Van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade<br />
HJ, et al. Fetal liver X receptor activation acutely induces lipogenesis but<br />
does not affect plasma lipid response to a high-fat diet in adult mice. Am J<br />
Physiol Endocrinol Metab. 2009;297:E1171–8.<br />
93. Fernandez-Twinn DS, Alfaradhi MZ, Martin-Gronert MS, Duque-Guimaraes<br />
DE, Piekarz A, Ferland-McCollough D, et al. Downregulation of IRS-1 in<br />
adipose tissue of offspring of obese mice is programmed cellautonomously<br />
through post-transcriptional mechanisms. Mol Metab.<br />
2014;3:325–33.<br />
94. Waterland RA, Travisano M, Tahiliani KG. Diet-induced hypermethylation at<br />
agouti viable yellow is not inherited transgenerationally through the female.<br />
FASEB J. 2007;21:3380–5.<br />
95. Ge ZJ, Luo SM, Lin F, Liang QX, Huang L, Wei YC, et al. DNA methylation in<br />
oocytes and liver of female mice and their offspring: effects of high-fat-dietinduced<br />
obesity. Env Heal Perspect. 2014;122:159–64.<br />
96. Ollikainen M, Ismail K, Gervin K, Kyllönen A, Hakkarainen A, Lundbom J, et al.<br />
Genome-wide blood DNA methylation alterations at regulatory elements<br />
and heterochromatic regions in monozygotic twins discordant for obesity<br />
and liver fat. Clin Epigenetics. 2015;7:1–13.

 

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Advances in epigenetic methodologies and the reduced cost of epigenome-wide association studies have led to a rapid expansion of studies.  For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

william's curator insight, September 14, 2022 2:06 PM

Acquista Online La Prescrizione Di Perdita Di Peso
Crediamo che i farmaci a volte possano essere molto urgenti da assumere. Se hai urgente bisogno di farmaci, possiamo anche fornirti una consegna espressa,

https://farmaciadimagrante.com/
https://farmaciadimagrante.com/Prodotto/acquista-ossicodone-online/
https://farmaciadimagrante.com/Prodotto/acquista-oxycontin-online/
https://farmaciadimagrante.com/Prodotto/acquista-percocet-online/
https://farmaciadimagrante.com/Prodotto/acquista-phentermine-online/
https://farmaciadimagrante.com/Prodotto/acquista-eroina-bianca/
https://farmaciadimagrante.com/Prodotto/a-215-ossicodone-actavis/
https://farmaciadimagrante.com/Prodotto/acquista-adderall-30mg/
https://farmaciadimagrante.com/Prodotto/acquista-adipex-online/
https://farmaciadimagrante.com/Prodotto/acquista-adma-online/
https://farmaciadimagrante.com/Prodotto/acquista-ambien/
https://farmaciadimagrante.com/Prodotto/acquista-ativan-online/
https://farmaciadimagrante.com/Prodotto/acquista-botox-online/
https://farmaciadimagrante.com/Prodotto/acquista-cerotti-al-fentanil/
https://farmaciadimagrante.com/Prodotto/acquista-codeina-linctus-online/
https://farmaciadimagrante.com/Prodotto/acquista-codeina-online/
https://farmaciadimagrante.com/Prodotto/acquista-demerol-online/
https://farmaciadimagrante.com/Prodotto/acquista-depalgo-online/
https://farmaciadimagrante.com/Prodotto/acquista-diazepam-online/
https://farmaciadimagrante.com/Prodotto/acquista-dilaudid-8mg/
https://farmaciadimagrante.com/Prodotto/acquista-endocet-online/
https://farmaciadimagrante.com/Prodotto/acquista-green-xanax/
https://farmaciadimagrante.com/Prodotto/acquista-hydrocodone-online/
https://farmaciadimagrante.com/Prodotto/acquista-instanyl-online/
https://farmaciadimagrante.com/Prodotto/acquista-l-ritalin-online/
https://farmaciadimagrante.com/Prodotto/acquista-metadone/
https://farmaciadimagrante.com/Prodotto/acquista-morfina-solfato/
https://farmaciadimagrante.com/Prodotto/acquista-opana-online/
https://farmaciadimagrante.com/Prodotto/acquista-roxicodone-30mg/
https://farmaciadimagrante.com/Prodotto/acquista-stilnox-online/
https://farmaciadimagrante.com/Prodotto/acquista-suboxone-8mg/
https://farmaciadimagrante.com/Prodotto/acquista-subutex-online/
https://farmaciadimagrante.com/Prodotto/acquista-vicodin-online/
https://farmaciadimagrante.com/Prodotto/acquista-vyvanse-online/
https://farmaciadimagrante.com/Prodotto/acquista-xanax-2mg/
https://farmaciadimagrante.com/Prodotto/acquistare-dapoxetina-online/
https://farmaciadimagrante.com/Prodotto/acquistare-rohypnol-2mg/
https://farmaciadimagrante.com/Prodotto/acquistare-sibutramina-online/
https://farmaciadimagrante.com/Prodotto/efedrina-hcl-in-polvere/
https://farmaciadimagrante.com/Prodotto/ephedrine-hcl-30mg/
https://farmaciadimagrante.com/Prodotto/sciroppo-di-metadone/
https://farmaciadimagrante.com/Prodotto/tramadolo-hcl-200mg/
https://farmaciadimagrante.com/Prodotto/acquista-cristallo-mdma-online/

 

https://farmaciadimagrante.com/blog/
https://farmaciadimagrante.com/2022/08/15/acquista-adderall-30mg-online/
https://farmaciadimagrante.com/2022/08/15/acquistare-sibutramina-online-2omg/
https://farmaciadimagrante.com/2022/08/15/acquista-efedrina-hcl-30mg/
https://farmaciadimagrante.com/2022/08/15/acquista-adipex-online-75mg/
https://farmaciadimagrante.com/2022/08/15/acquista-phentermine-online-senza-prescrizione-medica/
https://farmaciadimagrante.com/2022/08/15/acquistare-vyvanse-online-70mg/

 

Quando si tratta di questioni di salute, è fondamentale sapere quali sono le farmacie buone e cattive.
Devi imparare cosa cercare in una farmacia per sapere se è quella giusta. Ricorda, hai a che fare con la vita, ecco perché devi stare attento a dove acquistare i tuoi farmaci e altre necessità farmaceutiche.

https://profarmaceutico.com/
https://profarmaceutico.com/Prodotto/a-215-ossicodone-actavis/
https://profarmaceutico.com/Prodotto/acquista-adderall-30mg/
https://profarmaceutico.com/Prodotto/acquista-adipex-online/
https://profarmaceutico.com/Prodotto/acquista-ossicodone-online/
https://profarmaceutico.com/Prodotto/acquista-oxycontin-online/
https://profarmaceutico.com/Prodotto/acquista-codeina-online/
https://profarmaceutico.com/Prodotto/acquista-adma-online/
https://profarmaceutico.com/Prodotto/acquista-ambien/
https://profarmaceutico.com/Prodotto/acquista-ativan-online/
https://profarmaceutico.com/Prodotto/acquista-botox-online/
https://profarmaceutico.com/Prodotto/acquista-cerotti-al-fentanil/
https://profarmaceutico.com/Prodotto/acquista-codeina-linctus-online/
https://profarmaceutico.com/Prodotto/acquista-demerol-online/
https://profarmaceutico.com/Prodotto/acquista-depalgo-online/
https://profarmaceutico.com/Prodotto/acquista-diazepam-online/
https://profarmaceutico.com/Prodotto/acquistare-idromorfone-online/
https://profarmaceutico.com/Prodotto/acquista-endocet-online/
https://profarmaceutico.com/Prodotto/acquista-eroina-bianca/
https://profarmaceutico.com/Prodotto/acquista-green-xanax/
https://profarmaceutico.com/Prodotto/acquista-hydrocodone-online/
https://profarmaceutico.com/Prodotto/acquista-instanyl-online/
https://profarmaceutico.com/Prodotto/acquista-l-ritalin-online/
https://profarmaceutico.com/Prodotto/acquista-metadone/
https://profarmaceutico.com/Prodotto/acquista-morfina-solfato/
https://profarmaceutico.com/Prodotto/acquista-opana-online/
https://profarmaceutico.com/Prodotto/acquista-percocet-online/
https://profarmaceutico.com/Prodotto/acquista-phentermine-online/
https://profarmaceutico.com/Prodotto/acquista-roxy-roxicodone-30-mg/
https://profarmaceutico.com/Prodotto/acquista-stilnox-online/
https://profarmaceutico.com/Prodotto/acquista-suboxone-8mg/
https://profarmaceutico.com/Prodotto/acquista-subutex-online/
https://profarmaceutico.com/Prodotto/acquista-vicodin-online/
https://profarmaceutico.com/Prodotto/acquista-vyvanse-online/
https://profarmaceutico.com/Prodotto/acquista-xanax-2mg/
https://profarmaceutico.com/Prodotto/acquistare-dapoxetina-online/
https://profarmaceutico.com/Prodotto/acquistare-rohypnol-2mg/
https://profarmaceutico.com/Prodotto/acquistare-sibutramina-online/
https://profarmaceutico.com/Prodotto/efedrina-hcl-in-polvere/
https://profarmaceutico.com/Prodotto/ephedrine-hcl-30mg/
https://profarmaceutico.com/Prodotto/sciroppo-di-metadone/
https://profarmaceutico.com/Prodotto/tramadolo-hcl-200mg/

 

<a href="https://farmaciadimagrante.com/Prodotto/acquista-ativan-online/">acquista-ativan-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-botox-online/">acquista-botox-online</a></a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-cerotti-al-fentanil/">acquista-cerotti-al-fentanil</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-codeina-linctus-online/">acquista-codeina-linctus-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-codeina-online/">acquista-codeina-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-demerol-online/">acquista-demerol-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-depalgo-online/">acquista-depalgo-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-diazepam-online/">acquista-diazepam-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquistare-idromorfone-online/">acquistare-idromorfone-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-endocet-online/">acquista-endocet-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-green-xanax/">acquista-green-xanax</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-hydrocodone-online/">acquista-hydrocodone-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-instanyl-online/">acquista-instanyl-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-l-ritalin-online/">acquista-l-ritalin-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-metadone/">acquista-metadone</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-morfina-solfato/">acquista-morfina-solfato</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-opana-online/">acquista-opana-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-roxicodone-30mg/">acquista-roxicodone-30mg</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-stilnox-online/">acquista-stilnox-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-suboxone-8mg/">acquista-suboxone-8mg</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-subutex-online/">acquista-subutex-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-vicodin-online/">acquista-vicodin-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-vyvanse-online/">acquista-vyvanse-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquista-xanax-2mg/">acquista-xanax-2mg</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquistare-dapoxetina-online/">acquistare-dapoxetina-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquistare-rohypnol-2mg/">acquistare-rohypnol-2mg</a>;
<a href="https://farmaciadimagrante.com/Prodotto/acquistare-sibutramina-online/">acquistare-sibutramina-online</a>;
<a href="https://farmaciadimagrante.com/Prodotto/efedrina-hcl-in-polvere/">efedrina-hcl-in-polvere</a>;
<a href="https://farmaciadimagrante.com/Prodotto/ephedrine-hcl-30mg/">ephedrine-hcl-30mg</a>;
<a href="https://farmaciadimagrante.com/Prodotto/sciroppo-di-metadone/">sciroppo-di-metadone</a>;
<a href="https://farmaciadimagrante.com/Prodotto/tramadolo-hcl-200mg/">tramadolo-hcl-200mg</a>;

<a href="https://farmaciadimagrante.com/2022/08/15/acquista-adderall-30mg-online/">acquista-adderall-30mg-online</a>;
<a href="https://farmaciadimagrante.com/2022/08/15/acquistare-sibutramina-online-2omg/">acquistare-sibutramina-online-2omg</a>;
<a href="https://farmaciadimagrante.com/2022/08/15/acquista-efedrina-hcl-30mg/">acquista-efedrina-hcl-30mg</a>;
<a href="https://farmaciadimagrante.com/2022/08/15/acquista-adipex-online-75mg/">acquista-adipex-online-75mg</a>;
<a href="https://farmaciadimagrante.com/2022/08/15/acquista-phentermine-online-senza-prescrizione-medica/">acquista-phentermine-online-senza-prescrizione-medica</a>;
<a href="https://farmaciadimagrante.com/2022/08/15/acquistare-vyvanse-online-70mg/">acquistare-vyvanse-online-70mg</a>;

 

 

Quando si tratta di questioni di salute, è fondamentale sapere quali sono le farmacie buone e cattive. Devi imparare cosa cercare in una farmacia per sapere se è quella giusta. Ricorda, hai a che fare con la vita, ecco perché devi stare attento a dove acquistare i tuoi farmaci e altre necessità farmaceutiche.

<a href="https://profarmaceutico.com/Prodotto/a-215-ossicodone-actavis/">a-215-ossicodone-actavis</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-adderall-30mg/">acquista-adderall-30mg</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-adipex-online/">acquista-adipex-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-ossicodone-online/">acquista-ossicodone-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-oxycontin-online/">acquista-oxycontin-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-codeina-online/">acquista-codeina-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-adma-online/">acquista-adma-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-ambien/">acquista-ambien</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-ativan-online/">acquista-ativan-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-botox-online/">acquista-botox-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-cerotti-al-fentanil/">acquista-cerotti-al-fentanil</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-codeina-linctus-online/">acquista-codeina-linctus-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-demerol-online/">acquista-demerol-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-depalgo-online/">acquista-depalgo-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-diazepam-online/">acquista-diazepam-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-dilaudid-8mg/">acquista-dilaudid-8mg</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-endocet-online/">acquista-endocet-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-eroina-bianca/">acquista-eroina-bianca</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-green-xanax/">acquista-green-xanax</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-hydrocodone-online/">acquista-hydrocodone-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-instanyl-online/">acquista-instanyl-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-l-ritalin-online/">acquista-l-ritalin-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-metadone/">acquista-metadone</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-morfina-solfato/">acquista-morfina-solfato</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-opana-online/">acquista-opana-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-percocet-online/">acquista-percocet-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-phentermine-online/">acquista-phentermine-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-roxy-roxicodone-30-mg/">acquista-roxy-roxicodone-30-mg</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-stilnox-online/">acquista-stilnox-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-suboxone-8mg/">acquista-suboxone-8mg</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-subutex-online/">acquista-subutex-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-vicodin-online/">acquista-vicodin-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-vyvanse-online/">acquista-vyvanse-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquista-xanax-2mg/">acquista-xanax-2mg</a>;
<a href="https://profarmaceutico.com/Prodotto/acquistare-dapoxetina-online/">acquistare-dapoxetina-online</a>;
<a href="https://profarmaceutico.com/Prodotto/acquistare-rohypnol-2mg/">acquistare-rohypnol-2mg</a>;
<a href="https://profarmaceutico.com/Prodotto/acquistare-sibutramina-online/">acquistare-sibutramina-online</a>;
<a href="https://profarmaceutico.com/Prodotto/efedrina-hcl-in-polvere/">efedrina-hcl-in-polvere</a>;
<a href="https://profarmaceutico.com/Prodotto/ephedrine-hcl-30mg/">ephedrine-hcl-30mg</a>;
<a href="https://profarmaceutico.com/Prodotto/sciroppo-di-metadone/">sciroppo-di-metadone</a>;
<a href="https://profarmaceutico.com/Prodotto/tramadolo-hcl-200mg/">tramadolo-hcl-200mg</a>;

good health's curator insight, January 16, 2024 7:43 AM
https://farmaciadimagrante.com/ https://farmaciadimagrante.com/Prodotto/acquista-cristallo-mdma-online/ https://farmaciadimagrante.com/Prodotto/acquista-ativan-online/ https://farmaciadimagrante.com/Prodotto/acquista-botox-online/ https://farmaciadimagrante.com/Prodotto/acquista-cerotti-al-fentanil/ https://farmaciadimagrante.com/Prodotto/acquista-codeina-linctus-online/ https://farmaciadimagrante.com/Prodotto/acquista-codeina-online/ https://farmaciadimagrante.com/Prodotto/acquista-demerol-online/ https://farmaciadimagrante.com/Prodotto/acquista-depalgo-online/ https://farmaciadimagrante.com/Prodotto/acquista-diazepam-online/ https://farmaciadimagrante.com/Prodotto/acquistare-idromorfone-online/ https://farmaciadimagrante.com/Prodotto/acquista-endocet-online/ https://farmaciadimagrante.com/Prodotto/acquista-green-xanax/ https://farmaciadimagrante.com/Prodotto/acquista-hydrocodone-online/ https://farmaciadimagrante.com/Prodotto/acquista-instanyl-online/ https://farmaciadimagrante.com/Prodotto/acquista-l-ritalin-online/ https://farmaciadimagrante.com/Prodotto/acquista-metadone/ https://farmaciadimagrante.com/Prodotto/acquista-morfina-solfato/ https://farmaciadimagrante.com/Prodotto/acquista-opana-online/ https://farmaciadimagrante.com/Prodotto/acquista-roxicodone-30mg/ https://farmaciadimagrante.com/Prodotto/acquista-stilnox-online/ https://farmaciadimagrante.com/Prodotto/acquista-suboxone-8mg/ https://farmaciadimagrante.com/Prodotto/acquista-subutex-online/ https://farmaciadimagrante.com/Prodotto/acquista-vicodin-online/ https://farmaciadimagrante.com/Prodotto/acquista-vyvanse-online/ https://farmaciadimagrante.com/Prodotto/acquista-xanax-2mg/ https://farmaciadimagrante.com/Prodotto/acquistare-dapoxetina-online/ https://farmaciadimagrante.com/Prodotto/acquistare-rohypnol-2mg/ https://farmaciadimagrante.com/Prodotto/acquistare-sibutramina-online/ https://farmaciadimagrante.com/Prodotto/efedrina-hcl-in-polvere/ https://farmaciadimagrante.com/Prodotto/ephedrine-hcl-30mg/ https://farmaciadimagrante.com/Prodotto/sciroppo-di-metadone/ https://farmaciadimagrante.com/Prodotto/tramadolo-hcl-200mg/ acquista-ativan-online acquista-botox-online acquista-cerotti-al-fentanil acquista-codeina-linctus-online acquista-codeina-online acquista-demerol-online acquista-depalgo-online acquista-diazepam-online acquistare-idromorfone-online acquista-endocet-online acquista-green-xanax acquista-hydrocodone-online acquista-instanyl-online acquista-l-ritalin-online acquista-metadone acquista-morfina-solfato acquista-opana-online acquista-roxicodone-30mg acquista-stilnox-online acquista-suboxone-8mg acquista-subutex-online acquista-vicodin-online acquista-vyvanse-online acquista-xanax-2mg acquistare-dapoxetina-online acquistare-rohypnol-2mg acquistare-sibutramina-online efedrina-hcl-in-polvere ephedrine-hcl-30mg sciroppo-di-metadone tramadolo-hcl-200mg acquista-adderall-30mg-online acquistare-sibutramina-online-2omg acquista-efedrina-hcl-30mg acquista-adipex-online-75mg acquista-phentermine-online-senza-prescrizione-medica acquistare-vyvanse-online-70mg https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-ativan-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-botox-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-cerotti-al-fentanil/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-codeina-linctus-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-codeina-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-demerol-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-depalgo-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-diazepam-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquistare-idromorfone-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-endocet-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-green-xanax/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-hydrocodone-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-instanyl-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-l-ritalin-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-metadone/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-morfina-solfato/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-opana-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-roxicodone-30mg/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-stilnox-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-suboxone-8mg/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-subutex-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-vicodin-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-vyvanse-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquista-xanax-2mg/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquistare-dapoxetina-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquistare-rohypnol-2mg/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/acquistare-sibutramina-online/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/efedrina-hcl-in-polvere/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/ephedrine-hcl-30mg/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/sciroppo-di-metadone/ https://www.google.it/url?q=https://farmaciadimagrante.com/Prodotto/tramadolo-hcl-200mg/ acquista-ativan-online acquista-botox-online acquista-cerotti-al-fentanil acquista-codeina-linctus-online acquista-codeina-online acquista-demerol-online acquista-depalgo-online acquista-diazepam-online acquistare-idromorfone-online acquista-endocet-online acquista-green-xanax acquista-hydrocodone-online acquista-instanyl-online acquista-l-ritalin-online acquista-metadone acquista-morfina-solfato acquista-opana-online acquista-roxicodone-30mg acquista-stilnox-online acquista-suboxone-8mg acquista-subutex-online acquista-vicodin-online acquista-vyvanse-online acquista-xanax-2mg acquistare-dapoxetina-online acquistare-rohypnol-2mg acquistare-sibutramina-online efedrina-hcl-in-polvere ephedrine-hcl-30mg sciroppo-di-metadone tramadolo-hcl-200mg
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
October 25, 2017 6:18 PM
Scoop.it!

Body Composition Evaluation: A Clinical Practice Tool

Body Composition Evaluation: A Clinical Practice Tool | Diet and Supplements | Scoop.it

Body Composition: Key Words

  • Fat-free mass
  • Fat mass
  • Undernutrition
  • Bioelectrical impedance analysis
  • Sarcopenic obesity
  • Drug toxicity

 

Abstract

 

Undernutrition is insufficiently detected in in- and outpatients, and this is likely to worsen during the next decades. The increased prevalence of obesity together with chronic illnesses associated with fat-free mass (FFM) loss will result in an increased prevalence of sarcopenic obesity. In patients with sarcopenic obesity, weight loss and the body mass index lack accuracy to detect FFM loss. FFM loss is related to increasing mortality, worse clinical outcomes, and impaired quality of life. In sarcopenic obesity and chronic diseases, body composition measurement with dual-energy X-ray absorptiometry, bioelectrical impedance analysis, or computerized tomography quantifies the loss of FFM. It allows tailored nutritional support and disease-specific therapy and reduces the risk of drug toxicity. Body composition evaluation should be integrated into routine clinical practice for the initial assessment and sequential follow-up of nutritional status. It could allow objective, systematic, and early screening of undernutrition and promote the rational and early initiation of optimal nutritional support, thereby contributing to reducing malnutrition-induced morbidity, mortality, worsening of the quality of life, and global health care costs.

Introduction

Chronic undernutrition is characterized by a progressive reduction of the fat-free mass (FFM) and fat mass (FM) and  which has deleterious consequences on health. Undernutrition is insufficiently screened and treated in hospitalized or at-risk patients despite its high prevalence and negative impact on mortality, morbidity, length of stay (LOS), quality of life, and costs [1–4]. The risk of underestimating hospital undernutrition is likely to worsen in the next decades because of the increasing prevalence of overweight, obesity, and chronic diseases and the increased number of elderly subjects. These clinical conditions are associated with FFM loss (sarcopenia). Therefore, an increased number of patients with FFM loss and sarcopenic obesity will be seen in the future.

 

Sarcopenic obesity is associated with decreased survival and increased therapy toxicity in cancer patients [5–10], whereas FFM loss is related to decreased survival, a negative clinical outcome, increased health care costs [2], and impaired overall health, functional capacities, and quality of life [4–11]. Therefore, the detection and treatment of FFM loss is a major issue of public health and health costs [12].

 

Weight loss and the body mass index (BMI) lack sensitivity to detect FFM loss [13]. In this review, we support the systematic assessment of FFM with a method of body composition evaluation in order to improve the detection, management, and follow-up of undernutrition. Such an approach should in turn reduce the clinical and functional consequences of diseases in the setting of a cost- effective medico-economic approach (fig. 1). We discuss the main applications of body composition evaluation in clinical practice (fig. 2).

 

Fig. 1. Conceptualization of the expected impact of early use of body composition for the screening of fat-free loss and under-nutrition in sarcopenic overweight and obese subjects. An increased prevalence of overweight and obesity is observed in all Western and emerging countries. Simultaneously, the aging of the population, the reduction of the level of physical activity, and the higher prevalence of chronic dis- eases and cancer increased the number of patients with or at risk of FFM impairment, i.e. sarcopenia. Thus, more patients are presenting with ‘sarcopenic over- weight or obesity’. In these patients, evaluation of nutritional status using anthropometric methods, i.e. weight loss and calculation of BMI, is not sensitive enough to detect FFM impairment. As a result, undernutrition is not detected, worsens, and negatively impacts morbidity, mortality, LOS, length of recovery, quality of life, and health care costs. On the contrary, in patients with ‘sarcopenic overweight or obesity’, early screening of undernutrition with a dedicated method of body composition evaluation would allow early initiation of nutritional support and, in turn, improvements of nutritional status and clinical outcome.

 

Rationale for a New Strategy for the Screening of Undernutrition

 

Screening of Undernutrition Is Insufficient

 

Academic societies encourage systematic screening of undernutrition at hospital admission and during the hospital stay [14]. The detection of undernutrition is generally based on measurements of weight and height, calculations of BMI, and the percentage of weight loss. Nevertheless, screening of undernutrition is infrequent in hospitalized or nutritionally at-risk ambulatory patients. For example, in France, surveys performed by the French Health Authority [15] indicate that: (i) weight alone, (ii) weight with BMI or percentage of weight loss, and (iii) weight, BMI, and percentage of weight loss are reported in only 55, 30, and 8% of the hospitalized patients’ records, respectively. Several issues, which could be improved by specific educational programs, explain the lack of implementation of nutritional screening in hospitals (table 1). In addition, the accuracy of the clinical screening of undernutrition could be limited at hospital admission. Indeed, patients with undernutrition may have the same BMI as sex- and age- matched healthy controls but a significantly decreased FFM hidden by an expansion of the FM and the total body water which can be measured by bioelectrical impedance analysis (BIA) [13]. This example illustrates that body composition evaluation allows a more accurate identification of FFM loss than body weight loss or BMI decrease. The lack of sensitivity and specificity of weight, BMI, and percentage of weight loss argue for the need for other methods to evaluate the nutritional status.

Changes in Patients’ Profiles

In 2008, twelve and thirty percent of the worldwide adult population was obese or overweight; this is two times higher than in 1980 [16]. The prevalence of overweight and obesity is also increasing in hospitalized patients. A 10-year comparative survey performed in a European hospital showed an increase in patients’ BMI, together with a shorter LOS [17]. The BMI increase masks undernutrition and FFM loss at hospital admission. The increased prevalence of obesity in an aging population has led to the recognition of a new nutritional entity: ‘sarcopenic obesity’ [18]. Sarcopenic obesity is characterized by increased FM and reduced FFM with a normal or high body weight. The emergence of the concept of sarcopenic obesity will increase the number of situations associated with a lack of sensitivity of the calculations of BMI and body weight change for the early detection of FFM loss. This supports a larger use of body composition evaluation for the assessment and follow-up of nutritional status in clinical practice (fig. 1).

 

Fig. 2. Current and potential applications of body composition evaluation in clinical practice. The applications are indicated in the boxes, and the body composition methods that could be used for each application are indicated inside the circles. The most used application of body composition evaluation is the measurement of bone mineral density by DEXA for the diagnosis and management of osteoporosis. Although a low FFM is associated with worse clinical outcomes, FFM evaluation is not yet implemented enough in clinical practice. However, by allowing early detection of undernutrition, body composition evaluation could improve the clinical outcome. Body composition evaluation could also be used to follow up nutritional status, calculate energy needs, tailor nutritional support, and assess fluid changes during perioperative period and renal insufficiency. Recent evidence indicates that a low FFM is associated with a higher toxicity of some chemo- therapy drugs in cancer patients. Thus, by allowing tailoring of the chemotherapy doses to the FFM in cancer patients, body com- position evaluation should improve the tolerance and the efficacy of chemotherapy. BIA, L3-targeted CT, and DEXA could be used for the assessment of nutritional status, the calculation of energy needs, and the tailoring of nutritional support and therapy. Further studies are warranted to validate BIA as an accurate method for fluid balance measurement. By integrating body composition evaluation into the management of different clinical conditions, all of these potential applications would lead to a better recognition of nutritional care by the medical community, the health care facilities, and the health authorities, as well as to an increase in the medico-economic benefits of the nutritional evaluation.

Body Composition Evaluation For The Assessment Of Nutritional Status

Body composition evaluation is a valuable technique to assess nutritional status. Firstly, it gives an evaluation of nutritional status through the assessment of FFM. Secondly, by measuring FFM and phase angle with BIA, it allows evaluation of the disease prognosis and outcome.

Body Composition Techniques For FFM Measurement

Body composition evaluation allows measurement of the major body compartments: FFM (including bone mineral tissue), FM, and total body water. Table 2 shows indicative values of the body composition of a healthy subject weighing 70 kg. In several clinical situations, i.e. hospital admission, chronic obstructive pulmonary dis- ease (COPD) [21–23], dialysis [24–26], chronic heart failure [27], amyotrophic lateral sclerosis [28], cancer [5, 29], liver transplantation [30], nursing home residence [31], and Alzheimer’s disease [32], changes in body compartments are detected with the techniques of body composition evaluation. At hospital admission, body composition evaluation could be used for the detection of FFM loss and undernutrition. Indeed, FFM and the FFM index (FFMI) [FFM (kg)/height (m2)] measured by BIA are significantly lower in hospitalized patients (n = 995) than in age-, height-, and sex-matched controls (n = 995) [3]. Conversely, clinical tools of nutritional status assessment, such as BMI, subjective global assessment, or mini-nutritional assessment, are not accurate enough to estimate FFM loss and nutritional status [30, 32–34]. In 441 patients with non-small cell lung cancer, FFM loss deter- mined by computerized tomography (CT) was observed in each BMI category [7], and in young adults with all types of cancer, an increase in FM together with a de- crease in FFM were reported [29]. These findings reveal the lack of sensitivity of BMI to detect FFM loss. More- over, the FFMI is a more sensitive determinant of LOS than a weight loss over 10% or a BMI below 20 [3]. In COPD, the assessment of FFM by BIA is a more sensitive method to detect undernutrition than anthropometry [33, 35]. BIA is also more accurate at assessing nutrition- al status in children with severe neurologic impairment than the measurement of skin fold thickness [36].

Body Composition For The Evaluation Of Prognosis & Clinical Outcome

FFM loss is correlated with survival in different clinical settings [5, 21–28, 37]. In patients with amyotrophic lateral sclerosis, an FM increase, but not an FFM in- crease, measured by BIA, was correlated with survival during the course of the disease [28]. The relation between body composition and mortality has not yet been demonstrated in the intensive care unit. The relation between body composition and mortality has been demonstrated with anthropometric methods, BIA, and CT. Measurement of the mid-arm muscle circumference is an easy tool to diagnose sarcopenia [38]. The mid-arm muscle circumference has been shown to be correlated with survival in patients with cirrhosis [39, 40], HIV infection [41], and COPD in a stronger way than BMI [42]. The relation between FFM loss and mortality has been extensively shown with BIA [21–28, 31, 37], which is the most used method. Recently, very interesting data suggest that CT could evaluate the disease prognosis in relation to muscle wasting. In obese cancer patients, sarcopenia as assessed by CT measurement of the total skeletal muscle cross-sectional area is an independent predictor of the survival of patients with bronchopulmonary [5, 7], gastrointestinal [5], and pancreatic cancers [6]. FFM assessed by measurement of the mid-thigh muscle cross- sectional area by CT is also predictive of mortality in COPD patients with severe chronic respiratory insufficiency [43]. In addition to mortality, a low FFMI at hospital admission is significantly associated with an in- creased LOS [3, 44]. A bicentric controlled population study performed in 1,717 hospitalized patients indicates that both loss of FFM and excess of FM negatively affect the LOS [44]. Patients with sarcopenic obesity are most at risk of increased LOS. This study also found that ex- cess FM reduces the sensitivity of BMI to detect nutritional depletion [44]. Together with the observation that the BMI of hospitalized patients has increased during the last decade [17], these findings suggest that FFM and FFMI measurement should be used to evaluate nutritional status in hospitalized patients.

 

BIA measures the phase angle [45]. A low phase angle is related to survival in oncology [46–50], HIV infection/ AIDS [51], amyotrophic lateral sclerosis [52], geriatrics [53], peritoneal dialysis [54], and cirrhosis [55]. The phase angle threshold associated with reduced survival is variable: less than 2.5 degrees in amyotrophic lateral sclerosis patients [52], 3.5 degrees in geriatric patients [53], from less than 1.65 to 5.6 degrees in oncology patients [47–50], and 5.4 degrees in cirrhotic patients [55]. The phase angle is also associated with the severity of lymphopenia in AIDS [56], and with the risk of postoperative complications among gastrointestinal surgical patients [57]. The relation of phase angle with prognosis and disease severity reinforces the interest in using BIA for the clinical management of patients with chronic diseases at high risk of undernutrition and FFM loss.

 

In summary, FFM loss or a low phase angle is related to mortality in patients with chronic diseases, cancer (in- cluding obesity cancer patients), and elderly patients in long-stay facilities. A low FFM and an increased FM are associated with an increased LOS in adult hospitalized patients. The relation between FFM loss and clinical out- come is clearly shown in patients with sarcopenic obesity. In these patients, as the sensitivity of BMI for detecting FFM loss is strongly reduced, body composition evalua- tion appears to be the method of choice to detect under- nutrition in routine practice. Overall, the association between body composition, phase angle, and clinical outcome reinforces the pertinence of using a body com- position evaluation in clinical practice.

Which Technique Of Body Composition Evaluation Should Be Used For The Assessment Of Nutritional Status?

Numerous methods of body composition evaluation have been developed: anthropometry, including the 4-skinfold method [58], hydrodensitometry [58], in vivo neutron activation analysis [59], anthropogammametry from total body potassium-40 [60], nuclear magnetic resonance [61], dual-energy X-ray absorptiometry (DEXA) [62, 63], BIA [45, 64–66], and more recently CT [7, 43, 67]. DEXA, BIA, and CT appear to be the most convenient methods for clinical practice (fig. 2), while the other methods are reserved for scientific use.

 

Compared with other techniques of body composition evaluation, the lack of reproducibility and sensitivity of the 4-skinfold method limits its use for the accurate measurement of body composition in clinical practice [33, 34]. However, in patients with cirrhosis [39, 40], COPD [34], and HIV infection [41], measurement of the mid- arm muscle circumference could be used to assess sarcopenia and disease-related prognosis. DEXA allows non- invasive direct measurement of the three major components of body composition. The measurement of bone mineral tissue by DEXA is used in clinical practice for the diagnosis and follow-up of osteoporosis. As the clinical conditions complicated by osteoporosis are often associated with undernutrition, i.e. elderly women, patients with organ insufficiencies, COPD [68], inflammatory bowel diseases, and celiac disease, DEXA could be of the utmost interest for the follow-up of both osteoporosis and nutritional status. However, the combined evaluation of bone mineral density and nutritional status is difficult to implement in clinical practice because the reduced accessibility of DEXA makes it impossible to be performed in all nutritionally at-risk or malnourished patients. The principles and clinical utilization of BIA have been largely described in two ESPEN position papers [45, 66]. BIA is based on the capacity of hydrated tissues to conduct electrical energy. The measurement of total body impedance allows estimation of total body water by assuming that total body water is constant. From total body water, validated equations allow the calculation of FFM and FM [69], which are interpreted according to reference values [70]. BIA is the only technique which allows calculation of the phase angle, which is correlated with the prognosis of various diseases. BIA equations are valid for: COPD [65]; AIDS wasting [71]; heart, lung, and liver transplantation [72]; anorexia nervosa [73] patients, and elderly subjects [74]. However, no BIA-specific equations have been validated in patients with extreme BMI (less than 17 and higher than 33.8) and dehydration or fluid overload [45, 66]. Nevertheless, because of its simplicity, low cost, quickness of use at bedside, and high interoperator reproducibility, BIA appears to be the technique of choice for the systematic and repeated evaluation of FFM in clinical practice, particularly at hospital admission and in chronic diseases. Finally, through written and objective re- ports, the wider use of BIA should allow improvement of the traceability of nutritional evaluation and an increase in the recognition of nutritional care by the health authorities. Recently, several data have suggested that CT images targeted on the 3rd lumbar vertebra (L3) could strongly predict whole-body fat and FFM in cancer patients, as compared with DEXA [7, 67]. Interestingly, the evaluation of body composition by CT presents great practical significance due to its routine use in patient diagnosis, staging, and follow-up. L3-targeted CT images evaluate FFM by measuring the muscle cross-sectional area from L3 to the iliac crest by use of Hounsfield unit (HU) thresholds (–29 to +150) [5, 7]. The muscles included in the calculation of the muscle cross-sectional area are psoas, paraspinal muscles (erector spinae, quadratus lumborum), and abdominal wall muscles (transversus abdominis, external and internal obliques, rectus ab- dominis) [6]. CT also provided detail on specific muscles, adipose tissues, and organs not provided by DEXA or BIA. L3-targeted CT images could be theoretically per- formed solely, since they result in X-ray exposition similar to that of a chest radiography.

 

In summary, DEXA, BIA, and L3-targeted CT images could all measure body composition accurately. The technique selection will depend on the clinical context, hard- ware, and knowledge availability. Body composition evaluation by DEXA should be performed in patients having a routine assessment of bone mineral density. Also, analysis of L3-targeted CT is the method of choice for body composition evaluation in cancer patients. Body composition evaluation should also be done for every abdominal CT performed in patients who are nutritionally at risk or undernourished. Because of its simplicity of use, BIA could be widely implemented as a method of body com- position evaluation and follow-up in a great number of hospitalized and ambulatory patients. Future research will aim to determine whether a routine evaluation of body composition would allow early detection of the in- creased FFM catabolism related to critical illness [75].

Body Composition Evaluation For The Calculation Of Energy Needs

The evaluation of FFM could be used for the calculation of energy needs, thus allowing the optimization of nutritional intakes according to nutritional needs. This could be of great interest in specific situations, such as severe neurologic disability, overweight, and obesity. In 61 children with severe neurologic impairment and intellectual disability, an equation integrating body composition had good agreement with the doubly labeled water method. It gave a better estimation of energy expenditure than did the Schofield predictive equation [36]. However, in 9 anorexia nervosa patients with a mean BMI of 13.7, pre- diction formulas of resting energy expenditure including FFM did not allow accurate prediction of the resting energy expenditure measured by indirect calorimetry [76]. In overweight or obese patients, the muscle catabolism in response to inflammation was the same as that observed in patients with normal BMI. Indeed, despite a higher BMI, the FFM of overweight or obese individuals is similar (or slightly increased) to that of patients with normal BMI. Thus, the use of actual weight for the assessment of the energy needs of obese patients would result in over- feeding and its related complications. Therefore, the ex- perts recommend the use of indirect calorimetry or calculation of the energy needs of overweight or obese patients as follows: 15 kcal/kg actual weight/day or 20–25 kcal/kg ideal weight/day [77, 78], although these predictive formulas could be inaccurate in some clinical conditions [79]. In a US prospective study conducted in 33 ICU medical and surgical ventilated ICU patients, daily measurement of the active cell mass (table 2) by BIA was used to assess the adequacy between energy/protein intakes and needs. In that study, nutritional support with 30 kcal/ kg actual body weight/day energy and 1.5 g/kg/day protein allowed stabilization of the active cell mass [75]. Thus, follow-up of FFM by BIA could help optimize nutritional intakes when indirect calorimetry cannot be performed.

 

In summary, the measurement of FFM should help ad- just the calculation of energy needs (expressed as kcal/kg FFM) and optimize nutritional support in critical cases other than anorexia nervosa.

Body Composition Evaluation For The Follow-Up & Tailoring Of Nutritional Support

Body composition evaluation allows a qualitative assessment of body weight variations. The evaluation of body composition may help to document the efficiency of nutritional support during a patient’s follow-up of numerous clinical conditions, such as surgery [59], anorexia nervosa [76, 80], hematopoietic stem cell transplantation [81], COPD [82], ICU [83], lung transplantation [84], ulcerative colitis [59], Crohn’s disease [85], cancer [86, 87], HIV/AIDS [88], and acute stroke in elderly patients [89]. Body composition evaluation could be used for the follow-up of healthy elderly subjects [90]. Body composition evaluation allows characterization of the increase in body mass in terms of FFM and FM [81, 91]. After hematopoietic stem cell transplantation, the increase in BMI is the result of the increase in FM, but not of the increase in FFM [81]. Also, during recovery after an acute illness, weight gain 6 months after ICU discharge could be mostly related to an increase in FM (+7 kg) while FFM only increased by 2 kg; DEXA and air displacement plethysmography were used to measure the FM and FFM [91]. These two examples suggest that body composition evaluation could be helpful to decide the modification and/or the renewal of nutritional support. By identifying the patients gaining weight but reporting no or insufficient FFM, body composition evaluation could contribute to influencing the medical decision of continuing nutrition- al support that would have been stopped in the absence of body composition evaluation.

 

In summary, body composition evaluation is of the utmost interest for the follow-up of nutritional support and its impact on body compartments.

Body Composition Evaluation For Tailoring Medical Treatments

In clinical situations when weight and BMI do not reflect the FFM, the evaluation of body composition should be used to adapt drug doses to the FFM and/or FM absolute values in every patient. This point has been recently illustrated in oncology patients with sarcopenic obesity. FFM loss was determined by CT as described above. In cancer patients, some therapies could affect body com- position by inducing muscle wasting [92]. In patients with advanced renal cell carcinoma [92], sorafenib induces a significant 8% loss of skeletal muscular mass at 12 months. In turn, muscle wasting in patients with BMI less than 25 was significantly associated with sorafenib toxicity in patients with metastatic renal cancer [8]. In metastatic breast cancer patients receiving capecitabine treatment, and in patients with colorectal cancer receiving 5-fluorouracile, using the convention of dosing per unit of body surface area, FFM loss was the determinant of chemotherapy toxicity [9, 10] and time to tumor progression [10]. In colorectal cancer patients administered 5-fluoruracil, low FFM is a significant predictor of toxicity only in female patients [9]. The variation in toxicity between women and men may be partially explained by the fact that FFM was lower in females. Indeed, FFM rep- resents the distribution volume of most cytotoxic chemo- therapy drugs. In 2,115 cancer patients, the individual variations in FFM could change by up to three times the distribution volume of the chemotherapy drug per body area unit [5]. Thus, administering the same doses of chemotherapy drugs to a patient with a low FFM compared to a patient with a normal FFM would increase the risk of chemotherapy toxicity [5]. These data suggest that FFM loss could have a direct impact on the clinical outcome of cancer patients. Decreasing chemotherapy doses in case of FFM loss could contribute to improving cancer patients’ prognosis through the improvement of the tolerance of chemotherapy. These findings justify the systematic evaluation of body composition in all cancer patients in order to detect FFM loss, tailor chemotherapy doses according to FFM values, and then improve the efficacy- tolerance and cost-efficiency ratios of the therapeutic strategies [93]. Body composition evaluation should also be used to tailor the doses of drugs which are calculated based on patients’ weight, e.g. corticosteroids, immuno-suppressors (infliximab, azathioprine or methotrexate), or sedatives (propofol).

 

In summary, measurement of FFM should be implemented in cancer patients treated with chemotherapy. Clinical studies are needed to demonstrate the importance of measuring body composition in patients treated with other medical treatments.

Towards The Implementation Of Body Composition Evaluation In Clinical Practice

The implementation of body composition evaluation in routine care presents a challenge for the next decades. Indeed the concomitant increases in elderly subjects and patients with chronic diseases and cancer, and in the prevalence of overweight and obesity in the population, will increase the number of patients nutritionally at risk or undernourished, particularly those with sarcopenic obesity. Body composition evaluation should be used to improve the screening of undernutrition in hospitalized patients. The results of body composition should be based on the same principle as BMI calculation, towards the systematic normalization for body height of FFM (FFMI) and FM [FM (kg)/height (m)2 = FM index] [94]. The results could be expressed according to previously de- scribed percentiles of healthy subjects [95, 96]. Body com- position evaluation should be performed at the different stages of the disease, during the course of treatments and the rehabilitation phase. Such repeated evaluations of body composition could allow assessment of the nutritional status, adjusting the calculation of energy needs as kilocalories/kilogram FFM, following the efficacy of nutritional support, and tailoring drug and nutritional therapies. BIA, L3-targeted CT, and DEXA represent the techniques of choice to evaluate body composition in clinical practice (fig. 2). In the setting of cost-effective and pragmatic use, these three techniques should be alternatively chosen. In cancer, undernourished, and nutritionally at-risk patients, an abdominal CT should be completed by the analysis of L3-targeted images for the evaluation of body composition.

 

 

In other situations, BIA appears to be the simplest most reproducible and less expensive method, while DEXA, if feasible, remains the reference method for clinical practice. By allowing earlier management of undernutrition, body composition evaluation can contribute to reducing malnutrition-induced morbidity and mortality, improving the quality of life and, as a consequence, increasing the medico-economic benefits (fig. 1). The latter needs to be demonstrated. Moreover, based on a more scientific approach, i.e. allowing for printing reports, objective initial assessment and follow-up of nutritional status, and the adjustment of drug doses, body composition evaluation would contribute to a better recognition of the activities related to nutritional evaluation and care by the medical community, health care facilities, and health authorities (fig. 2).

Conclusion

Screening of undernutrition is insufficient to allow for optimal nutrition care. This is in part due to the lack of sensitivity of BMI and weight loss for detecting FFM loss in patients with chronic diseases. Methods of body com- position evaluation allow a quantitative measurement of FFM changes during the course of disease and could be used to detect FFM loss in the setting of an objective, systematic, and early undernutrition screening. FFM loss is closely related to impaired clinical outcomes, survival, and quality of life, as well as increased therapy toxicity in cancer patients. Thus, body composition evaluation should be integrated into clinical practice for the initial assessment, sequential follow-up of nutritional status, and the tailoring of nutritional and disease-specific therapies. Body composition evaluation could contribute to strengthening the role and credibility of nutrition in the global medical management, reducing the negative impact of malnutrition on the clinical outcome and quality of life, thereby increasing the overall medico-economic benefits.

 

Acknowledgements

 

R. Thibault and C. Pichard are supported by research grants from the public foundation Nutrition 2000 Plus.

 

Disclosure Statement

 

Ronan Thibault and Claude Pichard declare no conflict of interest.

 

References:

 

1 Pirlich M, Schutz T, Norman K, Gastell S,
Lübke HJ, Bischoff SC, Bolder U, Frieling
T, Güldenzoph H, Hahn K, Jauch KW,
Schindler K, Stein J, Volkert D, Weimann A,
Werner H, Wolf C, Zürcher G, Bauer P, Lochs
H: The German hospital malnutrition study.
Clin Nutr 2006;25:563–572.
2 Amaral TF, Matos LC, Tavares MM, Subtil
A, Martins R, Nazaré M, Sousa Pereira N:
The economic impact of disease-related malnutrition
at hospital admission. Clin Nutr
2007;26:778–784.
3 Pichard C, Kyle UG, Morabia A, Perrier A,
Vermeulen B, Unger P: Nutritional assessment:
lean body mass depletion at hospital
admission is associated with increased
length of stay. Am J Clin Nutr 2004;79:613–
618.
4 Capuano G, Gentile PC, Bianciardi F, Tosti
M, Palladino A, Di Palma M: Prevalence and
influence of malnutrition on quality of life
and performance status in patients with locally
advanced head and neck cancer before
treatment. Support Care Cancer 2010;18:
433–437.
5 Prado CM, Lieffers JR, McCargar LJ, Reiman
T, Sawyer MB, Martin L, Baracos VE: Prevalence
and clinical implications of sarcopenic
obesity in patients with solid tumours of the
respiratory and gastrointestinal tracts: a
population-based study. Lancet Oncol 2008;
9:629–635.
6 Tan BHL, Birdsell LA, Martin L, Baracos VE,
Fearon KC: Sarcopenia in an overweight or
obese patient is an adverse prognostic factor
in pancreatic cancer. Clin Cancer Res 2009;
15:6973–6979.
7 Baracos VE, Reiman T, Mourtzakis M,
Gioulbasanis I, Antoun S: Body composition
in patients with non-small cell lung cancer:
a contemporary view of cancer cachexia
with the use of computed tomography image
analysis. Am J Clin Nutr 2010;91(suppl):
1133S–1137S.
8 Antoun S, Baracos VE, Birdsell L, Escudier
B, Sawyer MB: Low body mass index and sarcopenia
associated with dose-limiting toxicity
of sorafenib in patients with renal cell carcinoma.
Ann Oncol 2010;21:1594–1598
9 Prado CM, Baracos VE, McCargar LJ,
Mourtzakis M, Mulder KE, Reiman T, Butts
CA, Scarfe AG, Sawyer MB: Body composition
as an independent determinant of 5-fluorouracil-based
chemotherapy toxicity. Clin
Cancer Res 2007;13:3264–3268.
10 Prado CM, Baracos VE, McCargar LJ, Reiman
T, Mourtzakis M, Tonkin K, Mackey JR,
Koski S, Pituskin E, Sawyer MB: Sarcopenia
as a determinant of chemotherapy toxicity
and time to tumor progression in metastatic
breast cancer patients receiving capecitabine
treatment. Clin Cancer Res 2009;15:2920–
2926.
11 Hofhuis JG, Spronk PE, van Stel HF, Schrijvers
GJ, Rommes JH, Bakker J: The impact of
critical illness on perceived health-related
quality of life during ICU treatment, hospital
stay, and after hospital discharge: a longterm
follow-up study. Chest 2008;133:377–
385.
12 Guest JF, Panca M, Baeyens JP, de Man F,
Ljungqvist O, Pichard C, Wait S, Wilson L:
Health economic impact of managing patients
following a community-based diagnosis
of malnutrition in the UK. Clin Nutr 2011;
30:422–429.
13 Kyle UG, Morabia A, Slosman DO, Mensi N,
Unger P, Pichard C: Contribution of body
composition to nutritional assessment at
hospital admission in 995 patients: a controlled
population study. Br J Nutr 2001;86:
725–731.
14 Kondrup J, Allison SP, Elia M; Vellas B,
Plauth M: Educational and Clinical Practice
Committee, European Society of Parenteral
and Enteral Nutrition (ESPEN): ESPEN
guidelines for nutrition screening 2002. Clin
Nutr 2003;22:415–421.
15 Haute Autorité de Santé: IPAQSS: informations.
2010. http://www.has-sante.fr/portail/
jcms/c_970427/ipaqss-informations.
16 World Health Organization: Obesity and
overweight: fact sheet No. 311. 2011. http://
www.who.int/mediacentre/factsheets/fs311/
en/index.html.
17 Thibault R, Chikhi M, Clerc A, Darmon P,
Chopard P, Picard-Kossovsky M, Genton L,
Pichard C: Assessment of food intake in hospitalised
patients: a 10 year-comparative
study of a prospective hospital survey. Clin
Nutr 2011;30:289–296.
18 Stenholm S, Harris TB, Rantanen T, Visser
M, Kritchevsky SB, Ferrucci L: Sarcopenic
obesity: definition, cause and consequences.
Curr Opin Clin Nutr Metab Care 2008;11:
693–700.
19 Pichard C, Kyle UG: Body composition measurements
during wasting diseases. Curr
Opin Clin Nutr Metab Care 1998;1:357–361.
20 Wang ZM, Pierson RN Jr, Heymsfield SB:
The five-level model: a new approach to organizing
body-composition research. Am J
Clin Nutr 1992;56:19–28.
21 Schols AM, Broekhuizen R, Weling-Scheepers
CA, Wouters EF: Body composition and
mortality in chronic obstructive pulmonary
disease. Am J Clin Nutr 2005;82:53–59.
22 Slinde F, Gronberg A, Engstrom CP, Rossander-Hulthen
L, Larsson S: Body composition
by bioelectrical impedance predicts
mortality in chronic obstructive pulmonary
disease patients. Respir Med 2005;99:1004–
1009.
23 Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard
BG, Andersen T, Sorensen TI,
Lange P: Body mass, fat-free body mass, and
prognosis in patients with chronic obstructive
pulmonary disease from a random population
sample: findings from the Copenhagen
City Heart Study. Am J Respir Crit Care
Med 2006;173:79–83.
24 Segall L, Mardare NG, Ungureanu S, Busuioc
M, Nistor I, Enache R, Marian S, Covic A:
Nutritional status evaluation and survival in
haemodialysis patients in one centre from
Romania. Nephrol Dial Transplant 2009;24:
2536–2540.
25 Beddhu S, Pappas LM, Ramkumar N, Samore
M: Effects of body size and body composition
on survival in hemodialysis patients. J
Am Soc Nephrol 2003;14:2366–2372.
26 Fürstenberg A, Davenport A: Assessment
of body composition in peritoneal dialysis
patients using bioelectrical impedance and
dual-energy X-ray absorptiometry. Am J
Nephrol 2011;33:150–156.
27 Futter JE, Cleland JG, Clark AL: Body mass
indices and outcome in patients with chronic
heart failure. Eur J Heart Fail 2011;13:207–
213.
28 Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud
B, Nicol M, Preux PM, Couratier P: Alteration
of nutritional status at diagnosis is
a prognostic factor for survival of amyotrophic
lateral sclerosis patients. J Neurol
Neurosurg Psychiatry 2011;82:628–634.
29 Janiszewski PM, Oeffinger KC, Church TS,
Dunn AL, Eshelman DA, Victor RG, Brooks
S, Turoff AJ, Sinclair E, Murray JC, Bashore
L, Ross R: Abdominal obesity, liver fat, and
muscle composition in survivors of childhood
acute lymphoblastic leukemia. J Clin
Endocrinol Metab 2007;92:3816–3821.
30 Wagner D, Adunka C, Kniepeiss D, Jakoby
E, Schaffellner S, Kandlbauer M, Fahrleitner-Pammer
A, Roller RE, Kornprat P, Müller
H, Iberer F, Tscheliessnigg KH: Serum albumin,
subjective global assessment, body
mass index and the bioimpedance analysis in
the assessment of malnutrition in patients up
to 15 years after liver transplantation. Clin
Transplant 2011;25:E396–E400.
31 Kimyagarov S, Klid R, Levenkrohn S, Fleissig
Y, Kopel B, Arad M, Adunsky A: Body
mass index (BMI), body composition and
mortality of nursing home elderly residents.
Arch Gerontol Geriatr 2010;51:227–230.
32 Buffa R, Mereu RM, Putzu PF, Floris G,
Marini E: Bioelectrical impedance vector
analysis detects low body cell mass and dehydration
in patients with Alzheimer’s disease.
J Nutr Health Aging 2010;14:823–827.
33 Schols AM, Wouters EF, Soeters PB, Westerterp
KR: Body composition by bioelectricalimpedance
analysis compared with deuterium
dilution and skinfold anthropometry in
patients with chronic obstructive pulmonary
disease. Am J Clin Nutr 1991;53:421–424.
34 Thibault R, Le Gallic E, Picard-Kossovsky
M, Darmaun D, Chambellan A: Assessment
of nutritional status and body composition
in patients with COPD: comparison of several
methods (in French). Rev Mal Respir
2010;27:693–702.
35 Kyle UG, Janssens JP, Rochat T, Raguso CA,
Pichard C: Body composition in patients
with chronic hypercapnic respiratory failure.
Respir Med 2006;100:244–252.
36 Rieken R, van Goudoever JB, Schierbeek H,
Willemsen SP, Calis EA, Tibboel D, Evenhuis
HM, Penning C: Measuring body composition
and energy expenditure in children with
severe neurologic impairment and intellectual
disability. Am J Clin Nutr 2011;94:759–
766
37 Avram MM, Fein PA, Borawski C, Chattopadhyay
J, Matza B: Extracellular mass/body
cell mass ratio is an independent predictor of
survival in peritoneal dialysis patients. Kidney
Int Suppl 2010;117:S37–S40.
38 Frisancho AR: New norms of upper limb fat
and muscle areas for assessment of nutritional
status. Am J Clin Nutr 1981;34:2540–2545.
39 Caregaro L, Alberino F, Amodio P, Merkel C,
Bolognesi M, Angeli P, Gatta A: Malnutrition
in alcoholic and virus-related cirrhosis.
Am J Clin Nutr l996;63:602–609.
40 Alberino F, Gatta A, Amodio P, Merkel C, Di
Pascoli L, Boffo G, Caregaro L: Nutrition and
survival in patients with liver cirrhosis. Nutrition
2001;17:445–450.
41 Liu E, Spiegelman D, Semu H, Hawkins C,
Chalamilla G, Aveika A, Nyamsangia S,
Mehta S, Mtasiwa D, Fawzi W: Nutritional
status and mortality among HIV-infected
patients receiving antiretroviral therapy in
Tanzania. J Infect Dis 2011;204:282–290.
42 Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia
MA, Sanchez PR, Salcedo E,
Navarro M: Mid-arm muscle area is a better
predictor of mortality than body mass index
in COPD. Chest 2005;128:2108–2115.
43 Marquis K, Debigaré R, Lacasse Y, LeBlanc P,
Jobin J, Carrier G, Maltais F: Midthigh muscle
cross-sectional area is a better predictor
of mortality than body mass index in patients
with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 2002;15;
166:809–813.
44 Kyle UG, Pirlich M, Lochs H, Schuetz T, Pichard
C: Increased length of hospital stay in
underweight and overweight patients at hospital
admission: a controlled population
study. Clin Nutr 2005;24:133–142.
45 Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg
P, Elia M, Gómez JM, Heitmann
BL, Kent-Smith L, Melchior JC, Pirlich M,
Scharfetter H, Schols AM, Pichard C, Composition
of the ESPEN Working Group. Bioelectrical
impedance analysis. 1. Review of
principles and methods. Clin Nutr 2004;23:
1226–1243.
46 Santarpia L, Marra M, Montagnese C, Alfonsi
L, Pasanisi F, Contaldo F: Prognostic
significance of bioelectrical impedance
phase angle in advanced cancer: preliminary
observations. Nutrition 2009;25:930–931.
47 Gupta D, Lammersfeld CA, Vashi PG, King
J, Dahlk SL, Grutsch JF, Lis CG: Bioelectrical
impedance phase angle in clinical practice:
implications for prognosis in stage IIIB and
IV non-small cell lung cancer. BMC Cancer
2009;9:37.
48 Gupta D, Lis CG, Dahlk SL, Vashi PG,
Grutsch JF, Lammersfeld CA: Bioelectrical
impedance phase angle as a prognostic indicator
in advanced pancreatic cancer. Br J
Nutr 2004;92:957–962.
49 Gupta D, Lammersfeld CA, Burrows JL,
Dahlk SL, Vashi PG, Grutsch JF, Hoffman S,
Lis CG: Bioelectrical impedance phase angle
in clinical practice: implications for prognosis
in advanced colorectal cancer. Am J Clin
Nutr 2004;80:1634–1638.
50 Paiva SI, Borges LR, Halpern-Silveira D, Assunção
MC, Barros AJ, Gonzalez MC: Standardized
phase angle from bioelectrical impedance
analysis as prognostic factor for
survival in patients with cancer. Support
Care Cancer 2010;19:187–192.
51 Schwenk A, Beisenherz A, Römer K, Kremer
G, Salzberger B, Elia M: Phase angle from
bioelectrical impedance analysis remains an
independent predictive marker in HIV-infected
patients in the era of highly active antiretroviral
treatment. Am J Clin Nutr 2000;
72:496–501.
52 Desport JC, Marin B, Funalot B, Preux PM,
Couratier P: Phase angle is a prognostic factor
for survival in amyotrophic lateral sclerosis.
Amyotroph Lateral Scler 2008;9:273–
278.
53 Wirth R, Volkert D, Rösler A, Sieber CC,
Bauer JM: Bioelectric impedance phase angle
is associated with hospital mortality of
geriatric patients. Arch Gerontol Geriatr
2010;51:290–294.
54 Mushnick R, Fein PA, Mittman N, Goel N,
Chattopadhyay J, Avram MM: Relationship
of bioelectrical impedance parameters to nutrition
and survival in peritoneal dialysis patients.
Kidney Int Suppl 2003;87:S53–S56.
55 Selberg O, Selberg D: Norms and correlates
of bioimpedance phase angle in healthy human
subjects, hospitalized patients, and patients
with liver cirrhosis. Eur J Appl Physiol
2002;86:509–516.
56 Shah S, Whalen C, Kotler DP, Mayanja H,
Namale A, Melikian G, Mugerwa R, Semba
RD: Severity of human immunodeficiency
virus infection is associated with decreased
phase angle, fat mass and body cell mass in
adults with pulmonary tuberculosis infection
in Uganda. J Nutr 2001;131:2843–2847.
57 Barbosa-Silva MC, Barros AJ: Bioelectric impedance
and individual characteristics as
prognostic factors for post-operative complications.
Clin Nutr 2005;24:830–838.
58 Durnin JV, Womersley J: Body fat assessed
from total body density and its estimation
from skinfold thickness: measurements on
481 men and women aged from 16 to 72
years. Br J Nutr 1974;32:77–97.
59 Hill GL: Body composition research: implications
for the practice of clinical nutrition.
JPEN J Parenter Enter Nutr 1992;16:197–218.
60 Pierson RN Jr, Wang J, Thornton JC, Van
Itallie TB, Colt EW: Body potassium by fourpi
40K counting: an anthropometric correction.
Am J Physiol 1984;246:F234–F239.
61 Sohlström A, Forsum E: Changes in total
body fat during the human reproductive cycle
as assessed by magnetic resonance imaging,
body water dilution, and skinfold thickness:
a comparison of methods. Am J Clin
Nutr 1997;66:1315–1322.
62 Leonard CM, Roza MA, Barr RD, Webber
CE: Reproducibility of DXA measurements
of bone mineral density and body composition
in children. Pediatr Radiol 2009;39:148–
154.
63 Genton L, Karsegard VL, Zawadynski S, Kyle
UG, Pichard C, Golay A, Hans DB: Comparison
of body weight and composition measured
by two different dual energy X-ray absorptiometry
devices and three acquisition
modes in obese women. Clin Nutr 2006;25:
428–437.
64 Jaffrin MY: Body composition determination
by bioimpedance: an update. Curr Opin
Clin Nutr Metab Care 2009;12:482–486.
65 Kyle UG, Pichard C, Rochat T, Slosman DO,
Fitting JW, Thiebaud D: New bioelectrical
impedance formula for patients with respiratory
insufficiency: comparison to dual-energy
X-ray absorptiometry. Eur Respir J 1998;
12:960–966.
66 Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg
P, Elia M, Manuel Gómez J, Lilienthal
Heitmann B, Kent-Smith L, Melchior
JC, Pirlich M, Scharfetter H, Schols AMWJ,
Pichard C, ESPEN: Bioelectrical impedance
analysis. 2. Utilization in clinical practice.
Clin Nutr 2004;23:1430–1453.
67 Mourtzakis M, Prado CM, Lieffers JR, Reiman
T, McCargar LJ, Baracos VE: A practical
and precise approach to quantification of
body composition in cancer patients using
computed tomography images acquired during
routine care. Appl Physiol Nutr Metab
2008;33:997–1006.
68 Bolton CE, Ionescu AA, Shiels KM, Pettit RJ,
Edwards PH, Stone MD, Nixon LS, Evans
WD, Griffiths TL, Shale DJ: Associated loss
of fat-free mass and bone mineral density in
chronic obstructive pulmonary disease. Am
J Respir Crit Care Med 2004;170:1286–1293.
69 Kyle UG, Genton L, Karsegard L, Slosman
DO, Pichard C: Single prediction equation
for bioelectrical impedance analysis in
adults aged 20–94 years. Nutrition 2001;17:
248–253.
70 Kyle UG, Genton L, Slosman DO, Pichard C:
Fat-free and fat mass percentiles in 5,225
healthy subjects aged 15 to 98 years. Nutrition
2001;17(7–8):534–541.
71 Kotler DP, Burastero S, Wang J, Pierson RN
Jr: Prediction of body cell mass, fat-free
mass, and total body water with bioelectrical
impedance analysis: effects of race, sex, and
disease. Am J Clin Nutr 1996;64:489S–497S.
72 Kyle UG, Genton L, Mentha G, Nicod L, Slosman
DO, Pichard C: Reliable bioelectrical
impedance analysis estimate of fat-free mass
in liver, lung, and heart transplant patients.
JPEN J Parenter Enteral Nutr 2001;25:45–51.
73 Mattar L, Godart N, Melchior JC, Falissard
B, Kolta S, Ringuenet D, Vindreau C, Nordon
C, Blanchet C, Pichard C: Underweight
patients with anorexia nervosa: comparison
of bioelectrical impedance analysis using
five equations to dual X-ray absorptiometry.
Clin Nutr 2011, E-pub ahead of print.
74 Genton L, Karsegard VL, Kyle UG, Hans DB,
Michel JP, Pichard C: Comparison of four
bioelectrical impedance analysis formulas in
healthy elderly subjects. Gerontology 2001;
47:315–323.
75 Robert S, Zarowitz BJ, Hyzy R, Eichenhorn
M, Peterson EL, Popovich J Jr: Bioelectrical
impedance assessment of nutritional status
in critically ill patients. Am J Clin Nutr 1993;
57:840–844.
76 Pichard C, Kyle UG, Slosman DO, Penalosa
B: Energy expenditure in anorexia nervosa:
can fat-free mass as measured by bioelectrical
impedance predict energy expenditure in
hospitalized patients? Clin Nutr 1996;15:
109–114.
77 Kreymann KG, Berger MM, Deutz NE, Hiesmayr
M, Jolliet P, Kazandjiev G, Nitenberg
G, van den Berghe G, Wernerman J, DGEM
(German Society for Nutritional Medicine),
Ebner C, Hartl W, Heymann C, Spies C, ESPEN:
ESPEN guidelines on enteral nutrition:
intensive care. Clin Nutr 2006;25:210–223.
78 Singer P, Berger MM, van den Berghe G, Biolo
G, Calder P, Forbes A, Griffiths R, Kreyman
G, Leverve X, Pichard C, ESPEN: ESPEN
guidelines on parenteral nutrition: intensive
care. Clin Nutr 2009;28:387–400.
79 Magnuson B, Peppard A, Auer Flomenhoft
D: Hypocaloric considerations in patients
with potentially hypometabolic disease
states. Nutr Clin Pract 2011;26:253–260.
80 Rigaud D, Boulier A, Tallonneau I, Brindisi
MC, Rozen R: Body fluid retention and body
weight change in anorexia nervosa patients
during refeeding. Clin Nutr 2010;29:749–
755.
81 Kyle UG, Chalandon Y, Miralbell R, Karsegard
VL, Hans D, Trombetti A, Rizzoli R,
Helg C, Pichard C: Longitudinal follow-up of
body composition in hematopoietic stem cell
transplant patients. Bone Marrow Transplant
2005;35:1171–1177.
82 Pison CM, Cano NJ, Cherion C, Caron F,
Court-Fortune I, Antonini M, GonzalezBermejo
J, Meziane L, Molano LC, Janssens
JP, Costes F, Wuyam B, Similowski T, Melloni
B, Hayot M, Augustin J, Tardif C,
Lejeune H, Roth H, Pichard C, the IRAD Investigators:
Multimodal nutritional rehabilitation
improves clinical outcomes of malnourished
patients with chronic respiratory
failure: a controlled randomised trial. Thorax
2011;66:953–960.
83 Pichard C, Kyle U, Chevrolet JC, Jolliet P,
Slosman D, Mensi N, Temler E, Ricou B: Lack
of effects of recombinant growth hormone
on muscle function in patients requiring
prolonged mechanical ventilation: a prospective,
randomized, controlled study. Crit
Care Med 1996;24:403–413.
84 Pichard C, Kyle UG, Jolliet P, Slosman DO,
Rochat T, Nicod L, Romand J, Mensi N,
Chevrolet JC: Treatment of cachexia with recombinant
growth hormone in a patient before
lung transplantation: a case report. Crit
Care Med 1999;27:1639–1642.
85 Leslie WD, Miller N, Rogala L, Bernstein
CN: Body mass and composition affect bone
density in recently diagnosed inflammatory
bowel disease: the Manitoba IBD Cohort
Study. Inflamm Bowel Dis 2009;15:39–46.
86 van der Meij BS, Langius JA, Smit EF,
Spreeuwenberg MD, von Blomberg BM,
Heijboer AC, Paul MA, van Leeuwen PA:
Oral nutritional supplements containing (n-
3) polyunsaturated fatty acids affect the nutritional
status of patients with stage III nonsmall
cell lung cancer during multimodality
treatment. J Nutr 2010;140:1774–1780.
87 Ryan AM, Reynolds JV, Healy L, Byrne M,
Moore J, Brannelly N, McHugh A, McCormack
D, Flood P: Enteral nutrition enriched
with eicosapentaenoic acid (EPA) preserves
lean body mass following esophageal cancer
surgery: results of a double-blinded randomized
controlled trial. Ann Surg 2009;249:
355–363.
88 Ndekha MJ, Oosterhout JJ, Zijlstra EE, Manary
M, Saloojee H, Manary MJ: Supplementary
feeding with either ready-to-use fortified
spread or corn-soy blend in wasted
adults starting antiretroviral therapy in Malawi:
randomised, investigator blinded, controlled
trial. BMJ 2009;338:b1867–b1875.
89 Ha L, Hauge T, Iversen PO: Body composition
in older acute stroke patients after treatment
with individualized, nutritional supplementation
while in hospital. BMC Geriatrics
2010;10:75.
90 Genton L, Karsegard VL, Chevalley T, Kossovsky
MP, Darmon P, Pichard C: Body
composition changes over 9 years in
healthy elderly subjects and impact of physical
activity. Clin Nutr 2011;30:436–442.
91 Reid CL, Murgatroyd PR, Wright A, Menon
DK: Quantification of lean and fat tissue repletion
following critical illness: a case report.
Crit Care 2008;12:R79.
92 Antoun S, Birdsel Ll, Sawyer MB, Venner P,
Escudier B, Baracos VE: Association of skeletal
muscle wasting with treatment with
sorafenib in patients with advanced renal
cell carcinoma: results from a placebo-controlled
study. J Clin Oncol 2010;28:1054–
1060.
93 Prado CM, Antoun S, Sawyer MB, Baracos
VE: Two faces of drug therapy in cancer:
drug-related lean tissue loss and its adverse
consequences to survival and toxicity. Curr
Opin Clin Nutr Metab Care 2011;14:250–
254.
94 Schutz Y, Kyle UG, Pichard C: Fat-free mass
index and fat mass index percentiles in Caucasians
aged 18–98 y. Int J Obes 2002;26:
953–960.
95 Kyle UG, Schutz Y, Dupertuis YM, Pichard
C: Body composition interpretation: contributions
of the fat-free mass index and the
body fat mass index. Nutrition 2003;19:597–
604.
96 Kyle UG, Piccoli A, Pichard C: Body composition
measurements: interpretation finally
made easy for clinical use. Curr Opin Clin
Nutr Metab Care 2003;6:387–393.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Body composition evaluation should be integrated into clinical practice for initial assessment & sequential follow-up of nutritional status. For Answers to any questions you may have please call Dr. Jimenez at 915-850-0900

good health's curator insight, January 15, 2024 9:14 AM

Acquista Online La Prescrizione Di Perdita Di Peso
Crediamo che i farmaci a volte possano essere molto urgenti da assumere. Se hai urgente bisogno di farmaci, possiamo anche fornirti una consegna espressa,


https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/

https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://globalefarmacia.com/Prodotto/acquista-metadone/
https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/


<a href="https://globalefarmacia.com/Prodotto/acquista-ozempic-online/">acquista-ozempic-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-victoza-online/">acquista-victoza-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/">acquista-mounjaro-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-mysimba-online/">acquista-mysimba-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-wegovy-online/">acquista-wegovy-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/">acquistare-saxenda-6mg-ml-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-phentermine-online/">acquista-phentermine-online</a>;
<a href="https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/">ephedrine-hcl-30mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/">acquista-ossicodone-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/">acquista-oxycontin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-percocet-online/">acquista-percocet-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-stilnox-online/">acquista-stilnox-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/">acquista-suboxone-8mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-subutex-online/">acquista-subutex-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-metadone/">acquista-metadone</a>;
<a href="https://globalefarmacia.com/Prodotto/buy-vyvanse-online/">buy-vyvanse-online</a>;
<a href="https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/">a-215-ossicodone-actavis</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/">acquista-adderall-30mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adipex-online/">acquista-adipex-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-adma-online/">acquista-adma-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-ativan-online/">acquista-ativan-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-botox-online/">acquista-botox-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/">acquista-cerotti-al-fentanil</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/">acquista-codeina-linctus-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-codeina-online/">ta-codeina-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-demerol-online/">acquista-demerol-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-depalgo-online/">acquista-depalgo-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-diazepam-online/">acquista-diazepam-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/">acquista-dilaudid-8mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-endocet-online/">acquista-endocet-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/">acquista-eroina-bianca</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/">acquista-l-ritalin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-opana-online/">acquista-opana-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-vicodin-online/">acquista-vicodin-online</a>;
<a href="https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/">acquista-xanax-2mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/">acquistare-rohypnol-2mg</a>;
<a href="https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/">acquistare-sibutramina-online</a>;
<a href="https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/">efedrina-hcl-in-polvere</a>;
<a href="https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/">sciroppo-di-metadone</a>;
<a href="https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/">tramadolo-hcl-200mg</a>;

 


<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/&quot; rel="dofollow">acquista-ozempic-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/&quot; rel="dofollow">acquista-victoza-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/&quot; rel="dofollow">acquista-mounjaro-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/&quot; rel="dofollow">acquista-mysimba-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/&quot; rel="dofollow">acquista-wegovy-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/&quot; rel="dofollow">acquistare-saxenda-6mg-ml-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/&quot; rel="dofollow">acquista-phentermine-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/&quot; rel="dofollow">acquistare-sibutramina-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/&quot; rel="dofollow">ephedrine-hcl-30mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/&quot; rel="dofollow">acquista-adderall-30mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/&quot; rel="dofollow">acquista-adipex-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/&quot; rel="dofollow">acquista-vyvanse-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/&quot; rel="dofollow">acquista-ossicodone-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/&quot; rel="dofollow">acquista-oxycontin-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/&quot; rel="dofollow">acquista-percocet-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/&quot; rel="dofollow">acquista-stilnox-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/&quot; rel="dofollow">acquista-suboxone-8mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/&quot; rel="dofollow">acquista-subutex-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/&quot; rel="dofollow">acquista-metadone</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/&quot; rel="dofollow">acquista-botox-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/&quot; rel="dofollow">acquista-adma-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/&quot; rel="dofollow">a-215-ossicodone-actavis</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/&quot; rel="dofollow">acquista-ativan-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/&quot; rel="dofollow">acquista-cerotti-al-fentanil</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/&quot; rel="dofollow">acquista-codeina-linctus-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/&quot; rel="dofollow">acquista-codeina-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/&quot; rel="dofollow">acquista-demerol-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/&quot; rel="dofollow">acquista-depalgo-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/&quot; rel="dofollow">acquista-diazepam-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/&quot; rel="dofollow">acquista-dilaudid-8mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/&quot; rel="dofollow">acquista-endocet-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/&quot; rel="dofollow">acquista-eroina-bianca</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/&quot; rel="dofollow">acquista-opana-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/&quot; rel="dofollow">acquista-vicodin-online</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/&quot; rel="dofollow">acquista-xanax-2mg</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/&quot; rel="dofollow">efedrina-hcl-in-polvere</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/&quot; rel="dofollow">sciroppo-di-metadone</a>
<a href="https://www.google.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/&quot; rel="dofollow">tramadolo-hcl-200mg</a>

https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/
https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/


<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ozempic-online/&quot; rel="dofollow">acquista-ozempic-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-victoza-online/&quot; rel="dofollow">acquista-victoza-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mounjaro-online/&quot; rel="dofollow">acquista-mounjaro-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-mysimba-online/&quot; rel="dofollow">acquista-mysimba-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-wegovy-online/&quot; rel="dofollow">acquista-wegovy-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-saxenda-6mg-ml-online/&quot; rel="dofollow">acquistare-saxenda-6mg-ml-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-phentermine-online/&quot; rel="dofollow">acquista-phentermine-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-sibutramina-online/&quot; rel="dofollow">acquistare-sibutramina-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/ephedrine-hcl-30mg/&quot; rel="dofollow">ephedrine-hcl-30mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adderall-30mg/&quot; rel="dofollow">acquista-adderall-30mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adipex-online/&quot; rel="dofollow">acquista-adipex-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vyvanse-online/&quot; rel="dofollow">acquista-vyvanse-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ossicodone-online/&quot; rel="dofollow">acquista-ossicodone-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-oxycontin-online/&quot; rel="dofollow">acquista-oxycontin-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-percocet-online/&quot; rel="dofollow">acquista-percocet-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-stilnox-online/&quot; rel="dofollow">acquista-stilnox-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-suboxone-8mg/&quot; rel="dofollow">acquista-suboxone-8mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-subutex-online/&quot; rel="dofollow">acquista-subutex-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-metadone/&quot; rel="dofollow">acquista-metadone</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-botox-online/&quot; rel="dofollow">acquista-botox-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquistare-rohypnol-2mg/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-l-ritalin-online/&quot; rel="dofollow">acquistare-rohypnol-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-adma-online/&quot; rel="dofollow">acquista-adma-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/a-215-ossicodone-actavis/&quot; rel="dofollow">a-215-ossicodone-actavis</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-ativan-online/&quot; rel="dofollow">acquista-ativan-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-cerotti-al-fentanil/&quot; rel="dofollow">acquista-cerotti-al-fentanil</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-linctus-online/&quot; rel="dofollow">acquista-codeina-linctus-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-codeina-online/&quot; rel="dofollow">acquista-codeina-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-demerol-online/&quot; rel="dofollow">acquista-demerol-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-depalgo-online/&quot; rel="dofollow">acquista-depalgo-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-diazepam-online/&quot; rel="dofollow">acquista-diazepam-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-dilaudid-8mg/&quot; rel="dofollow">acquista-dilaudid-8mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-endocet-online/&quot; rel="dofollow">acquista-endocet-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-eroina-bianca/&quot; rel="dofollow">acquista-eroina-bianca</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-opana-online/&quot; rel="dofollow">acquista-opana-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-vicodin-online/&quot; rel="dofollow">acquista-vicodin-online</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/acquista-xanax-2mg/&quot; rel="dofollow">acquista-xanax-2mg</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/efedrina-hcl-in-polvere/&quot; rel="dofollow">efedrina-hcl-in-polvere</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/sciroppo-di-metadone/&quot; rel="dofollow">sciroppo-di-metadone</a>
<a href="https://www.bing.it/url?q=https://globalefarmacia.com/Prodotto/tramadolo-hcl-200mg/&quot; rel="dofollow">tramadolo-hcl-200mg</a>

Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
August 24, 2017 5:54 PM
Scoop.it!

10 Common Ketogenic Diet Mistakes for Athletes | Advanced Fitness | Call: 915-850-0900

10 Common Ketogenic Diet Mistakes for Athletes | Advanced Fitness | Call: 915-850-0900 | Diet and Supplements | Scoop.it

In this guide, author, triathlete, and ketogenic expert extraordinaire Patricia Daly explains how to do things the ideal way. Patricia just finished writing an amazing publication called “Practical Keto Meal Plans For Endurance Athletes: Tips, Tricks And How To’s For Optimizing Performance Using A High Fat, Low Carb Meal Plan”, and she has a wealth of information on this topic. So in this article, you’re going to get the top 10 mistakes low-carb athletes make.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Since ketones are a preferred fuel for the heart and the diaphragm, and because a state of ketosis may provide extreme focus and cognitive performance during difficult mental activities, a ketogenic diet can be extremely useful for endurance athletes. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
August 21, 2017 4:15 PM
Scoop.it!

What is a Ketogenic Diet? | El Paso Chiropractor | El Paso Chiropractor | Call: 915-850-0900

What is a Ketogenic Diet? | El Paso Chiropractor | El Paso Chiropractor | Call: 915-850-0900 | Diet and Supplements | Scoop.it

A ketogenic diet is comparable to other rigorous low-carb diets, like the Atkins diet plan or LCHF (low carb, higher fat). These diets wind up being ketogenic more or less by accident. The main difference between LCHF and keto is that protein is restricted in the latter.

 

A keto diet plan is made specifically to lead to ketosis. It’s possible to measure and adapt to achieve optimal ketone amounts for wellness or for bodily and psychological performance. Below, you can learn how to use keto to achieve your personal goals.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

A ketogenic diet, or keto diet, is a diet, which turns your system into a fat-burning machine. It has some initial side effects towards health and functionality, as well as many advantages for weight loss. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.
Scooped by Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP
August 16, 2017 5:14 PM
Scoop.it!

Intermittent Fasting: When and What to Eat | El Paso Specialist | Call: 915-850-0900

Intermittent Fasting: When and What to Eat | El Paso Specialist | Call: 915-850-0900 | Diet and Supplements | Scoop.it

For the majority of individuals, fasting all day and then having a good evening meal is the best strategy for a fast day. A small calorie allowance on fast times is of 500-600 calories. A single 500 calorie meal can be very substantial, but you may be able to possess mini-meals if you try to spread the calories more than dinner, lunch and breakfast.

 

Most men and women find that eating just a small amount only cures the hunger pangs for a brief time and actually makes them hungrier for the rest of the day, therefore it is generally best to avoid snacking on fast days and spare your calories until you can have a full healthy meal.

 

In addition to being easier for many people, waiting to eat before is also more effective for weight loss, as you will have fasted for longer. A survey inquired into the factors that influence weight loss on the 5:2 diet has proven this. The analysis of our survey questionnaire discovered that fasting for over 20 hours on a fast day led to a greater weight loss than fasting for less than 16 hours. There are lots of possible scientific explanations for why this could be.

Dr. Alex Jimenez DC, APRN, FNP, IFMCP, CFMP's insight:

Intermittent fasting is an eating pattern where people cycle between periods of eating and fasting. While there are a variety of fasting schedules and methods, these don't often cover what and when you can eat while not fasting. The following can be helpful food options for IF. For more information, please feel free to ask Dr. Jimenez or contact us at (915) 850-0900.

No comment yet.